Journals

Call for Papers for Collections on Dove Medical Press

Authors are invited to browse Collections that are currently open for submissions – click on the title of the Collection to learn how you can contribute your own research. These Collections focus on specific topics of interest and importance to the research community.

    Biologics: Targets and Therapy

    Biosimilars, Biobetters, and Bioparallels

    Dove Medical Press is pleased to invite you to the upcoming Article Collection “Biosimilars, Biobetters, and Bioparallels” led by Professor Ivo Abraham, Ms. Ansam Beddor, Dr. Nimer Alkhatib, and Dr. Karen MacDonald in Biologics: Targets and Therapy.

    Looking back on almost three decades of biosimilars and despite their difficult start in Europe in 2015, biosimilars are solidly embedded in patient care and have become a mainstay in human therapeutics – at least in high income countries. Being equivalent in efficacy/effectiveness, safety and (mainly) priced lower than the originators they reference, biosimilars enable savings, expanded patient access, and greater patient equity. 

    Furthermore, two recent developments have broadened the “later-in-class” biologics space beyond biosimilars. In October 2023, the United States Food and Drug Administration (FDA) approved Zymfentra, a subcutaneous (SC) formulation of Inflectra, an intravenous (IV) biosimilar referencing infliximab (Remicade). Rather peculiar but this SC formulation is approved in other jurisdictions as a biosimilar – along with its IV formulation – but in the US as a biological. Zymfentra is increasingly being referred to as a biobetter, in this case of a biosimilar (Inflectra) of originator infliximab (Remicade). Additional biobetters are on the horizon – as novel agents of biosimilar candidates that failed the upper bound of the equivalence margin. 

    That same month, the FDA also approved toripalimab (Loqtorzi), the first Chinese PD-1 inhibitor based exclusively on Chinese clinical trials: not a biosimilar and neither a biobetter, but a bioparallel. It is a new biological molecule without the ambition of being an early-in-class innovator but instead a “later-in-class” entry, analogous (but not similar) in efficacy and safety, competing on price. There are more are on the horizon as well. 

    While there can be clear benefits for adopting biosimilars, biobetters and bioparallels, many issues remain to be addressed: regulatory pathways; clinical evidence in support of regulatory approval; interchangeability; pricing and competition; commoditization of biological therapy; and the need for global access, especially in low, lower-middle and higher-middle income countries – among many others. 

    To help address these issues, Biologics: Targets and Therapy invites authors to submit Original Research, Reviews, and Commentaries on relating to biosimilars, biobetters and bioparallels. Potential topics include but are not limited to:

    • Clinical studies into the use of biosimilars, biobetters and bioparallels.
    • Bioequivalence studies.
    • Pharmacoeconomic analyses
    • Research relating to the regulation, pricing, re-imbursement and market uptake of biosimilars, biobetters and bioparallels.

    Keywords
    Biosimilars, Biobetters, Bioparallels

    All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31st January 2025. Please note normal Article Processing Charges apply.

    Please submit your manuscript on our website, quoting the promo code ENTUK to indicate that your submission is for consideration in this Article Collection.

    Please contact Marya Baig at [email protected] with any queries and discount codes regarding this Article Collection.

    View all papers in this article collection

    Cancer Radiotherapeutic Targets for Enhanced Radiosensitization and/or Radioprotection Strategies

    Dove Medical Press is pleased to invite you to the upcoming Article Collection “Cancer Radiotherapeutic Targets for Enhanced Radiosensitization and/or Radioprotection Strategies” led by Professor Shuyu Zhang, Professor Shun Lu, and Professor Wenling Tu in Biologics: Targets and Therapy.

    Cancer radiotherapy, a cornerstone in cancer treatment, continually evolves to enhance its efficacy and minimize side effects. This Article Collection delves into the pivotal theme of "Cancer Radiotherapeutic Targets for Enhanced Radiosensitization and/or Radioprotection Strategies." Radiosensitization involves making cancer cells more susceptible to radiation, while radioprotection focuses on safeguarding surrounding healthy tissues. Understanding and manipulating these targets can revolutionize radiotherapy outcomes. From molecular pathways to novel therapeutic agents, this Collection explores the diverse strategies employed to augment the precision and safety of cancer radiotherapy.

    The significance of identifying targets for radiosensitization and radioprotection lies in the potential to optimize cancer treatment outcomes. By deciphering the molecular and cellular intricacies underlying these processes, researchers can fine-tune radiotherapeutic approaches, maximizing effectiveness while minimizing collateral damage. This Collection aspires to contribute to the evolution of personalized and targeted cancer treatments, heralding a new era in which patients experience improved responses and reduced side effects.

    We invite contributions spanning various subjects within cancer radiotherapy. Subtopics include the identification of novel molecular targets, exploration of emerging therapeutic agents, and advancements in technology facilitating precision treatments. Original research articles, reviews, and clinical studies are sought to create a mosaic of insights that align with the journal's commitment to disseminating impactful research in the broader field of oncology. This Collection aims to catalyze discussions and foster collaborations to drive further innovation in the realm of cancer radiotherapy.

    Keywords

    Cancer Radiotherapy, Radiosensitization, Radioprotection, Molecular Targets, Therapeutic Advancements

    All manuscripts submitted to this Article Collection will undergo desk assessment and a full peer-review. Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31st December 2024. Please note normal Article Processing Charges apply.

    Please submit your manuscript on our website, quoting the promo code OZOEM to indicate that your submission is for consideration in this Article Collection.

    Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

    View all papers in this article collection

    Clinical Interventions in Aging

    Nutrition in Aging

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Nutrition in Aging" in Clinical Interventions in Aging.

    A diet rich in nutrients and antioxidants is linked to the prevention of cardiovascular and cardiometabolic diseases, osteoporosis, and diabetes. Early vascular aging is linked to an increased risk of premature mortality related to cardiovascular, metabolic, and renal diseases. Malnutrition is associated with accelerated aging. Furthermore, insufficient intake of nutrients may lead to frailty, anemia, and impaired cognition. With advanced age and concomitant comorbidities, proper nutrition is even more important for supporting healthy aging, and nutrition is a part of secondary and tertiary prevention of different diseases that accompany aging. 

    A healthy lifestyle, which includes physical activity, the maintenance of an optimal weight, smoking cessation, and a healthy diet reduces the risk of subsequent cardiovascular events and mortality. There is more evidence that cardiovascular diseases are marked by vascular aging. Endothelial senescence represents one of the earliest features of arterial aging and contributes to many age-related diseases. Comprehending the pathophysiology of vascular aging, along with its repercussions and potential therapeutic opportunities, presents an advantageous prospect that may translate into effective prevention and the attainment of a cardiovascular disease-free survival over time. Studies demonstrate that the intake of antioxidants and food with anti-inflammatory properties may improve vascular function. Thus, research on the mechanism of nutrition’s impact on overall health, and particularly vascular health, has its significance in healthy aging. 

    This Article Collection invites original research articles and reviews of genetic, metabolic, clinical, and epidemiological studies related to nutrition in aging. Particularly, we are interested in studies presenting mechanisms affected or altered by nutrition and emphasized with aging or influencing aging. Nutritional supplements, functional food, different nutrients and their impact on (cardio)vascular and metabolic health is of interest for the present Collection. However, the Collection is open to other influences of nutrition (e.g., in oncologic disases, malnutrition, etc.) in aging. 

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 30 September 2024. For questions about this Article Collection, including inquiries regarding discounts of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected].

    Please submit your manuscript on our website, quoting the promo code TIUYO to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Ines Drenjančević, Institute and Department of Physiology and Immunology, Faculty of Medicine Osijek University of Osijek, Osijek, Croatia

    [email protected]

    Prof. Ines Drenjančević, MD, PhD is a professor of physiology and immunology at the Faculty of Medicine Osijek, Croatia. She obtained her PhD degree at the Medical College of Wisconsin, Milwaukee, WI, USA. She is a head of the national Scientific Centre of Excellence for Personalized Health Care. Her research interests are: microcirculation, mechanisms of vascular reactivity, impact of diet (such as high salt diet and enriched foodstuff), n-3 PUFAs, renin-angiotensin system, and hyperbaric oxygenation.

    View all papers in this article collection

    Tech for Tomorrow: Advancing Quality of Life for People with Dementia

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Tech for Tomorrow: Advancing Quality of Life for People with Dementia" in Clinical Interventions in Aging.

    Advancements in dementia care technology are becoming increasingly crucial as the global population affected by dementia continues to rise. With millions of individuals worldwide facing the challenges of dementia, there is a pressing need for innovative solutions that can empower individuals, enhance their quality of life, and address their specific needs. 

    Our Article Collection aims to explore the frontier of tomorrow's tech for people with dementia, exploring a range of new advancements. From personalized assistive devices to cutting-edge monitoring systems, these technologies are reshaping how we approach dementia care on a global scale. Concepts such as AI-driven interventions, sensor-based support systems, and virtual reality applications offer promising avenues for improving independence, supporting social connectivity and equity, and overall wellbeing for individuals living with dementia worldwide. 

    The significance of this topic can be understood from several angles. Firstly, innovative technologies have the potential to significantly improve the quality of life for individuals living with dementia by addressing daily challenges, building and maintaining independence, and facilitating meaningful social interactions. Secondly, dementia's social and economic impacts are substantial, affecting individuals, families, healthcare systems, and societies at large. Implementing effective technology solutions may help mitigate these impacts and improve outcomes for everyone involved. 

    Moreover, focusing on global advancements in dementia care technology encourages collaboration, knowledge-sharing, and the development of best practices that can benefit individuals with dementia across different regions and cultural contexts. Additionally, investing in tech-enabled solutions for dementia care is not just about addressing current needs but also about building sustainable systems that can adapt to future challenges and advancements in healthcare technology. 

    This Collection seeks to explore the intersection of technology and dementia care, with a particular emphasis on how innovative solutions can empower individuals, enhance their quality of life, and address their unique needs on a global scale. We invite contributions that align with the journal's scope, focusing on original research, epidemiological studies, reviews, expert opinions, and commentaries related to advancements in technology for dementia care. Topics of interest include, but are not limited to:

    • Co-design studies to develop assistive technology that meets the needs and values of people with dementia and centres lived experience.

    • Therapeutic outcomes of technological interventions in dementia care, including their impact on quality of life, independence, and social connectivity.

    • Neuronal, biological, and other mechanisms underlying the efficacy of technology-based approaches in addressing cognitive and functional deficits, and promoting psychosocial wellbeing in individuals with dementia.

    • Barriers and challenges to the implementation of technology-driven interventions in community-based dementia care settings.

    • Comparative analyses of different technological approaches (e.g., personalized assistive devices, monitoring systems, virtual reality applications) in terms of their success factors related to cognitive functioning and psychosocial wellbeing.

    • Exploration of participant characteristics (e.g., race and ethnicity, gender, prior experience with technology) that influence responses to technology-based interventions in dementia care.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 10 January 2025. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected]

    Please submit your manuscript on our website, quoting the promo code DZZLA to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Dr. Joyce Siette, Western Sydney University

    [email protected]

    Dr. Joyce Siette is a health services researcher whose mission is to contribute to reducing population-wide dementia risk and cognitive impairment through effective and acceptable dementia prevention public health approaches. She leads a program of research to identify how we can best prevent dementia by creating lifestyle changes for older adults using innovative methods. 

    Prof. Celia Harris, Western Sydney University

    [email protected]

    Associate Professor Celia Harris is a cognitive scientist interested in the way that cognition and memory can be scaffolded by the external social, material, and technological environment. Her research aims to create aged care environments that facilitate memory, identity, and meaning making. 

    Prof. Genevieve Z. Steiner-Lim, Western Sydney University

    [email protected]

    Associate Professor Genevieve Z. Steiner-Lim leads a cognitive neuroscience research program spanning the early detection, prevention, and treatment of cognitive decline in older people with the aim of reducing dementia risk and improving quality of life. She combines interdisciplinary research techniques such as clinical trials, neuroimaging, neuropsychology, artificial intelligence, and metabolomics to test novel therapeutics that can provide early intervention for dementia.

    View all papers in this article collection

    Clinical Ophthalmology

    Climate Change and Ophthalmology

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Climate Change and Ophthalmology" in Clinical Ophthalmology.

    Our climate is changing. The science behind this is irrefutable. We live on a planet that we are finely evolved to live on, and changes to our planet's climate therefore threaten us. There is already an increasing research base linking health issues with climate change but less work has been done on the threat to our eyes and visual system from these changes. 

    As climate change creates an increasingly hostile environment our vision becomes increasingly important. If climate change brings more eye disease, visual impairment and blindness then we need to urgently look at ways to mitigate this and at the same time prepare for it. Healthcare systems and eyecare charities need to know the eye diseases that will be most affected by climate change and move resources into those areas. As animal and plant migration occur in response to a changing environment practitioners need to be aware that eye diseases they have never encountered may appear. It is therefore vital that research efforts and academic publications address these issues - hence this special series. 

    Papers are welcomed that deal with any areas related to climate change and eye care. From original research to reviews, all article types are welcome. From treatment trials to healthcare delivery to ideas for new treatments to service delivery to ideas of how society and individuals might adapt to a greater burden of visual impairment and blindness, the whole breadth and depth of ophthalmology and eye care is welcome.

    Guest Advisor

    Dr. Scott Fraser, Editor-in-Chief of Clinical Ophthalmology, Sunderland, UK

    Submission Instructions

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code YCEAX to indicate that your article should be considered for this Collection. Please note that the standard Article Processing Charge will apply.

    The manuscript submission deadline is 1 November 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

     

    View all papers in this article collection

    Clinical, Cosmetic and Investigational Dermatology

    Artificial Intelligence in Dermatology

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection on “Artificial Intelligence in Dermatology” in Clinical, Cosmetic and Investigational Dermatology.

    Artificial Intelligence (AI) is revolutionizing dermatology by offering advanced tools for diagnosis and treatment. By leveraging machine learning algorithms, AI analyzes vast amounts of dermatological data to detect patterns, classify skin conditions, and even predict disease progression. These AI-powered systems can assist dermatologists in making accurate diagnoses, especially in complex cases where human interpretation may fall short. Moreover, AI applications enable personalized treatment plans by considering individual patient characteristics and historical data. With the capability to sift through images, medical records, and research findings rapidly, AI expedites diagnosis timelines, leading to timely interventions and improved patient outcomes. Additionally, AI-driven telemedicine platforms extend dermatological expertise to remote areas, enhancing accessibility to quality care. As AI continues to evolve, its integration into dermatology promises not only enhanced efficiency but also opens avenues for groundbreaking research and innovation in skincare.

    The integration of Artificial Intelligence (AI) in dermatology holds paramount importance for several reasons. Firstly, it enhances diagnostic accuracy and efficiency, reducing the likelihood of misdiagnoses and ensuring appropriate treatment plans. This not only improves patient outcomes but also minimizes unnecessary procedures and treatments, thereby reducing healthcare costs. Secondly, AI facilitates quicker and more widespread access to dermatological expertise, particularly in underserved or remote areas where dermatologists may be scarce. Additionally, AI-driven technologies have the potential to streamline workflows in dermatological practices, freeing up healthcare professionals' time to focus on patient care and complex cases. Furthermore, AI enables the analysis of vast amounts of data, leading to the discovery of new insights, treatments, and predictive models for skin diseases. Ultimately, the incorporation of AI in dermatology represents a significant step towards more efficient, accessible, and personalized healthcare in the field of dermatology.

    Subtopics include but are not limited to:

    • AI-Based Diagnostic Tools
    • Personalized treatment approach
    • Telemedicine and Remote Care
    • Data Analysis and Research Insights

    Preferred Article Types

    • Original Research. Presenting novel findings on AI applications in dermatology.
    • Review. Providing comprehensive overviews of specific AI technologies or applications.
    • Case Study. Offering in-depth analyses of individual cases or clinical experiences with AI in dermatology.
    • This collection aims to contribute to the growing body of literature on AI in dermatology, fostering dialogue among researchers, clinicians, and industry professionals to propel the field forward.

    Keywords

    • Dermatology
    • Artificial Intelligence
    • Teledermatology
    • Personalized treatment
    • Personalized medicine

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 September 2024. Please submit your manuscript on our website, quoting the promo code HTKCX to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Luca Potestio, University of Naples Federico II, Italy

    [email protected]

    Matteo Megna, University of Naples Federico II, Italy

    [email protected]

    Fabrizio Martora, University of Naples Federico II, Italy

    [email protected]

    View all papers in this article collection

    Chronic inflammatory skin diseases: From pathogenesis to treatment

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection on “Chronic inflammatory skin diseases: From pathogenesis to treatment” in Clinical, Cosmetic and Investigational Dermatology.

    Significant progress has been achieved in the last few decades in dermatology, especially regarding chronic inflammatory skin diseases. In recent years, great progress has also been made in understanding the pathogenesis of the most common inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa that has led to the development of selective and targeted innovative therapies. In particular, biological drugs (chimeric, humanized, and fully human monoclonal antibodies), biosimilars, and small molecules have completely revolutionized the treatment of chronic inflammatory skin diseases by opening new avenues for clinicians.

    However, significant research efforts are still needed. New studies are needed to identify biomarkers for each disease, so that clinicians may be able to diagnose and treat chronic inflammatory diseases early and predict responses to treatments so that we can choose the best treatment for each type of patient.

    All article types, including case reports, case series, original research articles, and review articles, are in line with the scope of this Article Collection.

    This Collection welcomes submissions covering a range of related areas of chronic inflammatory skin diseases, including psoriasis, atopic dermatitis, hidradenitis suppurativa, alopecia areata and others.

    Keywords

    • Psoriasis
    • Hidradenitis Suppurativa
    • Atopic dermatitis
    • Alopecia areata
    • Skin inflammatory disease

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31 December 2024. Please submit your manuscript on our website, quoting the promo code TSMRY to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Fabrizio Martora, University of Naples Federico II, Italy

    [email protected]

    Matteo Megna, University of Naples Federico II, Italy

    [email protected]

    Teresa Battista, University of Naples Federico II, Italy

    [email protected]

    View all papers in this article collection

    Hidradenitis Suppurativa: Insights from pathogenesis to treatment

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection on “Hidradenitis Suppurativa: Insights from pathogenesis to treatment” in Clinical, Cosmetic and Investigational Dermatology.

    Hidradenitis suppurativa (HS) is an inflammatory disorder that is characterized by chronic deep-seated nodules, abscesses, fistulae, sinus tracts, and scars in the axilla, inguinal area, submammary folds, and perianal area. This disfiguring condition is accompanied by pain, embarrassment, and a significantly decreased quality of life. Although the mechanism of HS has not been entirely elucidated, lesion formation is believed to center around follicular hyperkeratosis within the pilosebaceous-apocrine unit. Recent research has provided new insight into the role of cytokines in the pathogenesis of HS, helping close some existing knowledge gaps in the development of this condition. Immune cells and keratinocyte-mediated products are widely accepted as key players in HS pathogenesis. Indeed, both pro-inflammatory (e.g., IL-1β, TNF-α, IL-23, and IL-17) and anti-inflammatory cytokines (e.g., IL-10) are found to be increased in HS lesional and perilesional skin.

    The identification of predictive biomarkers of therapeutic response is one of the greatest challenges of modern medicine, particularly in a pathology as HS with a high percentage of therapeutic failures. Although several studies have shown that anti-TNF-α agents clinically reduce the disease activity in HS, the efficacy of these agents is inconstant in some cases. Identifying predictive markers of response is, thus, of strong interest. Several small molecules and biologics are under investigation, for moderate-to-severe HS therapy. With phase III trials ongoing, the anti-IL-17 agents bimekizumab (which blocks IL-17 A and F) and secukinumab (which blocks IL17A) are in the most advanced stage of clinical development showing promising results, based on the extensive evidence of the activation and upregulation of the IL-17 pathway in HS inflammation. Other molecules and biologics are under investigation such as jak inhibitors and IL-23 drugs. New studies are needed to identify biomarkers.

    The Article Collection entitled: “Hidradenitis Suppurativa: Insights from pathogenesis to treatment” aims to bring together the most important recent findings on pathogenesis and treatments for this disease.

    The deadline for submissions is 31 December 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code HWNEN to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Fabrizio Martora, University of Naples

    [email protected]

    Matteo Megna, University of Naples

    [email protected]

    Luca Potestio, University of Naples

    [email protected]

    View all papers in this article collection

    Teledermatology, Inflammatory Skin Disorders and COVID-19: What the Experience Has Taught Us

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection on “Teledermatology, Inflammatory Skin Disorders and COVID-19: What the Experience Has Taught Us” in Clinical, Cosmetic and Investigational Dermatology.

    The COVID-19 pandemic has drastically transformed healthcare delivery, forcing medical professionals to seek innovative ways to provide patient care while minimizing face-to-face interactions. Teledermatology, the remote diagnosis and treatment of skin conditions using telecommunication technologies, has emerged as a valuable tool in dermatology practice during this challenging time. This Article Collection explores the application of teledermatology in the context of inflammatory skin disorders and the lessons learned from the COVID-19 experience.

    Inflammatory skin disorders encompass a wide range of conditions. These diseases often require long-term management and frequent follow-ups, making teledermatology a suitable alternative to traditional in-person visits. With the aid of secure digital platforms, dermatologists can remotely assess skin lesions, evaluate disease severity, and provide treatment recommendations. Patients can upload images of their skin lesions or participate in real-time video consultations, allowing dermatologists to make accurate diagnoses and initiate appropriate therapies. The COVID-19 pandemic has highlighted several key benefits of teledermatology for inflammatory skin disorders. Firstly, it reduces the risk of virus transmission by minimizing physical contact between patients and healthcare providers. This is particularly crucial for patients with chronic skin conditions who are at a higher risk of severe illness from COVID-19. Secondly, teledermatology enhances accessibility to specialized care, especially for individuals residing in remote areas or facing transportation barriers. It enables patients to receive expert advice without the need for long-distance travel, thereby improving healthcare equity.

    However, the use of teledermatology in inflammatory skin disorders also comes with certain limitations. To address these limitations, dermatologists have adapted their practices and developed strategies for optimizing teledermatology services. Globally, the experience gained during the COVID-19 pandemic has emphasized the importance of incorporating teledermatology into routine dermatology practice beyond the crisis. Teledermatology has demonstrated its value in triaging patients, improving access to care, and facilitating timely interventions. It has the potential to reduce healthcare costs, decrease patient waiting times, and enhance overall patient satisfaction. Moving forward, efforts should be made to establish guidelines and policies to ensure the ethical practice of teledermatology while maintaining patient privacy and data security. In conclusion, the COVID-19 pandemic has accelerated the adoption of teledermatology in managing inflammatory skin disorders.

    While there are certain limitations associated with remote consultations, the experience gained during the pandemic has taught us that teledermatology is a valuable tool for providing accessible and efficient care.

    The deadline for submissions is 31 December 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code ZOMSS to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Luca Potestio, University of Naples

    [email protected]

    Matteo Megna, University of Naples 

    [email protected]

    Angelo Ruggiero, University of Naples 

    [email protected]

    Fabrizio Martora, University of Naples 

    [email protected]

    View all papers in this article collection

    ClinicoEconomics and Outcomes Research

    Demographic Changes and Health Inequality in Developing Countries

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Demographic Changes and Health Inequality in Developing Countries", organized by Guest Advisor Prof. Qihui Chen in ClinicoEconomics and Outcomes Research

    At least since World War II, structural changes in the population, including those in age structures, fertility rates, sex ratio, marital status, and migration patterns, have been undergoing in many developing countries, which have had profound impacts on the formation of human capital and the development of education, food, health, and welfare systems. Since these changes affect how resources may be allocated to different segments of the population, they will ultimately impact the distribution of individual well-being, health-related outcomes included. Uncertainties introduced by recurring natural disasters, geo-political conflicts, disease outbreaks, and related policies add another layer of complexity to the relationship between demographic changes and health inequality. 

    Understanding the demographic change-health inequality relationship is undoubtedly of policy relevance. Take population aging, for example. With proper inventions, aging tends to create health disparities between older and younger adults. Compared with younger adults, older adults face declines in somatic function and cognitive ability and are more vulnerable to chronic diseases; they need more healthcare but usually lack a stable income to finance this need. The recent COVID-19 pandemic brings about new challenges to older adults. Problems such as reduced access to healthcare, limited food supply, and separation from family members due to safety concerns and travel restrictions are likely to impact older adults more seriously than younger adults, widening existing health gaps between the two groups. Similarly, health disparities may exist between other population segments and along other dimensions. As such, advancements in knowledge about the health challenges faced by different subpopulations introduced by demographic changes, the strategies adopted by different entities to cope with these challenges, as well as the roles of families, private organizations, and public policy, are necessary for informing healthcare policy. 

    This call for a collection of articles provides a forum for scholarly discussions on how demographic changes affect health behavior and outcomes for different subpopulations in developing countries, the roles of and interactions between different entities, and the effectiveness of related policies. Research articles and in-depth reviews examining these issues, especially those combining rigorous empirical analysis and clear policy implications, are welcome for this article collection. 

    Keywords

    1. Demographic changes

    2. Population policy

    3. Health behavior and outcomes

    4. Health inequality

    5. Health policy

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    Please submit your manuscript on our website, quoting the promo code EDKUO to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 31 August 2024.

    Guest Advisor

    Professor Qihui Chen, College of Economics and Management, China Agricultural University, China 

    [email protected]

    Dr. Qihui Chen is a professor in the Center for Food and Health Economic Research at China Agricultural University. He received his Ph.D. degree in Applied Economics from the University of Minnesota in 2012. Dr. Chen’s research focuses on applying causal inference methods to study education and health issues in developing countries, such as how population policies affect child education and health, how retirement policy affects older adults’ nutrition intake and health, and how health information (e.g., disease diagnoses) affect patients’ health behavior. He has served as a consultant for the World Bank Groups for many years since 2011.

    View all papers in this article collection

    Diabetes, Metabolic Syndrome and Obesity

    Managing obesity with pharmacotherapy

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Managing obesity with pharmacotherapy" in Diabetes, Metabolic Syndrome and Obesity.

    Obesity is a chronic, relapsing, progressive disease causing or negatively impacting numerous medical conditions, including diabetes mellitus, cardiovascular disease, and some types of cancer. The foundation of its treatment is lifestyle modification. However, for many people with obesity, these changes are difficult to achieve and to maintain long-term. For this reason, great efforts have been made to develop effective drugs weight-reducing drugs.

    In the past, pharmacotherapy for obesity produced discouragingly modest weight loss on the whole, and several drugs had to be withdrawn from the market due to unacceptably severe side effects. However, the future of obesity pharmacotherapy looks promising. Glucagon-like peptide-1 (GLP-1) receptor agonists have shown promise in promoting sustained and healthy weight loss in patients with obesity with or without type 2 diabetes. Furthermore, drug combinations that target multiple complementary pathways influencing food intake have the potential to promote more significant weight loss.

    However, several questions need to be addressed. The long-term effectiveness and tolerability of new weight loss drugs have not been fully determined, and many more data are needed on their clinical efficacy on cardiovascular disease and type 2 diabetes prevention, as well as real-word effectiveness. More research is also needed to understand better their mechanisms of action, which patients can benefit most from their use, and when and how these drugs should be combined with lifestyle modifications. It is also crucial to know their long-term effect on the specific subpopulations of obesity patients, such as adolescents, those with binge-eating disorder and their effectiveness before and after bariatric surgery.

    The goal of this Article Collection is to solicit the contribution and submission of any article in the area of pharmacological treatment of obesity, including preclinical studies, clinical trials, and reviews.

    Potential topics include but are not limited to the following:
    • Combination of pharmacotherapy with lifestyle modification for the management of obesity
    • Pharmacotherapy for obesity and bariatric surgery
    • Pharmacotherapy for obesity in binge-eating disorders
    • Pharmacotherapy for obesity in adolescents
    • Pharmacotherapy for obesity and cardiovascular diseases
    • Pharmacotherapy of obesity and type 2 diabetes management
    • Mechanisms of action of medications for obesity
    • Safety of pharmacotherapy for obesity

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 1 October 2024.

    Please submit your manuscript on our website, quoting the promo code JTCZR to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Riccardo Dalle Grave, Villa Garda Hospital, Italy

    [email protected]

    Dr. Riccardo Dalle Grave is director of the Department of Eating and Weight Disorders at Villa Garda Hospital (Garda, VR, Italy). In this department, he developed an intensive rehabilitative treatment for severe and disabling obesity and eating disorders both for adults and adolescents based on cognitive behavior therapy. He is the author of 178 peer review articles (Scopus h-index, 40), several book chapters, and books, on the treatment of obesity and eating disorders.

    Giulio Marchesini, “Alma Mater” University, Italy

    [email protected]

    Prof. Giulio Marchesini is former Professor of Clinical Dietetics, “Alma Mater” University. After retirement from clinical duties, he maintained a research contract and chairs several research programs inside the IRCCS Azienda Ospedaliera di Bologna. Specifically involved in studies in the area of obesity, diabetes and non-alcoholic fatty liver disease, he wrote over 500 peer-reviewed papers (Scopus h-index, 87), with over 50k citations.

    Conflict of Interest: In accordance with Taylor & Francis policy and my ethical obligation as a researcher, I am reporting that I received funding from Eli Lilly for a lecture, a company that may be affected by the research reported in the enclosed paper. I have disclosed those interests fully to Taylor & Francis, and I have in place an approved plan for managing any potential conflicts arising from that involvement. I will not handle the paper and I will not be involved in the peer-review process.

    View all papers in this article collection

    Drug Design, Development and Therapy

    Advances in design and development of ophthalmic drugs

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advances in design and development of ophthalmic drugs", organized by Guest Advisors Dr. Georgios D. Panos in Drug Design, Development and Therapy.

    This Article Collection will focus on the latest advances in drug design and development for the treatment of various ophthalmic diseases and conditions.

    Ophthalmic diseases, including glaucoma, age-related macular degeneration, diabetic retinopathy, and dry eye disease, are a significant public health concern, affecting millions of people worldwide. Despite the increasing availability of some effective treatments, there is still an unmet need for safe and even more effective drugs that can treat these conditions.

    This Article Collection will bring together leading researchers and clinicians in the field to present their latest research on the design and development of ophthalmic drugs. Topics that will be covered in this special issue include but are not limited to:

    - New drug delivery systems for ophthalmic drugs
    - Advances in small molecule drug design and development for ophthalmic conditions
    - Nanotechnology-based approaches for ocular drug delivery
    - Pharmacokinetics and pharmacodynamics of ophthalmic drugs
    - Design and development of sustained-release ophthalmic drug delivery systems
    - Gene Therapy and novel biological therapies for the treatment of ocular diseases

    We welcome submissions of original research articles and review articles that address any aspect of drug design and development for ophthalmic diseases. All submitted manuscripts will undergo a rigorous peer-review process to ensure the highest quality of the published papers.

    This Article Collection will provide a valuable resource for researchers, clinicians, and pharmaceutical companies working in the field of ophthalmic drug design and development and will further advance the understanding of the current state of the art in ophthalmic drug research and help pave the way for the development of safe and effective treatments for ophthalmic diseases.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 July 2024.

    Please submit your manuscript on our website, quoting the promo code HMYJF to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Using Innovative Drug Delivery Systems to Improve the Efficacy and Applicability of Poorly Water-soluble Drugs" in Drug Design, Development and Therapy.

    Failure of the conventional delivery of poorly water-soluble drugs could be attributed to their low solubility and hence their limited bioavailability that hinder their pharmacological applications.

    The improvement of drug solubility is of a critical concern in boosting the dissolution rate and bioavailability. Recently, different techniques have been used to increase the solubility and bioavailability of poorly water-soluble drugs.

    Using novel drug delivery systems and nano-based drug delivery systems can improve their solubility. Moreover, many of these systems act as drug reservoirs that also improve the drug permeability and stability. Accordingly, these delivery systems are important in improving the efficacy and applicability of poorly water-soluble drugs.

    Topics that will be covered in this Article Collection include but are not limited to:

    • Novel drug delivery systems such as microemulsions, inclusion complexes, solid dispersions, cocrystals.
    • Nano-based drug delivery systems like nanosuspensions, liposomes, niosomes, proniosomes, transfersomes, etc.
    • Techniques to increase the solubility and bioavailability of poorly water-soluble drugs.

    We welcome submissions of original research articles and review articles that address any aspect of design and development of innovative drug delivery systems to improve the efficacy and applicability of poorly water-soluble drugs. All submitted manuscripts will undergo a rigorous peer-review process to ensure the highest quality of the published papers.

    The deadline for submissions is 5 July 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code KBOSG to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Eman A. Mazyed, Department of pharmaceutical technology, Faculty of pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt

    [email protected]

    Kariman M. AbouElhassan, Department of Pharmaceutics, Faculty of Pharmacy, South Valley University, Qena, Egypt

    [email protected]

    View all papers in this article collection

    Eye and Brain

    Neurodegenerative diseases: link between eye and brain

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on "Neurodegenerative diseases: link between eye and brain” in our journal Eye and Brain. This Thematic Series is Guest Edited by Aroucha Vickers, D.O. Founder & Chair, Neuro-Ophthalmology Department, Las Vegas Neurology Center, USA and Andrew G. Lee, MD, Herb and Jean Lyman Centennial Chair in Ophthalmology, Professor of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medicine, USA.

    Upon submission, please use the promo code PQYDF for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series of " Neurodegenerative diseases: Link between eye and brain”. The deadline for manuscripts is 31 May 2024.

    For any enquiries, please email Vicky Ship, Commissioning Editor at [email protected]

    About the Thematic Series

    Neurodegenerative diseases affect millions of individuals worldwide. These conditions can lead to progressive degeneration of the central and peripheral nervous system, and a link between the eye and the brain has long been postulated. The eye in particular has been implicated in neurodegenerative disease in a variety of ways. Here we aim to characterize the effect of neurodegenerative disease on the eye, investigate potential biomarkers that may help predict early detection, and assist with the management and prognosis of neurodegenerative disorders.

    Dr Vickers and Professor Lee are seeking original research, and review article submissions on the following topics:

    • Alzheimer dementia and the eye
    • Parkinson disease and the eye
    • Lewy body dementia and the eye
    • Progressive supranuclear palsy and the eye
    • Multiple system atrophy and the eye
    • Chronic traumatic encephalopathy and the eye
    • Amyloid angiopathy and the eye

    Submit your manuscript

    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    Transcription Factors in Eye Development and Disease

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Transcription Factors in Eye Development and Disease" in Eye and Brain.

    In the human and mouse genomes there are more than 1800 DNA-binding transcription factors. At least 1000 genes are required for the normal development of the eye. It is now established that several transcription factors are of crucial importance for the normal development of specific retinal cells and functions. 

    However, less is known about the role of these transcription factors in eye diseases affecting the retina, the cornea, and other parts of the eye. There is an increasing literature on the consequences of mutations in transcription factors involved in eye development in both mouse models and in human eye diseases. Still, there are many issues concerning the clinical and biological implications of these mutations that are unresolved. 

    This Article Collection is intended to be a platform for experts in transcription factors involved in eye development to address the role of these genes in both the normal function of the eye and in eye diseases using the available methods. 

    We welcome original research articles, reviews, expert opinions, and commentaries.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor will not be handling the manuscripts. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code AZQOC to indicate that your submission is for consideration in this Article Collection. 

    The deadline for submitting a manuscript is 1 September 2024. If you have questions, please contact Krista Thom at [email protected].

    Guest Advisors

    Thor Eysteinsson, Full Professor of Physiology, University of Iceland 

    Andrea Garcia-Llorca, Postdoctoral Fellow, University of Iceland

    View all papers in this article collection

    ImmunoTargets and Therapy

    Autoimmune Disease

    Immunotargets and Therapy is pleased to invite you to submit your research to its latest Article Collection on "Autoimmune Disease.” The Collection, led by Editor-In-Chief Professor Michael Shurin, welcomes relevant Reviews, Original Research and Editorials up until the 31st December 2024. The Collection promises to be a valuable resource for years to come, with articles published alongside some of our finest hot-topic reviews.

    Please submit your manuscript on our website, using the promo code ZFWRR for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Autoimmune Diseases” Collection.

    Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

    While the call is open to receive manuscripts across the broad spectrum of autoimmune diseases, the Editors are particularly interested in manuscripts relating to these key areas:

    • Natural Autoantibodies
    • Autoimmune disorders: New epidemiological data
    • Pathophysiology of autoimmune diseases
    • Novel diagnostic and therapeutic approaches for autoimmune disorders
    • Therapeutic targeting of autoantibodies
    • Clinical utilization of autoantibodies
    • Regulatory immune cells for the treatment of autoimmune diseases
    • Autoantigenomics
    • AI in autoimmunity

    View all papers in this article collection

    Molecular and Cellular Mechanisms of Hypersensitivity

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Molecular and Cellular Mechanisms of Hypersensitivity" in ImmunoTargets and Therapy.

    Hypersensitivity refers to abnormal or exaggerated immune responses against an antigen or allergen. There are several types of hypersensitivity, each classified by the types of antigens and immune responses involved. Allergic disease alone affects more than one billion people worldwide, and its prevalence is anticipated to reach up to 4 billion in the 2050s. The avoidable indirect costs of failure to treat allergy in the EU alone are estimated to range between 55 and 151 billion Euros per annum.

    Given the global importance of understanding and managing hypersensitivity reactions, ImmunoTargets and Therapy is publishing a timely Article Collection focusing on the molecular and cellular mechanisms of hypersensitivity reactions. The Collection promises to be a valuable resource for years to come, with articles published alongside some of our finest hot-topic reviews.

    While the call is open to receive manuscripts across the broad spectrum of hypersensitivity mechanisms, the Editors are particularly interested in manuscripts relating to the following areas:

    · Key mediators and regulators in immediate and delayed hypersensitivity

    · IgE-dependent and IgE-independent mechanisms in the development of allergic hypersensitivities

    · Metabolic events of acute and chronic T-cell-driven inflammatory immune responses

    · Complement-mediated immune mechanisms in hypersensitivity

    · Biomarkers associated with hypersensitivity reactions

    · Pathogenesis of immune complex-mediated diseases

    The Collection Editors welcome relevant Reviews, Original Research and Editorials up until the 31st January 2025. The Collection promises to be a valuable resource for years to come, with articles published alongside some of our finest hot-topic reviews.

    Please submit your manuscript via our website. Upon submission, please use the promo code JDTBX for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the “Molecular and Cellular Mechanisms of Hypersensitivity” Collection.

    Keywords

    Hypersensitivity, Immediate and Delayed Hypersensitivity

    View all papers in this article collection

    Oral Vaccines for Infectious and or Non-Infectious Diseases

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Oral Vaccines for Infectious and or Non-Infectious Diseases" in ImmunoTargets and Therapy.

    Vaccines are biological formulations of antigenic material(s) and excipients capable of inducing protection against one or more infectious or malignant diseases of interest. Next to safe drinking water, vaccines have remained the cornerstone of public health interest as they remain the most cost-effective way to prevent infectious and malignant diseases. Vaccines are most commonly administered by needle injections and only a few are administered through the oral or the nasal routes. Oral vaccines are more advantageous than injection-based vaccines for a number of reasons: including increased safety, ease of administration and compliance, and simpler manufacture and delivery. Additionally, the oral route allows for the development of cellular and humoral immune responses at mucosal and systemic locations to provide a more extensive and long-lasting immunity. Convenient for all ages, oral vaccines can offer immunity against varieties of infectious diseases. 

    Edible vaccines, also referred to as food vaccines, plant-based vaccines, or green vaccines, are a group of newly emerging oral vaccines and may later become possible alternatives to cold-chain vaccines, especially for developing countries. The concept of using edible tissues of genetically engineered crops as a manufacturing and delivery system for biologics was first introduced in the early 1990s by Dr. Charles Arntzen and his associates. This plant-based vaccine can be developed against both communicable and non-communicable diseases and can be taken either by eating the edible part of the transgenic crop or by oral administration of the refined protein extract. 

    It is essential to invest more research efforts into developing stable oral vaccines as a delivery route. Furthermore, oral vaccines which are grown in antigen-producing plants will eliminate the need for transportation and cold chains, and will overcome the challenges of inaccessibility to vaccines in many rural communities of developing countries. More scientific studies are needed in various aspects of oral vaccine to tackle myriads of human and veterinary diseases. 

    We welcome papers covering In silico studies relating to any aspects of epitope identification and oral vaccine design: Immunology and immunological aspects of oral vaccines; Animal models of diseases (communicable and non-communicable) being experimented upon with any form of oral vaccine; Oral and edible vaccines; Implementation Science and management; Oral vaccines for animal and human diseases; and other aspects of oral vaccines. Original research, Commentaries, Letters to the Editor, and Reviews are welcome.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript. 

    Please submit your manuscript on our website, quoting the promo code XYTAJ to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 1 October 2024.

    Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

    Guest Advisors

    Angus Nnamdi Oli, Nnamdi Azikiwe University

    [email protected]

    Dr. Oli, a trained Pharmacist, is a Reader at Nnamdi Azikiwe University, Awka, Nigeria with expertise in Vaccinology, Immunology, Pharmaceutical Microbiology Quality Assurance and Infectious Disease Researches. He is listed among the first 500 scholars in Nigeria by Scopus for the years 2022 and 2023. He has undergone several trainings including Massive Open Online Courses (MOOC) on Implementation Research (IR) with a focus on Infectious Diseases of Poverty (IDP) organised by African Regional Training Centre, University of Ghana School of Public Health and the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR).

    Adekunle Rowaiye, National Biotechnology Development Agency

    [email protected]

    Dr. Rowaiye is a Veterinarian and Pharmaceutical Biotechnologist. His research interest is in the discovery, design, and evaluation of drug candidates which include small molecules, natural products, peptides, and proteins. Dr Rowaiye has several publications in international journals and he is presently working on the discovery of drug candidates that will retard the aging process and prevent neurodegenerative diseases.

    View all papers in this article collection

    The Role of Natural Killer Cells in Disease

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Role of Natural Killer Cells in Disease" in ImmunoTargets and Therapy.

    Natural killer (NK) cells were first identified by Dr. Ronald B. Herberman, who unfortunately passed away several years ago. Since their first identification, it was clear that these cells expressed anti-tumor activity and were initially named natural cytotoxicity (NC) cells, and later as NK cells. Although they respond to danger whilst circulating in the peripheral blood, they can rapidly migrate into sites of immune reactions in peripheral tissues. It is also apparent that whilst responsible for killing tumor cells, they additionally display an immunoregulatory function. Consequently, they react to microbes, particularly virally-infected cells, as well as protecting the immune system by depleting unwanted antigen-presenting cells - which can sometimes be detrimental due to provoking autoimmunity.

    Although the therapeutic potentials of NK cells in cancer and to some extent in autoimmune diseases are well established, these cells also play important roles in other diseases which will constitute an important aspect of this Article Collection. This Article Collection aims to explore the involvement and/or therapeutic potentials of NK cells in various diseases. Reviews and original articles from worldwide experts dealing with the role of NK cells in any of the below mentioned fields are highly encouraged to submit their valuable work.

    1. Cancers
    2. Autoimmune diseases
    3. Neurodegenerative diseases
    4. Stroke and heart diseases
    5. Virus infection, including COVID
    6. Other microbial infections
    7. Pulmonary diseases
    8. Gastrointestinal diseases
    9. Musculoskeletal diseases
    10. Hematological disorders
    11. Skin diseases

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code HUAAS to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 1 October 2024.

    Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

    Guest advisors

    Dr. Azzam A. Maghazachi, Research Department, ImmunoProfiling and Boosting, Oslo, Norway

    [email protected]

    Dr. Azzam A Maghazachi received a masters degree from New York University Medical School (USA), and a PhD degree in Immunology from the University of Manitoba Medical School (Canada). He completed post-doctoral fellowships at NYU Medical School (USA) and then worked under the supervision of the late Dr. Ronald B. Herberman at the Pittsburgh Cancer Institute. Between 1988-2007, he held several senior positions in various institutes and universities in the USA, Canada and Norway. He was a Professor of Physiology in the faculty of Medicine at the University of Oslo, Norway, and later a professor of Immunology in the college of Medicine, University of Sharjah. Dr. Maghazachi research interests include cancer immunology, autoimmune diseases, chemokines, and drug mechanisms of action. Dr. Maghazachi is an editor or editor-in-chief for more than 10 scientific journals in the fields of Immunology, Oncology and Neuroscience. He has published more than 120 scientific papers as well as book chapters and ebooks.

    View all papers in this article collection

    Integrated Pharmacy Research and Practice

    Telepharmacy Innovations: The Great Opportunity for Advancing Healthcare in the Digital Age

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Telepharmacy Innovations: The Great Opportunity for Advancing Healthcare in the Digital Age" in Integrated Pharmacy Research and Practice.

    Telepharmacy, an innovative branch of pharmacy that uses technology to provide services remotely, has emerged as a crucial response to changing healthcare needs in the digital age. Its importance lies in its ability to overcome geographic barriers and increase patient access to quality pharmaceutical services. As the world faces challenges such as the COVID-19 pandemic, telepharmacy has become a valuable resource for ensuring continuity of care and reducing the risk of exposure to the virus in healthcare settings. 

    However, despite its growth and acceptance, telepharmacy remains an evolving field that requires continued research. Research is critical to better understand how to maximize its effectiveness, ensure patient safety, and address ethical and legal issues. In the future, potential lines of research could focus on improving communication technologies, integrating effectively with other healthcare professionals, identifying appropriate reimbursement models, and exploring how telepharmacy can be used in primary and specialty care settings. 

    The new concept and model of pharmaceutical care presents telepharmacy as a great opportunity for permanent and real-time contact with the patient. 

    Potential subtopics:

    • Clinical Effectiveness Evaluation: Investigate the efficacy and safety of telepharmacy services compared to traditional pharmaceutical care in a variety of medical conditions. This could include collecting data on clinical outcomes, compliance rates, and patient satisfaction.
    • Technology Integration: Study how the incorporation of emerging technologies, such as artificial intelligence and machine learning, can improve pharmaceutical decision making, drug-drug interaction identification, and treatment personalization.
    • Data Security and Patient Privacy: Investigate advanced data security methods to protect patient privacy and ensure the integrity of health information transmitted through telepharmacy platforms.
    • Reimbursement Models and Economic Sustainability: Explore sustainable reimbursement models for telepharmacy that incentivize the delivery of high-quality services and encourage pharmacist involvement in healthcare.
    • Pharmacist Education and Training: Investigate how effective training can be provided to pharmacists to acquire the skills needed in the telepharmacy environment and keep up with technological advances.
    • Access and Equity: Examine how telepharmacy can address disparities in access to pharmaceutical care, especially in rural and underserved areas.
    • Multidisciplinary Integration: Investigate how more effective collaboration between pharmacists and other healthcare professionals can be achieved through telepharmacy for comprehensive patient care.
    • Patient Experience: Study patient satisfaction and preferences in the use of telepharmacy and how to improve the overall patient experience.
    • Regulation and Standards: Investigate how regulations and standards are evolving in response to the growth of telepharmacy and how they can be adapted to ensure patient safety and quality of care.
    • Cost and Societal Benefit Assessment: Conduct cost-benefit analyses to determine the financial and societal impact of telepharmacy on the healthcare system as a whole.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is August 31st 2024.

    Please submit your manuscript on our website, quoting the promo code KAIKS to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Ramón Alejandro Morillo Verdugo, Associate Professor, Hospital Pharmacy, University of Seville, AGS Sevilla Sur, Hospital de Valme

    [email protected]

    Dr. Ramón Alejandro Morillo Verdugo has worked at Hospital Pharmacy Seville since 2006. He has been an Associate Professor at University of Seville since 2011. He is also the Spanish national coordinator of the “MAPEX Project” from SEFH since 2014.

    View all papers in this article collection

    International Journal of Chronic Obstructive Pulmonary Disease

    Current insights and future trends for inhalation therapy in chronic obstructive respiratory disease

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Current insights and future trends for inhalation therapy in chronic obstructive respiratory disease" in the International Journal of Chronic Obstructive Pulmonary Disease.

    Current respiratory inhalers used by individuals with chronic obstructive pulmonary disease (COPD) and/or asthma have been in use since the 1950s, though the practice of using an inhaler device to deliver therapeutic aerosols as a treatment has existed for a thousand years or longer. Having an aerosol formulation as opposed to an oral tablet that requires a device introduces complexity into the treatment regimen. That many patients have difficulty using inhalers in a manner that optimizes treatment is well-documented. Recent literature has begun to differentiate between critical and non-critical errors and how these errors may be associated with suboptimal outcomes, but gaps remain. Methods for improving inhaler technique have been studied and better outcomes are usually associated with interventions, however identifying scalable and reproducible methods is still challenging. For future inhaler development, there is both a desire for low-cost generic inhalers (with healthcare costs increasing globally), alongside an interest in more “high-tech” inhalers capable of interfacing with smart devices.

    The connection between suboptimal inhaler technique and worse health outcomes has been demonstrated. The societal burden associated with suboptimal delivery of aerosolized medication is substantive. Insight into how best to address this problem and the extent to which other factors such as patient characteristics (e.g., pediatric, existing visual/physical impairments), setting (inpatient, institutional care, outpatient), frequency of use, intent of use (e.g., rescue vs maintenance), may impact inhaler use is also needed. Finally, identifying a roadmap forward – perhaps “thinking outside the box” may be needed in developing future inhalation devices.

    This Article Collection welcomes submissions of original research and systematic review papers as well as opinion articles on current/future technology. Research may include prospective and retrospective studies, clinical trials and observational studies, surveys. Specific areas of interest include:

    • Critical vs non-critical inhalation errors and association with outcomes
    • Inhaler use among individuals with health limitations (physical and cognitive impairment)
    • Pediatric inhaler use
    • Scalable interventions to improve inhaler technique/use
    • New inhaler technologies in development

    Keywords

    • Chronic Obstructive Pulmonary Disease
    • Inhaler technique
    • Healthcare technology
    • Patient engagement

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31 December 2024.

    Please submit your manuscript on our website, quoting the promo code JHRDC to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Melissa H. Roberts, University of New Mexico College of Pharmacy, USA

    [email protected]

    The preponderance of Dr. Roberts’ research is on outcomes associated with chronic disease, particularly with COPD. Her research focuses not only on treatment effectiveness but also on burden associated with having chronic disease and assessing quality-of-life and barriers to improving patient outcomes.

    Douglas Mapel, Northern Arizona Pulmonary Associates PLLC, University of New Mexico College of Pharmacy, USA

    [email protected]

    Dr. Mapel is a founding partner of Northern Arizona Pulmonary Associates of Flagstaff Arizona, and a research affiliate of the University of New Mexico College of Pharmacy. His primary interests are in epidemiology and health outcomes research in chronic pulmonary diseases including COPD, asthma, and interstitial lung diseases. Specific outcomes of interest have included frailty and other multi-dimensional clinical measures as predictors of outcomes, comparative effectiveness of respiratory treatments, and healthcare cost and utilization in COPD.

    View all papers in this article collection

    Precision Medicine in COPD

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Precision Medicine in COPD" in the International Journal of Chronic Obstructive Pulmonary Disease.

    Precision Medicine in cancer patients refers to a method of analyzing the genes of cancer cells using a next-generation sequencer, finding the gene mutation that caused the cancer, and using a molecularly targeted drug designed to be effective against that gene mutation. This is also called tailormade or personalized medicine. Is this possible in a real clinical setting in people with chronic obstructive pulmonary disease (COPD)? Although studies on the etiology and pathogenesis of COPD have yielded many insights at the genetic level, unfortunately there are no insights that can be directly translated into the content of treatment for individual patients, and it is not unreasonable to suggest that the application of precision medicine in cancer treatment to COPD may still be a fairy tale.

    In general, most medical treatments are designed for the average patient, but this approach may not be effective for everyone. Rather, we would like to think of precision medicine in COPD as: novel strategies for personalizing disease management that take into account variations in the environment, lifestyle, symptoms, and characteristics of individuals. The goal of precision medicine, as many have noted, is to get the right treatments to the right patients at the right time. In the field of medicine for COPD, this policy has been emphasized with increasing importance in recent years and various terms have come into use. A surrogate term for this is "Treatable Traits". Treatable traits have been proposed as an innovative approach to the management of COPD. Many advanced studies and review articles have already been published in the literature on treatable traits, giving an idea of the approaches that have been taken.

    The Global Initiative for Chronic Obstructive Lung Disease (GOLD) document emphasizes the ABCD assessment tool since 2011, or the recently revised ABE assessment tool, which classifies using symptoms (or dyspnoea) on the horizontal axis and exacerbations on the vertical axis. Dyspnoea and exacerbations may be one of the treatable traits there, which also relates to the basis for determining which drug to administer.

    Additionally, COPD patients with a blood eosinophil count (BEC) of 300 cells/mm3 or higher are currently recommended to receive inhaled medications, including inhaled corticosteroids (ICS), because ICS are expected to reduce the frequency of acute exacerbations. In this case, BEC of 300 cells/mm3 or more is considered one of the treatable features and peripheral blood eosinophil count can be positioned as a biomarker.

    A definition of Precise Medicine in COPD does not yet exist. This attempt is rather a first step towards a definition. In this sense, we are trying to cover as broad an area of COPD as possible. We hope that different researchers from around the world will submit their ideas without preconceived notions. If you are involved in real clinical practice, the term Precision Medicine may be difficult to grasp as a familiar term because it is an esoteric term and is associated with advanced medicine related to gene therapy. We have no intention of playing with words. We hope to see the development of steady research that directly contributes to the treatment of individual COPD patients in a familiar patient care setting. A slight change in perspective should lead to new insights that are still being overlooked. We hope that everyone from young researchers to experienced clinicians will take a second look at this field of practice and contribute their findings.

    It is our great pleasure to invite you to submit articles on the topic of COPD. This article collection, entitled "Precision medicine in COPD", will cover all aspects of clinical investigations regarding COPD. I believe this is the best opportunity to publish your excellent work. Both original articles and reviews are welcome. In light of scientific originality this Article Collection is not currently accepting case reports, case series, meeting reports, photo essays, poster extracts, or study protocols.

    Topics include but are not limited to:

    • Early COPD or late COPD
    • Blood eosinophil count as biomarker
    • Asthma and COPD overlap
    • Frequent exacerbators
    • Patient-reported outcomes
    • Health status or health-related quality of life
    • Dyspnoea measurement
    • Definition of COPD exacerbation

    Keywords

    • COPD
    • precision medicine
    • treatable traits
    • biomarker
    • inhaled corticosteroids

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code MXSKB to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Dr. Koichi Nishimura, Visiting Researcher at National Center for Geriatrics and Gerontology, and Director of Clinic Nishimura, Japan

    [email protected]

    Dr. Nishimura has more than 30 years of experience in the practice of COPD and asthma in Japan since the early 1990s. He spent six months at St. George's University of London in 2012 supervised by Professor Paul Jones to research this. Dr. Nishimura retired from the National Center for Geriatrics and Gerontology (NCGG) of Japan in March 2023 and currently serves as a visiting researcher at NCGG while contributing to community health care in his own clinic.

    Dr. Toru Oga, Kawasaki Medical School, Japan

    [email protected]

    Dr. Toru Oga has been a respiratory physician for about 25 years. His major includes clinical and basic research in asthma, COPD, pulmonary fibrosis, sleep-disordered breathing, and respiratory failure. Dr. Toru Oga has led the Department of Respiratory Medicine, Kawasaki Medical School, as a professor, since 2018.

    Dr. Susumu Sato, Kyoto University, Japan

    [email protected]

    Dr. Susumu Sato is an associate professor at Kyoto University Graduate School of Medicine. His experiences are more than 20 years in practicing respiratory medicine, particularly in COPD and pulmonary rehabilitation. He spent two years as a research associate at Boston University and worked with Professor Bela Suki, a distinguished physicist.

    View all papers in this article collection

    Promoting Optimized Health Care for Individuals with COPD in the Era of Telehealth

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Promoting Optimized Health Care for Individuals with COPD in the Era of Telehealth", organized by Guest Advisors Dr. Yumin Zhou (The First Affiliated Hospital of Guangzhou Medical University, China, [email protected]), Dr. Juan Chen (General Hospital of Ningxia Medical University, China, [email protected]), and Dr. Ning Deng (Zhejiang University, China, [email protected]) in the International Journal of Chronic Obstructive Pulmonary Disease.

    This subject highlights the telehealth of COPD for better management and care of COPD patients. As we all know, COPD is a leading cause of morbidity and mortality worldwide, with an economic and social burden that is both substantial and increasing. Patients with COPD typically complain of dyspnea, activity limitation and/or cough and may experience exacerbations that require specific preventive and therapeutic measures. However, many challenges are encountered in delivering preventive and therapeutic measures, including the COVID-19 pandemic and people living far from their healthcare providers and having limited access to services. Now, as a means to mitigate the risk of viral transmission for both patients and clinicians during the COVID-19 pandemic, many health systems have rapidly converted ≥70% of their outpatient visits to telehealth via phone or video delivery. Due to this, telehealth system has become a hotbed of research in recent years.

    Telehealth may offer a bridge to care and now offers a chance to consider virtual and hybrid virtual/in-person care models, with a goal of improved healthcare access, outcomes, and affordability. There are many critical potential benefits of telehealth, as follows:
    • Telehealth systems may improve COPD medication adherence. Self-management education by telehealth system can help a person understand their disease and the benefits of proper use of medication.
    • Telehealth technologies could improve the delivery of healthcare for people with COPD, reduce exacerbations, improve quality of life, anxiety and depression, and lower rates of hospitalization and emergency department visits.
    • Tele-rehabilitation has been proposed as an alternative to the traditional approach.

    Despite the hope of telehealth as a means of COPD patient care, the evidence base is still evolving, and best practices are not established at this time for COPD. We therefore need much more exploration.

    This Article Collection provides a high-quality forum for interdisciplinary researchers to propose novel informatics methods for telehealth to improve patients' mode of visit and health conditions for patients with COPD. We welcome submissions across the evidence spectrum, ranging from studies of component technologies (e.g., sensors, algorithms, and software) to research articles, database articles, software articles, study protocols, reviews, matters arising, comments, etc.

    This Collection welcomes submissions covering a range of related areas of telehealth, including but not limited to:
    • Remote monitoring plus usual care versus usual care alone.
    • Remote consultation plus usual care versus usual care alone (e.g., Face to face visit for a check-up in a health service with a health professional, or as reported by trialists).
    • Remote monitoring or remote consultation versus usual care (e.g., where telehealthcare has replaced an element of usual face-to-face care).
    • Telehealth interventions' long-term effects.
    • Self-education/follow-up/behavioral intervention and compliance monitoring based on the telehealth system.
    • The field of telerehabilitation: i) standardization of delivery platform; ii) tests performed remotely allowing for accurate exercise prescription; iii) post-exacerbation rehabilitation, etc.

    Keywords:
    • Chronic Obstructive Pulmonary Disease
    • mHealth, Telehealth or Digital Health
    • Internet based pulmonary rehabilitation
    • Intelligent/personalized healthcare
    • Remote monitoring and Interventions

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code KFSQK to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Sarcopenia and frailty in COPD: Mechanisms, Biomarkers, and Potential Interventions

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Sarcopenia and frailty in COPD: Mechanisms, Biomarkers, and Potential Interventions" in the International Journal of Chronic Obstructive Pulmonary Disease.

    Chronic obstructive pulmonary disease (COPD) is primarily a respiratory disease with several extra-pulmonary manifestations. For example, many COPD patients present with an advanced form of age-related muscle impairment, called sarcopenia. In addition, these patients may also exhibit reduced physiological reserves and an increased susceptibility to adverse health outcomes, termed frailty. It is generally well recognized that the presence of sarcopenia and/or frailty in COPD patients increases functional dependency, disease exacerbation, and mortality.

    Timely recognition and intervention of sarcopenia and frailty are critical for treating COPD. Both these conditions have multifactorial etiologies, necessitating a rigorous characterization of the associated molecular mechanisms and biomarkers before optimal therapeutic interventions are applied. However, the driving molecular mechanisms, biomarkers for identification, and effective therapeutic strategies for sarcopenia and frailty in COPD remain elusive.

    This Article Collection aims to unravel the molecular and cellular alterations governing pathogenesis of sarcopenia and frailty in COPD. These may include but are not limited to cellular proteostasis, apoptosis and autophagy, bioenergetics, the roles of satellite cells, muscle vasculature, and myonuclear transcription. We also invite studies investigating the diagnostic potential of novel biomarkers of these conditions in COPD. Here, we aim to primarily unravel the blood biomarkers of muscle or non-muscle origin, that reflect the changes in muscle mass, strength, and frailty phenotype in COPD patients. Lastly, we will reflect on therapeutic interventions, including exercise modalities, novel molecules, nutritional supplements, and other modalities of sarcopenia and frailty in COPD patients.

    We invite basic and clinical research for expanding our understanding of disease mechanisms, biomarkers, and therapeutics of sarcopenia and frailty in COPD patients. Original articles, reviews, case reports, and clinical trials are encouraged for submission.

    Keywords

    • Chronic obstructive pulmonary disease
    • Sarcopenia
    • Frailty
    • Biomarkers
    • Muscle wasting

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 October 2024.

    Please submit your manuscript on our website, quoting the promo code GKTXA to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Rizwan Qaisar, University of Sharjah, UAE

    [email protected]

    Dr. Qaisar investigates the mechanisms and biomarkers of muscle impairment associated with physical inactivity, aging, and age-related diseases. His work includes evaluating the regulation of muscle contraction at the motor protein, single fibers, and whole muscle levels using in-vitro, in-situ, and in-vivo methods in experimental animal models and clinical settings. Additionally, he investigates the therapeutic interventions to prevent and/or reduce accelerated muscle loss in older adults with age-associated comorbidities.

    Johan Lindqvist, University of Arizona, USA

    [email protected]

    Dr. Lindqvist is interested in how giant sarcomeric proteins influence skeletal muscle function in both healthy and disease states using molecular to whole animal techniques. His disease interests range from inherited to acquired diseases with a focus on the diaphragm, the main respiratory muscle, related pathologies. He has special focus on structural adaptations to diseases.

    View all papers in this article collection

    International Journal of General Medicine

    Artificial Intelligence (AI) and the future of General Medicine 

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Artificial Intelligence (AI) and the future of General Medicine ", organized by Guest Advisors Prof. Antonio Coronato and Dr. Muddasar Naeem in the International Journal of General Medicine.

    Artificial Intelligence (AI) is a wide-ranging branch of computer science concerned with building smart machines capable of performing tasks that typically require human intelligence. AI in varying forms and degrees has been used to develop and advance a wide spectrum of fields including medicine and healthcare. AI can identify meaningful relationships in raw data, it can support diagnostic, treatment, and prediction outcomes in many medical situations. AI can automate a substantial portion of the manual work and speed up the process. AI based techniques help in identifying targets for intervention, discovering drug candidates, speeding up clinical trials, finding Biomarkers for diagnosing the disease. 

    This Article Collection is intended to report on applications in the healthcare and medicine domain that benefit from the AI technologies including Machine learning, Reinforcement learning and deep learning. In this context, we are envisaging contributions covering one or more of the following topics: 

    • Medical knowledge engineering.
    • Knowledge-based and agent-based systems.
    • AI-based clinical decision making.
    • Natural language processing in medicine.
    • New computational platforms and models for biomedicine.
    • Intelligent devices and instruments.
    • Automated reasoning and meta-reasoning in medicine.
    • AI and data science in medicine, medically oriented human biology, and healthcare.
    • AI-based modelling and management of healthcare pathways and clinical guidelines.
    • Models and systems for AI-based population health.
    • Data analytics and mining for biomedical decision support.
    • Machine learning in medicine, medically oriented human biology, and healthcare.
    • AI in medical and healthcare education.
    • Methodological, ethical, and social issues of AI in medicine.

    Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code JBZJM to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    International Journal of Nanomedicine

    DNA Nanotechnology Direction Towards Biomedical Applications

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "DNA Nanotechnology Direction Towards Biomedical Applications", organized by Guest Advisor Dr. Oleg Lunov (Institute of Physics of the Czech Academy of Sciences, Czech Republic).

    DNA nanotechnology has shown remarkable advances in various applications in biomedicine such as biosensing, drug delivery, cell modulation and bioimaging. However, it is crucial to understand how DNA nanostructures interact with living cells and the consequences of such interactions. This Collection summarizes the current knowledge on the interactions of DNA nanostructures with cells. There are a number of recent reviews on the interactions of DNA nanostructures with cells; however, they are all from the physicochemical perspective. It would be beneficial to provide critical biomedical analysis that is crucial for the progress towards the clinical translation of DNA nanostructures.

    Evidence from extensive research in recent years has indicated that our current approach to the biomedical applicability of conventional nanomaterials is broken, significantly hampering the clinical translation of nanomedicines. Self-assembled DNA nanostructures (DNs) offer unique opportunities to overcome persistent challenges in the nanobiotechnology field. However, the interactions between engineered DNs and living cells are still not well defined. Therefore, this Collection will be of great interest for both the wider community of academic and private researchers working in DNA nanostructure research and development, as well as for scientists using DNs in physical, biological and chemical studies.

    Additionally, the Collection will appeal to the wider community of academic and private researchers working in DNA nanostructure research and development, as well as scientists using DNA nanostructures (DNs) in physical, biological and chemical studies.

    Topics to be discussed

    1. Current progress in synthesis and characterization of DNA nanostructures
      To discuss the importance of DNA nanostructures (DNs). To guide readers towards the architectural diversity of DNs and their biomedical applications. To indicate the knowledge gaps that are still present in the field. To provide a set of papers on current progress in synthesis of novel DNA nanostructures.
    2. Protein corona and its impact on DNA nanostructures
      To guide readers to the problem of protein corona formation over DNs. To show how the formation of protein corona dramatically affects designed biological properties of DNs. To highlight the importance of protein corona for the design and optimization of DNs.
    3. Analysis of DNA nanostructure cytotoxicity and adverse reactions
      To provide critical systematization of current knowledge of cytotoxicity of DNs. To systematize tested cell models, identify persistent knowledge gaps and provide an outlook for future research towards designing better and safer DNs.
    4. Analysis of DNA nanostructures interactions with cells and perspectives for biomedical applications
      To provide systematic analysis and summarization of what is currently known on DN uptake by cells and what kind of cellular responses are affected upon DN engulfment. To underline novel DNs as perspective materials for biomedical applications. To highlight applications of DNs in biology and medicine.

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code FLEVT to indicate that your article should be considered for this Collection. Please note that normal Article Processing Charges will apply.

    The manuscript submission deadline is 30 November 2024.

    Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

    Guest advisor

    Dr. Oleg Lunov, Institute of Physics of the Czech Academy of Sciences

    [email protected]

    Dr. Oleg Lunov is now serving as the Head of the Laboratory of Biophysics at the Institute of Physics of the Czech Academy of Sciences. His primary research focus revolves around Nanoparticle-cell and nanomaterial-cell interactions; Nanoparticle-induced hepatotoxicity; Mechanobiology; In vitro models of liver; 3D cell culturing; Mechanics of liver cancer; Biological effects of non-thermal plasma; Laser irradiation and cellular responses; Advanced physical methods in hepatotoxicity studies.

    View all papers in this article collection

    Surfactants in Nanomedicine: Enhancing Efficacy and Potential Applications

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Surfactants in Nanomedicine: Enhancing Efficacy and Potential Applications", organized by Guest Advisors Dr. Taiki Miyazawa (Tohoku university, Japan), Dr. Maharshi Bhaswant (Tohoku university, Japan) and Dr. Hiroaki Komuro (Cedars-Sinai Medical Center, United States).

    Surfactants, classified as amphiphilic compounds, have evolved significantly in response to recent technological advancements. These innovations enable precise tuning of their charge, chain length, and physicochemical properties to meet specific needs. These versatile compounds play a pivotal role in a wide array of applications, spanning from adhesives, paints, cosmetics, household and industrial cleaners, oilfield chemicals, pesticides, plastics, textiles, food, and pharmaceuticals. They are indispensable for promoting a healthy and comfortable human lifestyle.

    Notably, there is a growing utilization of surfactants in the burgeoning field of nanomedicine, driven by strides in nanotechnology. Prominent examples include their role as templates for crafting nanoparticles, as key components in niosomes, and as solubilizers for proteins and antibodies. Furthermore, surfactants hold the potential to impart advanced functionalities in nanomedicine, including the ability to regulate capture by the mononuclear phagocyte system (MPS) within the body, mitigate hemolysis, target specific organs, and mitigate adverse drug effects.

    The potential of surfactants in nanomedicine is expansive, and research results have demonstrated significant promise in various medical domains. These include oncology, cardiovascular diseases, neurodegenerative diseases, gastroenterological diseases, dermatological conditions, ocular disorders, and immunotherapy. Particularly noteworthy are the achievements observed when utilizing surfactants series of poloxamer and polysorbate. In essence, surfactants, with their enduring historical legacy spanning ancient civilizations to the modern era, remain indispensable to human existence. They continue to adapt and find relevance in emerging fields of application.

    The primary objective of this collection of articles is to spotlight the forefront of nanomedicine research harnessing the potential of surfactants. This endeavor takes place against the backdrop of an escalating demand for these compounds. Given the wide-reaching versatility of surfactants across a spectrum of research domains, this collection aspires to function as a conduit. It aims to attract not only specialists in nanomedicine but also thought leaders from related disciplines. Through this interdisciplinary exchange, we anticipate the initiation of innovative avenues of scientific exploration.

    This Article Collection comprehensively explores various facets of nanomedicine research leveraging surfactants.

    The potential applications encompass a wide spectrum and include, but are not restricted to, the following areas:

    • Impact of Surfactants on the Biocompatibility of Nanomedicine

    • Enhancing Nanomedicine's Ability to Evade the Mononuclear Phagocyte System (MPS)

    • Augmenting Nanomedicine's Targeting Precision

    • Preserving the Physical and Chemical Stability of Nanomedicine

    • Functional Evaluation of Niosomes Utilizing Surfactants as Building Blocks

    • Influence of Surfactants on the Antimicrobial Activity of Nanomedicine

    • Modulation of Drug Release Rate by Surfactants in Nanomedicine

    • Enhancing Nanomedicine's Dispersibility

    • Surfactant-Mediated Enhancement of Therapeutic Efficacy

    • Future Directions and Challenges in the field of nanomedicine utilizing surfactants

    This comprehensive coverage underscores the pivotal role surfactants play in advancing nanomedicine research across a multitude of dimensions, offering a promising avenue for innovations in healthcare and therapeutic interventions.

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code JWYJL to indicate that your article should be considered for this Collection.

    The manuscript submission deadline is 30 September 2024

    Please contact Haoyang Yi at [email protected] with any queries regarding this Article Collection. 

    Guest advisors

    Dr. Taiki Miyazawa, Tohoku university

    [email protected]

    Taiki Miyazawa has been an associate professor at the Tohoku university, New industry creation hatchery center (Niche). He received Ph.D. from Tohoku university in April 2014. His research focuses on carotenoids, polyphenols, and vitamins with the aim of elucidating the biological activities of these components. He is also working on the application of nanoparticle-based nanomedicine to efficiently utilize these food components and other pharmaceuticals in the body. He also been developing an AI system for explain the physiological functions exhibited by thousands of molecular species in foods. 

    Dr. Maharshi Bhaswant, Tohoku university

    [email protected]

    Maharshi Bhaswant is currently a JSPS research fellow at Tohoku University, based at the New Industry Creation Hatchery Center (Niche). He completed his Ph.D. degree at Victoria University in Melbourne, Australia, in the year 2016. His primary research focus revolves around natural molecules, with the overarching goal of gaining a comprehensive understanding of their cardiometabolic properties and functions. Furthermore, his research extends to the practical application of micronutrients, with the aim of effectively fortifying these vital components within various food constituents, thereby contributing to improved health and overall well-being. Maharshi's research interests also encompass the identification and assessment of novel therapeutic molecules for the treatment of chronic diseases. 

    Dr. Hiroaki Komuro, Cedars-Sinai Medical Center

    [email protected]

    Hiroaki Komuro has been a postdoctoral fellow at the Smidt Heart Institute, Cedars-Sinai Medical Center, US. In march 2021, he received a Ph.D under the guidance of professor Tetsuo Sasano at Department of Cardiovascular Medicine, Tokyo Medical and Dental University in Japan. His research interests include development of therapeutic and diagnostic using biomaterials, especially extracellular vesicles.

    View all papers in this article collection

    Unveiling the Potential of Nanobiomaterials: Pioneering Insights into Biomedical Engineering

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the International Journal of Nanomedicine on "Unveiling the Potential of Nanobiomaterials: Pioneering Insights into Biomedical Engineering", organized by Guest Advisor Dr. Narsimha Mamidi, University of Wisconsin-Madison, United States and Editor-in-Chief Dr. R.D.K. Misra, University of Texas at El Paso, United States.

    Nanobiomaterials (NBMs) are a class of materials that combine the principles of nanotechnology and biomaterials to create innovative solutions for various biomedical applications. They are designed and engineered at the nanoscale level, which typically involves working with materials and structures that range from 1 to 100 nanometers in size. The field of NBMs has gained significant attention in recent years due to its potential to revolutionize medicine and healthcare. NBMs have unique properties and interactions at the nanoscale that make them suitable for a wide range of applications in biology, medicine, and medical devices. Some of the key characteristics and applications of NBMs include:

    High surface area: Due to their nanoscale size, NBMs have a large surface area relative to their volume. This property is advantageous for applications such as drug delivery, where increased surface area allows for better drug loading and release kinetics.

    Enhanced bioactivity: NBMs can be functionalized with specific molecules to improve their interactions with biological systems, such as cells and tissues. This enables better biocompatibility and targeted delivery of therapeutic agents.

    Drug delivery: NBMs can be engineered to encapsulate and deliver drugs, proteins, or genetic material to specific sites in the body. This targeted drug delivery can improve the efficacy of treatments while reducing side effects.

    Tissue engineering: NBMs play a vital role in tissue engineering and regenerative medicine. They can serve as scaffolds to support cell growth and tissue formation, facilitating the repair and regeneration of damaged tissues and organs.

    Diagnostics: NBMs are utilized in diagnostic applications, such as nanosensors for detecting biomarkers, nanoprobes for imaging, and nanoparticle-based assays for disease detection.

    Therapeutics: Some NBMs have inherent therapeutic properties, such as antibacterial nanoparticles that can combat infections or nanoscale materials with photothermal or photodynamic properties for cancer therapy.

    Implants and medical devices: NBMs are used in the development of advanced implants and medical devices with improved mechanical properties, biocompatibility, and reduced risk of adverse reactions.

    Despite their promising potential, the development and application of NBMs also raise concerns about their long-term safety, toxicity, and environmental impact. As research in this field continues to progress, it is essential to balance innovation with a thorough understanding of the potential risks and benefits associated with these novel materials.

    In this Article Collection, we collect research devoted to the interaction between NBMs and tissue/cell, the effect of size, morphology, shape, and surface of NBMs on their toxicity, biocompatibility, immunogenicity, design of novel biodegradable and biocompatible NBMs, instrumentation, and technologies to analyze biocompatibility of NBMs and challenges to overcome the toxicity of NBMs. This exposure could potentially pave the way for exciting and innovative concepts of NBMs and provide game-changing solutions for several research areas, including tissue engineering, drug delivery, medical devices, biosensors, and other biomedical applications.

    This topic covers several successful models of NBMs, including polymer-based NBMs, magnetic and gold nanoparticles, quantum dots, and inorganic-organic-based and carbon nanomaterials (CNMs)-based NBMs, used in biomedical engineering and biosensing applications. We are specifically emphasizing articles narrating the cell and NBMs interaction, toxicity and biocompatibility advancing protocol, structural-property relationship, degradation of NBMs, etc. Topics include but are not limited to: 

    • Biocompatibility Assessment of NBMs:
    • Designing NBMs with multiple functions for medical purposes.
    • Developing drug delivery strategies using NBMs as carriers.
    • Using in vitro/in vivo approaches to understand the biological effects of NBMs.

    Overall, it is hoped that this Article Collection will facilitate the assembling of new collaborations and motivate new generations to engage in the engineering of NBMs for a wide range of applications. 

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author submission instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code EJJKG to indicate that your article should be considered for this Collection.

    The manuscript submission deadline is 30 September 2024.

    Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection. 

    Guest advisors

    Dr. Narsimha Mamidi, University of Wisconsin-Madison

    [email protected]

    Dr. Narsimha Mamidi is now serving as Scientist-I at WiscNano, University of Wisconsin-Madison, Wisconsin, USA. His primary research focus revolves around pioneering the development of Nanoformulations for the co-delivery of drugs and genes, with a particular emphasis on cancer immunotherapy. His overarching objective is to advance the application of Nanoformulations for clinical use, revolutionizing the landscape of immunotherapy. This endeavor entails the creation of user-friendly drug delivery platforms tailored for a spectrum of cancer types, including but not limited to triple-negative breast cancer, lung cancer, liver cancer, brain cancer, and pancreatic cancer.

    Dr. R.D.K. Misra, University of Texas at El Paso

    [email protected]

    Dr. Misra is a Professor in the Department of Metallurgical, Materials, and Biomedical Engineering at the University of Texas at El Paso, USA. He is also the Editor-in-Chief of the International Journal of Nanomedicine. His inter-/multidisciplinary research interests include advanced manufacturing of biomedical devices, nanoparticle-systems for drug delivery, antimicrobial systems, super-hydrophobic nanocomposites for wound dressing, nanostructured implants, impact of nanostructured surfaces on protein adsorption, quantum dots for bio-imaging, and bio-nano interactions. His research programs involve the use of a broad spectrum of biomaterials characterization techniques such as electron microscopy, confocal microscopy, X-ray diffraction, EBSD, atomic force microscopy, and mechanical testing, to list a few.

    View all papers in this article collection

    International Journal of Women's Health

    The Prevention, Early Diagnosis and Treatment of Cervical Cancer

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Prevention, Early Diagnosis and Treatment of Cervical Cancer" in the International Journal of Women's Health.

    The morbidity and mortality of cervical cancer are fourth ranked in global female malignant tumors. It can be reduced significantly by implementing cytology and HPV testing effectively. The use of the HPV vaccine has also significantly reduced the incidence of human papillomavirus (HPV)-related diseases. Early diagnosis and treatment is the key to preventing cervical cancer, and can definitely reduce the incidence and mortality of cervical cancer.

    Cervical cancer is a preventable and curable disease, and HPV is a necessary but not sufficient cause of cervical cancer. Over the past few decades, the incidence and mortality of cervical cancer have decreased in most countries and regions, especially in developed countries. However, in developing countries and regions, cervical cancer morbidity and mortality remain high, which is closely related to the human development index, poverty rate, the coverage rate of cervical cancer screening, the sensitivity of cervical cytological testing, the accessibility of HPV vaccine, sexual lifestyle, and HPV virus transmission. In 2018, to reduce the global burden of cervical cancer, the WHO Director-General called for the elimination of cervical cancer worldwide (≤4 per 100,000 women worldwide). With the increasing coverage of cervical cancer screening and HPV vaccine, more and more HPV-independent cervical cancer is being identified. The questions of how to effectively achieve the goal of eliminating cervical cancer, how to effectively implement vaccination, early diagnosis and treatment, as well as the difficulties and challenges existing in practice, have been the concern of governments and medical institutions globally.

    We are calling for papers on cervical cancer (HPV dependent and HPV-independent) prevention, early diagnosis and treatment, including:
    • HPV vaccination
    • epidemiology of cervical cancer
    • risk factors
    • disparities and challenges
    • screening methods of cervical cancer
    • screening frequency and interval
    • screening outcomes and follow-up
    • screening in special populations
    • cost-effectiveness and implementation
    • the role of colposcopy in cervical cancer prevention and treatment
    • the treatment of cervical precancer.
    • innovative approaches to cervical cancer screening and prevention
    • clinicopathological and molecular characteristics of cervical precancer and cancer

    Submission types include research articles, clinical studies, reviews, case reports, technology reports, opinion and commentary.

    Keywords:
    • Screening tests
    • HPV vaccine
    • HPV-independent cervical cancer
    • Prevention
    • Diagnosis
    • Treatment

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 October 2024.

    Please submit your manuscript on our website, quoting the promo code ADVEH to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Jianliu Wang, Peking University People’s Hospital, China

    [email protected]

    Dr. Wang is the professor of Obstetrics and Gynecology Department, Vice-Dean of Peking University People’s Hospital. He is Editor-in-Chief of Gynecology and Obstetrics Clinical Medicine.

    Jae-Weon Kim, Seoul National University and Seoul National University Hospital, South Korea

    [email protected]

    Dr. Kim is the current President of the Korean Society of Gynecologic Oncology and the Asian Society of Gynecologic Oncology. He has been a Board Executive of the Gynecologic Cancer InterGroup.

    Aikou Okamoto, Jikei University School of Medicine, Japan

    [email protected]

    Jae-Yun Song, Korea University College of Medicine, South Korea

    [email protected]

    Masataka Takenaka, Jikei University School of Medicine, Japan

    [email protected]

    Junya Tabata, Jikei University School of Medicine, Japan

    [email protected]

     

     

     

     

    View all papers in this article collection

    Journal of Asthma and Allergy

    Atopic Dermatitis and Other Atopic Comorbidities

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Atopic Dermatitis and Other Atopic Comorbidities” in the Journal of Asthma and Allergy.

    Atopic dermatitis (AD) is a chronic inflammatory cutaneous disorder. Currently, AD has been found to be associated with substantial patient burden and numerous atopic comorbidities, including asthma, allergic rhinitis, food allergy, and eosinophilic esophagitis, as well as nonatopic comorbidities, including allergic contact dermatitis, anxiety, depression, suicidality, infections, and cardiovascular disease. All these comorbidities led to the recognition of AD as a systemic disease. Of note, the relationship between AD and comorbidities is likely bidirectional and multifactorial, as well as some comorbidities may be secondary to the effects of the burden of chronic AD.

    This Article Collection aims to explore the association between atopic dermatitis and other atopic comorbidities, shedding light on the shared pathophysiological mechanisms and the implications for clinical management.

    This Article Collection aims to bring together original research articles, review articles, and commentaries exploring the pathogenesis of atopic diseases, also considering primary immune defects presenting as AD, the role of environmental factors, the impact of environmental allergies and infections, novel diagnostic approaches (including biomarkers), and emerging therapeutic approaches (including biologic treatments and JAK inhibitors). Articles regarding all the atopic diseases (asthma, food allergy, allergic rhinitis, eosinophilic esophagitis, and atopic dermatitis) are welcome.

    Potential topics include the following aspects:
    - Epidemiology and burden of atopic comorbidities
    - Pathophysiological mechanisms
    - The role of environmental allergies in atopic diseases
    - Biomarkers in atopic diseases
    - Asthma and allergic rhinitis in atopic dermatitis
    - Atopic dermatitis and food allergies
    - Atopic dermatitis and mental health
    - Novel therapeutic approaches
    - The use of biologics in atopic diseases
    - Clinical management and guidelines

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 31 December 2024.

    Please submit your manuscript on our website, quoting the promo code DFHHN to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors
    Maddalena Napolitano, Professor, MD, Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
    [email protected]

    Luca Potestio, MD, Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
    [email protected]

    Cataldo Patruno, Professor, MD, Department of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro
    [email protected]

    View all papers in this article collection

    Recurrent Pulmonary Infections: Diagnosis, Treatment, and Pathophysiology

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Recurrent Pulmonary Infections: Diagnosis, Treatment, and Pathophysiology” in the Journal of Asthma and Allergy.

    Recurrent pulmonary infections may occur due to a number of underlying conditions and also among normal hosts. To further our understanding of recurrent infections, this Article Collection will be published. Recurrent pulmonary infections occur when the immune system is unable to effectively clear a pathogen. Examples of such chronic infections include tuberculosis, pneumonia, sinusitis, rhinitis, and influenza. Though recurrent pulmonary infections may occur in any individual, typically those with underlying conditions such as pulmonary structural abnormalities, primary or secondary immunodeficiencies, or congenital diseases like cystic fibrosis (CF), are affected the most. Other common sources of recurrent pulmonary infections include ciliary defects (both primary and secondary), aspiration, foreign body presence, and bronchiectasis. The pathophysiology, diagnosis, and treatment of recurrent pulmonary infections will be further explored in this Collection.

    The Editors welcome relevant clinical Original Research, Reports, Editorials, Commentaries, and Case Series. These articles may pertain broadly to the field of recurrent pulmonary infections, though special attention will be given to the following subareas:

    • Recurrent pulmonary infections caused by aspiration or presence of foreign body
    • Primary and secondary ciliary defects and the role they play in recurrent infection
    • Diagnosis and treatment of both CF and non-CF bronchiectasis
    • Recurrent infections due to primary and secondary immunodeficiencies
    • Imaging studies to detect recurrent pulmonary infections
    • Structural abnormalities, including esophageal disorders, of the pulmonary system
    • Infections due to transplant-associated immunodeficiency
    • Prevention of pulmonary infection recurrence
    • Novel diagnostic criteria or biomarkers associated with recurrent pulmonary infections
    • Case reports of recurrent pulmonary infections with novel pathophysiology or treatment plan
    • Cases of tuberculosis and non-tuberculosis mycobacterial infection

    Keywords:

    • Recurrent pulmonary infections
    • Immunodeficiency
    • congenital disease
    • ciliary defects
    • bronchiectasis

    Please review the journal scope and author submission instructions prior to submitting a manuscript. The deadline for submitting manuscripts is 28 February 2025.

    Please submit your manuscript on our website, quoting the promo code GIYJF to indicate that your submission is for consideration in this Article Collection.

     

    View all papers in this article collection

    Wheezing in Preschool Children: From Origins to Outcomes

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Wheezing in Preschool Children: From Origins to Outcomes” in the Journal of Asthma and Allergy.

    Wheezing is very common in children under 6 years. Beyond allergens and irritants, respiratory infections are the main triggers of wheezing, as demonstrated by the significant reduction of wheezing exacerbations during the COVID-19 pandemic in which the circulation of common respiratory viruses was significantly reduced. 

    Despite the existence of asthma predictive tools, the natural evolution of wheezing is uncertain since not all children with wheezing will develop asthma in later age. Wheezing is a heterogeneous disease with many risk factors and many clinical phenotypes. Despite the difficulty in performing certain examinations in young children, different underlying pathophysiological mechanisms have been also found and described as specific endotypes. However, more research is needed to identify children with severe phenotypes and at a higher risk of asthma. Strategies to prevent respiratory infections might be helpful to reduce the burden of wheezing in preschool age. 

    Preschool wheezing is associated with a significant burden, both for families and pediatricians in their daily clinical practice. Most children are treated with medications, sometimes including steroids, and some need hospitalization for severe attacks. Diagnosis and management may be improved by better describing phenotypes and endotypes with measurable biomarkers and lung function tests. The management of daily therapies and acute attacks can be very demanding for caregivers; moreover, they must be provided education, wheezing plans, and support. More research is needed on parental- and caregiver-reported outcomes. 

    The purpose of this Article Collection is to outline and discuss: a) the recent advances on phenotypes and endotypes of preschool wheezing; b) the role of virus and bacteria in its pathogenesis; c) the management not only of the acute attack but also of daily symptoms with particular attention to support caregivers and their needs; d) the feasibility of lung function tests and other assessments to identify wheezing characteristics; and e) the need and the timing for specialist referral and invasive investigations. 

    All data on preschool wheezing are accepted: epidemiological studies, cohort studies, or randomized controlled trials, but also reviews on a particular subtopic like pathogenesis, diagnosis, or management.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code TRNZO to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 31 December 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected].

    Guest Advisors

    Prof. Susanna Esposito, University of Parma

    [email protected]

    Full Professor of Pediatrics, Director of the Specialty School of Pediatrics, Chief of the Third Mission Committee and Director of the Pediatric Clinic. She is President of the World Association for Infectious Diseases and Immunological Disorders and Chair of the Technical Committee in Infectious Diseases and Vaccination of the Italian Society of Pediatrics. Her research activities have led to the publication of more than 1,000 articles (PubMed) with an h-index of 82 (Scopus) and an IF >5,000.

    Dr. Valentina Fainardi, University of Parma

    [email protected]

    Researcher in Pediatric pulmonology and Cystic fibrosis at the University of Parma. She is a member of the Italian Society of Pediatric Pulmonology (SIMRI) and European Respiratory Society (ERS).

    View all papers in this article collection

    Journal of Healthcare Leadership

    Breaking the Vicious Cycle: Strengthening Leadership Resilience to Overcome Staff Crisis in Healthcare Systems

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Breaking the Vicious Cycle: Strengthening Leadership Resilience to Overcome Staff Crisis in Healthcare Systems" in the Journal of Healthcare Leadership.

    Healthcare systems worldwide are confronted with a formidable challenge that threatens their sustainability. The increasing number of patients, extended life expectancy, rapid changing technological and pharmaceutical complexity, and aspects of planetary health demand more comprehensive care. Paradoxically, healthcare systems are thus becoming victims of their success. The combination of the shortage of specialists with outdated management concepts, toxic management behavior, and a lack of psychological safety among healthcare professionals in the context of a generational conflict exacerbates this predicament.

    In the face of the current staffing crisis in healthcare systems, recent and future leaders at every level must take decisive and competent actions to ameliorate this concerning trajectory. Failing to do so may threaten the hard-won achievements of modern healthcare systems. Contributions addressing effective leadership strategies in the upcoming Article Collection are essential to navigating and overcoming this critical challenge.

    This Article Collection aims to explore effective leadership strategies to address the crisis arising from the insufficient healthcare workforce. We invite submissions of diverse studies that delve into innovative approaches for bolstering the resilience, safety, and longevity of healthcare systems. Contributions may range from conceptual frameworks to empirical research, shedding light on practical solutions.

    Papers submitted for consideration should focus on, but are not limited to, the following areas:

    • Leadership initiatives to attract and retain healthcare professionals.
    • Innovative workforce management strategies to optimize healthcare delivery.
    • Case studies highlighting successful interventions in overcoming staffing challenges.
    • Policies and practices fostering a supportive and sustainable healthcare work environment.
    • Research exploring the impact of leadership interventions on healthcare system effectiveness.
    • Educational research on healthcare leadership

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code UEVPT to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Reinhard Strametz, Wiesbaden Institute for Healthcare Economics and Patient Safety (WiHelP), RheinMain UAS, Wiesbaden/Germany

    [email protected]

    Dr. Strametz is a Professor for Patient Safety at RheinMain University of Applied Sciences in Wiesbaden, Germany. He is anesthesiologist specialized in quality management, clinical risk management and emergency medicine and economist. He was Head of Quality at Frankfurt University Hospital now leading Wiesbaden Institute for Healthcare Economics and Patient Safety (WiHelP). He is Vice Chair of EU CoST Actions European Researchers' Network Working von Second Victims ERNST (CA19113) and Supporting emerging care economy, empowering caregivers to provide safe care at home “BetterCare” (CA22152).

    José Joaquin Mira Solves, Fundacion para el foment de la Investigacion Sanitaria y Biomedica de la comunitat Valenciana

    (FISABIO), Alicante/Spain

    [email protected]

    Dr. Mira is a Professor of the University Miguel Hernández, and clinical psychologist conducting clinical assistance at Alicante-Sant Joan Health District. Dr Mira is also an Associate Editor at BMC Health Service Research offering his expertise in health quality, performance, safety and outcomes, and BMC Primary Care, where he is Co-Editor of the Journal of Healthcare Quality Research (Spanish Journal of Quality Assurance). Additionally, he is President of the Scientific Committee at the FISABIO Research Institute in the Valencian Community and Chair of the EU CoST-Actions ERNST (CA19113) and BetterCare (CA22152).

    Stefan Bushuven, Training Center for Emergency Medicine (NOTIS e.V)

    [email protected]

    Dr. Bushuven is an Infection Control Specialist and Intensive Care Physician in the District of Constance, Germany. He is Vice Chair of NOTIS e.V., an NPO Training Center for Emergency Medicine. His research group focuses on Medical Didactics and Medical Education in Emergency and Intensive Care Medicine especially in the fields of Cognitive Error, Learning Motivation and Second Victim Phenomena.

     

    View all papers in this article collection

    Digital Healthcare Leadership in an Era of Value-Based Care, Health Equity, and Patient Consumerism

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Digital Healthcare Leadership in an Era of Value-Based Care, Health Equity, and Patient Consumerism" in the Journal of Healthcare Leadership.

    The proliferation of health information technology to support patient care, which gained accelerated momentum during the COVID-19 pandemic, has continued unabated in the post-pandemic period, with no sign of waning. The pandemic also served to expose and exacerbate disparities in healthcare and health outcomes both in the United States and globally. In the process, the pandemic served to highlight the potential of value-based payment models to reduce health disparities by encouraging organizations to develop partnerships and invest in infrastructure to address people’s clinical and social needs. Since value-based care requires a concurrent focus on improving outcomes and promoting population health, while keeping costs in check, the success of value-based payment models has been inextricably linked to the use of technology. This in turn has fostered growing recognition of the role of health information technology in reducing health disparities and advancing health equity. 

    With the growing emphasis on value in the industry and concurrent push towards health equity by public payers and policymakers, health information technology remains central to enabling the shift towards value-based equitable care. While barriers exist, value-based care is a concept that appeals to all stakeholder groups in the healthcare ecosystem, including providers, payers, and patients, who are all seeking better data, more interoperability across health IT systems, actionable, real-time insights, and more effective engagement. 

    At the same time, health information technology is also recognized to be central to meeting the increasing demands of patient consumerism. Consumerism refers to growing expectations of patients to be actively involved in decisions related to their own care. Healthcare providers and payers will need to work together to deliver on consumer expectations for convenient, functional high-quality services. In other words, achieving the goals of value-based care in an era of consumerism will require effective personalized care that is seamlessly corroborated across industry operators. This systemwide approach in turn will require organizations to bring together disparate sources of information to create an integrated approach to facilitating improved outcomes and consumer engagement. 

    As patients become more engaged consumers of healthcare, providers will need to continue to reevaluate how they interact with patients with the use of engagement and empowerment tools, data ownership and price transparency. Ultimately, as healthcare organizations learn to thrive in the emerging patient-centric, equity-focused, value-based healthcare system, technology that facilitates connectivity across disparate stakeholders, payers, providers, and consumers, will be a foundational cornerstone that enables high-quality, cost-effective care. 

    To successfully adapt to this industry transformation, leaders of healthcare organizations need to be prepared to proactively address a variety of challenges. Accordingly, this Article Collection invites original research papers and informed commentary for a global audience, on a variety of topics relevant to digital healthcare leadership in an era of value-based care, health equity, and consumer-centric technology solutions. 

    Topics of interest:

    • Health IT and value-based payment models
    • Health IT and health equity
    • Health IT and consumerism
    • Value-based consumer-centric technology solutions
    • Use and impact of telemedicine use on health outcomes
    • Use and impact of telemedicine use on health disparities
    • EHR usability and clinician burden
    • Personalized medicine and predictive analytics
    • Population health analytics
    • Data exchange and interoperability
    • Data safety and privacy
    • Adoption of advanced health IT capabilities
    • Use of health IT for learning and continuous improvement
    • Use of health IT to promote consumer, provider, and payer engagement
    • Health IT and healthcare delivery system reform

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code YNFWF to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Pavani Rangachari, University of New Haven

    [email protected]

    Pavani Rangachari, Ph.D., CPH, serves as Professor of Healthcare Administration and Public health and Director of the Master of Healthcare Administration (MHA) program in the School of Health Sciences at the University of New Haven. Her expertise is in health policy and administration, including healthcare organization, delivery, financing, health disparities, and public health. Her special interest lies in the implementation of innovation and change in healthcare organizations. Dr Rangachari holds an M.S. in Health Management & Policy from the School of Public Health at the University at Albany, State University of New York (SUNY), and a Ph.D. in Public Administration & Policy, from the Rockefeller College of Public Affairs & Policy at the University at Albany, SUNY. Dr Rangachari also has extensive work experience in the healthcare industry, through service in leadership roles at both a state hospital association and a community hospital.

    Dr. Rangachari has received independent research grants as Principal Investigator from the U.S. Agency for Healthcare Research and Quality (AHRQ) and has published numerous primary-authored articles in the fields of healthcare management, leadership, health informatics, and public health. Her scholarship has contributed towards the: 1) identification of evidence-based management strategies for successful innovation implementation in healthcare organizations and 2) development of policy implications for consistent implementation of evidence-based and patient-centered care practices to promote population health. Her research projects have also contributed towards improving healthcare practices and outcomes at her study institutions. Dr. Rangachari’s scholarship has been recognized at a national level with the "Best-Theory-to-Practice Paper Award" from the Academy of Management Healthcare Management Division and nomination for the "Distinguished Paper Award" from the American Medical Informatics Association.

    View all papers in this article collection

    Interdisciplinary Leadership for Healthcare Systems

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Interdisciplinary Leadership for Healthcare Systems" in the Journal of Healthcare Leadership.

    Healthcare systems are increasingly reliant on interdisciplinary teams and integrated data systems to deliver cost-effective quality care. Even though today’s healthcare organizations are complex adaptive systems, leadership training programs focus on targeted professional groups, e.g., physicians or nurses. Today’s integrated systems need leaders that function across disciplines and take advantage of integrated information and communication systems. It is critical to train leaders to operate in interdisciplinary teams and to take a systems approach to managing their organizations. We are interested in learning about experiences within healthcare organizations that have developed interdisciplinary leadership teams to manage their organization. As hospitals merge into larger systems, the leadership is more distant from on-site operations and needs to develop new models for institutional management. The emerging multi-institutional systems also need more in-depth study to understand leadership challenges and successes.

    The rise of large systems and hospital mergers created leadership challenges that make it difficult to understand the day-to-day work of providers and support staff. Likewise, system-wide policies designed to create administrative efficiencies, have limited provider autonomy, and created problems of burnout and high staff turnover. Under an interdisciplinary model of leadership quality issues are more easily solved at the point-of-care and subsequently distributed across the larger health system. Current information systems are data-intensive and interdisciplinary in nature. We need decision-making models that are more inclusive and provide leaders with a comprehensive picture of their institutions and systems. We believe that interdisciplinary models of leadership can address these long-standing challenges. It is important to describe existing strategies to identify best practices. System data analytics are becoming more sophisticated, expanded communication models can share this information broadly and take advantage of the interdisciplinary expertise that can understand and act on it.

    We are soliciting articles that describe how leadership supports making integrated health care systems more successful. The use of expanded participation in organizational decisions and policies is important. We also are interested in descriptions of interdisciplinary team leadership at the organizational level. How do interdisciplinary leadership models impact burnout, morale, and retention? Can interdisciplinary leadership practices impact patient satisfaction? Are institutions training and implementing models of team science in their operations? If so, how is this further integrated into organizational leadership? We are seeking manuscripts related to training programs that introduce interdisciplinary leadership models into health system administration. How has leadership been adapted to improve patient care? What are leadership requirements and approaches at various levels of the system and organizations that support change management? Do interdisciplinary models help overcome the current healthcare quality challenges?

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31 October 2024.

    Please submit your manuscript on our website, quoting the promo code JJTVN to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Project management in the changing healthcare context

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Project management in the changing healthcare context" in the Journal of Healthcare Leadership.

    It is a global phenomenon that healthcare systems and organizations have been pressured to adopt innovative and effective tools to manage service delivery. Since its inception in the early 1900s, project management has become a systematic management tool bringing people and resources together to achieve specific purposes. Its popularity in health and community services has significantly increased in the last two decades to enable implementation of changes and service innovation, achieve service improvement, and trailing new ideas and service models. Project management has changed from being a management tool with limited use by project managers to becoming a common method embedded in the general management and strategies of organizations. However, the significant changes in the scope and complexity of projects have brought significant uncertainty and volatility and the changing economic, demographic, technological, social, cultural, legal and political environments have influenced how projects are designed, delivered and evaluated.

    The growing importance of projects in health and community services has been evident over the past twenty years. The unique characteristics of projects provide opportunities to create new knowledge and techniques that improve practice, and capture learnings to inform future project design. Projects brings together many different occupational groups, functional areas of the organization and resources to achieve the specific objectives, enriching the understanding of stakeholder engagement, teamwork effectiveness and relationship management. Learnings from the project design, planning, implementation and evaluation processes and project management experiences in health and community care are important to maximize the contribution of project management in improving health service efficiency. Such learnings may include factors that are critical to project success, tested tools and techniques that improve project effectiveness and efficiency, application of project management in innovation and digital health adoption, and developing team dynamics involving wide range of roles, skills and expertise.

    The Article Collection will explore recent changes and evidence in the application of project and project management in the health sector and provide the most relevant guidance to health professionals, trainers and researchers who are involved in leading and managing project work and developing project management competencies by covering the following sub-topics:

    · Project application and case examples

       o Tools and techniques

       o Project management competency requirements

       o Competency development and training curriculum

       o Project career pathway

       o Project critical success factors

    · Project management challenges

    · Virtual Project Teams

    · Project evaluation examples

    · Project management in innovation and digital health adoption

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 November 2024. Please submit your manuscript on our website, quoting the promo code EGLRR to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Associate Professor Zhanming Liang , James Cook University, Australia

    [email protected]

    Associate Professor Carmen Reaiche , James Cook University, Australia

    [email protected]

    View all papers in this article collection

    Journal of Hepatocellular Carcinoma

    The Dynamic Landscape of Liver Transplantation and Hepatocellular Carcinoma

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Dynamic Landscape of Liver Transplantation and Hepatocellular Carcinoma" in the Journal of Hepatocellular Carcinoma.

    There has been an ongoing evolution of the role of liver transplantation in the treatment of patients who have a diagnosis of hepatocellular carcinoma over the last four decades. From the beginnings of the Milan criteria to the use of liver transplantation as a salvage therapy for patients who have exhausted other medical and surgical interventions, we are living in a field that is rapidly changing. Newer immunotherapies and incorporating a multi-faceted approach to treat this disease subsequently expands the potential pool of patients who may ultimately require and will subsequently benefit from liver transplantation. Unfortunately the ongoing shortage of donor livers (both deceased and living) plays a role in the availability of liver transplantation as a treatment option. The impact of these therapies on liver transplant outcomes are intertwined and with the field rapidly growing it is important to look at the current state from a research and translational perspective. The following subjects fit within this call for papers:

    • Salvage liver transplantation
    • Pre-transplant immunotherapies
    • Post-transplant HCC recurrence and treatment options
    • Role of living donor liver transplant and HCC
    • Portal vein tumor thrombus and liver transplantation

    Please view the journal Aims and Scope and author submission guidelines. The deadline for submissions is 15 September 2024

    Please submit your manuscript on our website, quoting the promo code PMOQM to indicate that your submission is for consideration in this Article Collection. Standard article publishing charges apply.

    Guest advisor

    David Gerber, Christian R. Holmes Memorial Chair of Surgery and Chair of the Department of Surgery, University of Cincinnati College of Medicine

    Dr. Gerber received his medical degree from the University of Pittsburgh and completed general surgery training at Emory University in Atlanta, GA with a post-doctoral fellowship in Transplantation Immunology. He subsequently completed his clinical transplant fellowship at the Starzl Transplantation Institute at the University of Pittsburgh School of Medicine. Clinically he has expertise in solid organ transplantation with a focus on liver cancer including the integration of navigation into minimally invasive surgery procedures.

    Dr. Gerber has received over 25 basic science grants including extramural funding from the National Institutes of Health, the American Liver Foundation, the Roche Organ Transplant Research Foundation, the American Society of Transplant Surgeons, and the American College of Surgeons. He has been principal investigator or co-investigator of more than 40 industry-sponsored clinical trials focusing on advancing patient outcomes in hepatocellular carcinoma and transplantation. He has published over 200 peer reviewed publications, peer-reviewed abstracts and book chapters in the areas of liver cancer, transplantation, stem cell biology, and regenerative medicine. In addition, he has received two patents and has given over 100 national and international presentations in healthcare and biotechnology.

    View all papers in this article collection

    Journal of Inflammation Research

    New Insights into Autoinflammatory Diseases From South America

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "New Insights into Autoinflammatory Diseases From South America", in the Journal of Inflammation Research.

    The concept of autoinflammatory disease was only recognized by the medical field 20 years ago. Now, around 60 genes have been identified that lead to related inborn errors of immunity. 

    Although autoinflammatory diseases have gained relevance in the medical literature data through clinical, basic, and translational research, most published research comes from high-income countries. 

    Research from middle-income countries, such as those in South America, is needed to help us understand the manifestations and prevalence of these conditions in a variety of social, economic, and geographic contexts. 

    This Article Collection will highlight research on autoinflammatory diseases from researchers in South America and in South American populations. We welcome original research, reviews, symposium reports, expert opinions, and commentaries. 

    Topics of interest include: 

    • Genomic findings related to autoinflammatory diseases
    • Genotype/phenotype manifestations of autoinflammatory diseases
    • Pharmacological and non-pharmacological interventions in autoinflammatory diseases
    • Epidemiological data on autoinflammatory diseases
    • Environmental factors contributing to autoinflammatory diseases

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor will not be handling the manuscripts. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript. Standard Article Publishing Charges apply.

    Please submit your manuscript on our website, quoting the promo code FGRXV to indicate that your submission is for consideration in this Article Collection. Promo codes are used to identify articles that belong to a specific Collection, so it is important to use the correct code.

    The deadline for submitting a manuscript is 1 October 2024. If you have questions, please contact Krista Thom at [email protected].

    Guest Advisor

    Leonardo Oliveira Mendonca, Professor of Clinical Immunology and Allergy, Universidade Santo Amaro, Sao Paolo, Brazil

     

    View all papers in this article collection

    Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes", in the Journal of Inflammation Research.

    Takayasu arteritis (TAK) is a rare large vessel vasculitis (LVV). Although more common in Asia, TAK is diagnosed worldwide. The pathology of TAK is a granulomatous inflammation of the aorta and its major branches. Limited studies available from mostly Europe and North America have revealed an increased mortality risk with TAK relative to the general population. 

    Much remains to be understood about TAK. The assessment of disease activity is challenging. In many instances, TAK sets in insidiously. Patients with TAK might simply be diagnosed incidentally upon the detection of asymmetry of pulses or blood pressure. On the other hand, it can also present with prominent constitutional symptoms without pulse loss at the onset or can present with severe ischemic manifestations such as stroke, myocardial infarction, or vision loss. While the pathology is an inflammatory vasculitis, in many instances, traditional inflammatory markers such as C-reactive protein (CRP) are not elevated. In such instances, 18-F fluorodeoxyglucose PET can identify active TAK even in the absence of CRP elevation. Of late, novel PET ligands such as SST2R and FAPI have been explored as denoting macrophage infiltration or fibroblast activation in the arterial wall. 

    The treatment of TAK is also challenging. Despite the key pathology of vessel wall inflammation, no immunosuppressive agent has been identified to be effective in a clinical trial of TAK. There is a need to explore newer therapies or therapeutic strategies in TAK, which could include the exploration of adjunctive therapies that affect arterial wall fibrosis (which is a prominent histopathological feature of TAK) in addition to the targeting of inflammation. 

    This Article Collection invites original and review articles of translational relevance in TAK, including those related to novel blood and imaging biomarkers of disease activity and arterial wall damage, novel therapeutic strategies, and biomarkers of long-term outcomes in TAK. 

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor will not be handling the manuscripts. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code AHYGD to indicate that your submission is for consideration in this Article Collection. Promo codes are used to identify articles that belong to a specific Collection, so it is important to use the correct code.

    The deadline for submitting a manuscript is 15 August 2024. If you have questions, please contact Krista Thom at [email protected].

    Guest Advisor

    Prof. Durga Prasanna Misra, Associate Professor, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    View all papers in this article collection

    Journal of Multidisciplinary Healthcare

    Crosstalk in multidisciplinary approaches for evidence-based medicine

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection in the Journal of Multidisciplinary Healthcare on "Crosstalk in multidisciplinary approaches of evidence-based medicine", organized by co-Guest Advisors Dr. Yao-Chin Wang (Min-Sheng General Hospital and Taipei Medical University, Taiwan), Dr. Sunil Kumar (Nottingham Trent University, England), and Lead Guest Advisor Dr. Woon-Man Kung (Taipei Tzu Chi Hospital and Chinese Culture University, Taiwan).

    Evidence-based medicine (EBM) provides care to patients using the appropriate use of the best available evidence. EBM has increased due to the advancement of clinical measurements, research design, and efficient data analysis techniques. A multidisciplinary approach and the capacity of available evidence have made EBM more reliable than ever. The current development's objective is to achieve high-quality clinical research in the field of clinical decision-making. Now EBM is laced with new clinician skills that provide the edge in collecting vital information about patients' diagnosis, therapy, prognosis, clinical trial studies, and healthcare issues. Therefore, crosstalk in EBM with interdisciplinary consideration has become essential to better understand and serve patients and our society. Certainly, crosstalk on EBM in a multidisciplinary approach will provide options for treatments, medications, harmful side effects, and any potential risks involved.

    Any article types related to healthcare, clinical, and medicines are welcomed. Relevant subtopics may include but are not limited to the following:
    • Diagnosis and nonsurgical treatment of diseases
    • Elucidation of disease processes and management protocols
    • Patient perspectives, including satisfaction, quality of life, health literacy, and communication
    • Development of new healthcare programs and optimizing clinical outcomes
    • Monitoring and treatment protocols
    • Multi-system disease processes

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31 December 2024.

    Please submit your manuscript on our website, quoting the promo code GGICE to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Journal of Pain Research

    The Future of Pain Medicine: Emerging Technologies, Treatments, and Education

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “The Future of Pain Medicine: Emerging Technologies, Treatments, and Education” organized by Guest Advisors Dr. Giuliano Lo Bianco, Dr. Christopher Robinson, Dr. Ryan S D'Souza, Dr. Robert Jason Yong, and Dr. Tess Veuthey in the Journal of Pain Research.

    "Emerging Technologies, Treatments, and Education" is an in-depth examination of how cutting-edge technologies are revolutionizing pain medicine and education for chronic pain providers and trainees. This Collection explores the transformative impact of emerging technologies such as artificial intelligence, virtual reality, cloud-based technologies, wearables, and novel roles for neuromodulation. By integrating these technologies, pain management and training can be enhanced and patient outcomes improved. Authors are encouraged to contribute their expertise and research findings to advance our understanding of these technologies' role in shaping the future of pain management and education. Whether you are an established researcher or an emerging scholar, this Collection provides a unique opportunity to contribute to the evolving narrative of pain medicine. Join us in exploring the frontiers of technology-driven advancements that promise to transform how we perceive, diagnose, and alleviate pain.

    Traditional approaches to pain management face challenges in providing personalized and effective interventions. The integration of artificial intelligence allows for data-driven precision medicine, enabling tailored treatment plans based on individual patient characteristics. Virtual reality offers innovative therapeutic interventions, providing patients an immersive environment to alleviate pain and improve well-being. Cloud-based technologies facilitate seamless data sharing, fostering collaboration among healthcare professionals and researchers globally. Wearables provide real-time monitoring and feedback, enhancing the understanding of pain patterns and enabling timely interventions. Neuromodulation continues to expand its applicability, treating even more conditions than previously considered. Furthermore, pain education must continually evolve to meet the growing arsenal of tools that providers can utilize in their practice. This Collection aims to showcase the significance of these advancements, encouraging researchers to contribute to the ongoing dialogue and propel the field toward a future where technology serves as a powerful ally in the fight against pain.

    The Collection invites contributions that span a spectrum of subjects aligned with the scope of our journal.

    Subtopics include, but are not limited to:

    • Application of artificial intelligence, virtual reality, wearables, and cloud-based technologies in collaboration, monitoring, diagnosis, management, and outcomes.
    • Novel applications of neuromodulation such as sensory, motor, or functional restoration.
    • Exploration of psychedelics for the management of chronic pain.
    • Education reform to accommodate a more efficient and comprehensive training process that equips trainees with the necessary skills to start practice.

    Preferred article types for this Collection include original research articles, scoping reviews, systematic reviews and/or meta-analyses, editorials, and perspectives that contribute to the scholarly discourse and foster a deeper understanding of the intersection between emerging technologies and pain management.

    Through this diverse array of contributions, we aim to assemble a Collection that not only informs but also sparks dialogue and innovation in the field.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 1 September 2024.

    Please submit your manuscript on our website, quoting the promo code MYDFN to indicate that your submission is for consideration in this Article Collection.

    Please do not hesitate to contact Commissioning Editor Alice Soteriou at [email protected] should you have any questions with regards to your submission.

    Guest Advisors

    Dr. Giuliano Lo Bianco, MD, PhD, FIPP, EDPM, is a distinguished expert in Anesthesia and Pain Therapy, specializing in percutaneous fluoro/ultrasound-guided interventions. With a commitment to advancing pain therapy, he collaborates with leading experts globally and holds key positions at Fondazione G. Giglio di Cefalù since 2020, serving as the Head of the Operational Unit for Analgesia and Percutaneous Surgery. Dr. Lo Bianco is an esteemed educator, sharing his expertise through lectures at the University of Palermo and the University of Pavia, contributing to the development of pain therapy programs. His dedication to advancing pain medicine and research makes a lasting impact on healthcare and well-being.

    Dr. Christopher Robinson, MD, PhD is a resident physician-scientist at Harvard Medical School-BIDMC and will be doing his chronic pain fellowship at Brigham and Women's Hospital. Dr. Robinson did his MD, PhD in stem cell biology in the lab of Dr. Shuibing Chen at the Weill Cornell Medicine/Rockefeller University/Sloan-Kettering Tri-Institutional MD-PhD Program. His team leadership experience from running a startup during his PhD allowed him and his PhD team including the 2020 Nobel Prize winner in medicine, Dr. Charles Rice, to discover a new anti-viral drug targeting Zika virus during the epidemic. Prior to his MD/PhD, he completed his undergraduate studies at Georgetown University in Washington DC. Now, his chronic pain research team, consisting of members across the globe, work together to accomplish science and medicine in a whole different way utilizing everyone's skillsets across all specialties from machine learners (artificial intelligence developers) to physician-scientists to ethicists to bring education and research to all while keeping the patient at the center.

    Dr. Ryan S D’Souza is an interventional pain physician and anesthesiologist in Mayo Clinic. He was ranked in the top 1% of physicians in the country based on national clinical knowledge testing required to graduate from residency and fellowship. Dr. D'Souza is currently an Associate Professor of Anesthesiology and Perioperative Medicine at Mayo Clinic (Rochester). His clinical and research interests include spinal cord stimulation, peripheral nerve stimulation, fibromyalgia, evidence appraisal, and education. He has lectured both national and internationally and has published extensively in neuromodulation and chronic pain.

    Dr. Robert Jason Yong earned his medical degree and Master of Business Administration at Baylor College of Medicine in Houston. He completed his internship in General Surgery at Beth Israel Deaconess Medical Center in Boston and completed his residency in Anesthesiology at Brigham and Women’s Hospital in Boston, where he was named Chief Resident, an FAER Scholar and a Distinguished Resident. Dr. Young completed his fellowship in Pain Medicine at Brigham and Women’s Hospital in Boston. He completed his Bachelor of Arts in Biology at the University of Texas at Austin.

    Dr. Tess Veuthey MD/PhD is a neurology resident at Stanford interested in neural engineering, chronic pain, psychedelics, and health disparities. Her PhD examined neural representations of behavior in rodents learning motor skills and brain-machine interface tasks. She is looking to bring tools from those fields into the study of chronic pain and its treatment. Dr. Veuthey aims to integrate neuromodulation and psychedelics to collaboratively develop safe, effective treatments for neuropsychiatric conditions both within and outside of formal medical contexts. She has been supported by a Fulbright Fellowship, National Defense Science and Engineering Graduate Fellowship (NDSEG), North American Neuromodulation Society Diversity and Outreach Committee Pipeline Fellowship Grant, and NINDS R25.

    View all papers in this article collection

    Nature and Science of Sleep

    Dreaming of Victory: The Influence of Sleep on Athletic Performance

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Dreaming of Victory: The Influence of Sleep on Athletic Performance" in Nature and Science of Sleep.

    The intricate relationship between sleep and athletic performance is an emerging field of interest within sports science and medicine. This Article Collection seeks to explore and deepen our understanding of how sleep impacts the physical and mental capabilities of athletes. We aim to address the dynamic interplay between sleep patterns and athletic performance, acknowledging the crucial role that rest and recovery play in achieving peak performance levels.

    Recent studies underscore the significance of sleep as a cornerstone of athletic recovery and performance enhancement. Insufficient or disrupted sleep can severely impair cognitive functions, mood, and physiological recovery, leading to decreased performance and increased injury risk. However, there is a pressing need for evidence-based interventions and strategies tailored to the unique lifestyle and stressors of this population. This call for research aims to fill the gap in our current understanding and provide actionable insights for athletes, coaches, and practitioners.

    We invite contributions that shed light on the multifaceted relationship between sleep and athletic performance. Submissions may cover a range of topics, including, but not limited to:

    • The effects of sleep quality and quantity on physical performance.
    • The impact of travel, training schedules, and psychological stress on sleep patterns.
    • The effectiveness of various sleep intervention strategies tailored for athletes.
    • The importance of napping on cognitive performance.

    We welcome original research articles, systematic reviews, and meta-analyses that contribute to our understanding of how to optimize sleep for enhancing athletic performance and recovery.

    By focusing on intervention research, this collection aims to offer new perspectives and evidence-based recommendations to improve sleep health among elite athletes. We encourage submissions from a diverse array of disciplines to foster a holistic understanding of the topic.

    This call for papers represents an exciting opportunity for researchers and practitioners to advance the science of sleep and athletic performance. Join us in contributing to a specialized Collection that promises to inform best practices and foster innovative approaches to athlete health and well-being.

    Guest Advisor

    Matt Driller, Associate Professor in Sport and Exercise Science, La Trobe University, Melbourne, Australia

    Submission Instructions

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code EABZJ to indicate that your article should be considered for this Collection. Standard article publishing charges apply.

    The manuscript submission deadline is 30 September 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

    View all papers in this article collection

    The Fundamentals of Sleep-Wake and Consciousness

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Fundamentals of Sleep-Wake and Consciousness" in Nature and Science of Sleep.

    Consciousness remains one of the most elusive and fascinating mysteries of life. Every day and night, human beings and other species naturally transition between consciousness and unconsciousness, i.e., between wakefulness and sleep. A disruption of this process can result in sleep-wake disorders, such as central disorders of hypersomnolence, parasomnia, or insomnia. However, the alteration of consciousness or presence of unconsciousness is not limited to sleep-wake cycles but includes other prominent examples such as anesthesia, disorders of consciousness (e.g. due to brainstem lesions), epilepsy, and neuro-psychiatric disorders (e.g., encephalitis or psychosis).

    The identification of essential brain structures and their associated networks involved in the regulation of sleep-wake functions and other altered states of consciousness is key to the understanding of the formation and modulation of consciousness. This fundamental pillar of neuroscience contributes to the understanding of (patho)physiology and forms the foundation for diagnosis, prognostication, and therapeutic approaches of many disorders.

    We welcome original articles, study protocols, and reviews (narrative and systematic) that highlight new advances and provide insight into the fundamentals of sleep and consciousness. Although submissions should be sleep-wake related, this call emphasizes inter- and transdisciplinary research.

    • Areas of interest include but are not limited to:
    • Theoretical concepts
    • Innovative study protocols
    • Novel methodologies for monitoring sleep and consciousness
    • The impact of circadian rhythms on sleep-wake and consciousness
    • New therapeutic concepts for improving sleep-wake functions and promotion of consciousness
    • Public health implications of disorders affecting sleep-wake and consciousness

    There is no restriction on species.

    Guest Advisor

    Dr. David Schreier, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA

    Submission Instructions

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code VVTXY to indicate that your article should be considered for this Collection. Standard article publishing charges apply.

    The manuscript submission deadline is 15 November 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

    View all papers in this article collection

    The Interplay Between Sleep and Pain

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The Interplay Between Sleep and Pain" in Nature and Science of Sleep.

    Among individuals with chronic pain, more than half suffer from sleep problems. Emerging evidence from different settings and methodological approaches suggests that sleep problems can lead to a greater risk and poorer prognosis for chronic pain conditions. This has led to the view that sleep and pain perpetuate and exacerbate each other. 

    To develop more refined therapeutic strategies for individuals suffering from pain and sleep problems, we need a better understanding concerning the long-term trajectories of these conditions, the impact of sleep quality on pain management, and the underlying mechanisms of the sleep-pain relationship. 

    Important questions remain about the role of sleep in the treatment of chronic pain, including what components of the sleep therapy are useful, in what format, and whether targeting sleep problems is effective for all types of patients. 

    Moreover, technological innovations may offer great potential for a better understanding of the impact of different sleep characteristics in the development and clinical course of different types of chronic pain – knowledge that may have great implications for healthcare policy and clinical practice. 

    We seek rigorous and high-quality observational, experimental, or intervention-based studies in the area of sleep and pain to address gaps in knowledge. We will consider reviews/meta-analyses, expert opinions, and commentaries if they make a significant contribution to the field. 

    Topics of interest include: 

    • The impact of sleep quality on pain management, including pharmacological and non-pharmacological approaches for the management of sleep problems
    • Mechanisms contributing to the sleep-pain relationship
    • Longitudinal studies and factors influencing the sleep-pain relationship
    • Causal approaches that address confounding and/or reverse causation
    • Technological innovations and their clinical relevance in individuals with sleep and pain
    • Population-specific considerations (e.g., psychosocial and sociodemographic factors)

    Guest Advisor 

    Dr. Eivind Schjelderup Skarpsno

    Norwegian University of Science and Technology (NTNU), Trondheim, Norway

    Submission Instructions

    All manuscripts submitted to this Article Collection will undergo full peer-review; Guest Advisors will not be handling submitted articles. Please review the journal’s aims and scope and author instructions prior to submission.

    Please submit your manuscript through the Dovepress website. During submission, enter the promo code ZATAE to indicate that your article should be considered for this Collection. Standard article publishing charges apply.

    The manuscript submission deadline is 1 October 2024. If you have any questions about this Article Collection, please contact Krista Thom at [email protected].

    View all papers in this article collection

    Neuropsychiatric Disease and Treatment

    Advanced Neurorestoratology: Basic and Clinical Research

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advanced Neurorestoratology: Basic and Clinical Research", organized by Guest Advisors Dr. Lin Chen, Dr. Tao Feng, and Dr. Gengsheng Mao in Neuropsychiatric Disease and Treatment

    Neurorestoratology is an emerging clinical discipline of neuroscience and medicine and intersects with many other medical disciplines. It mainly treats patients with neuropsychiatric disorders, impairments, and sequelae that seriously affect human health, diseases that were once believed to have no effective treatments, such as Alzheimer's disease, stroke, severe Parkinson's disease, traumatic brain injury, depression, autism, spinal cord injury, cerebral palsy, etc. The aim of its treatments is to improve patients' damaged neurological functions and/or structures and enhance their quality of life. 

    The basic theory of Neurorestoratology is “Neurorestorable theory in the central nervous system” which integrates various scattered and isolated neurorestorative mechanisms that lack correlation with each other. The treatment mode of Neurorestoratology is to integrate different single neurorestorative techniques into a comprehensive neurorestorative treatment strategy. Currently, this discipline is changing the traditional cognitive and therapeutic mode for neuropsychiatric diseases and damage. Research in the field of advanced neurorestoratology is a hot topic and is developing rapidly. 

    Basic and clinical research papers, case reports, and reviews on geriatric, pediatric, hereditary, and traumatic disorders in the central nervous system are of particular interest. Exploring neurorestorative strategies is welcome, which involves cell therapy, tissue engineering or bioengineering, neuromodulation by electro-magnetic stimulation, neural prostheses or a brain-machine interface, pharmacotherapy or chemical therapies, neurorestorative surgery, active rehabilitation training, etc., and combining applications. 

    Keywords

    • Neurorestoratology
    • Basic research
    • Clinical research
    • Treatment
    • Cell therapy

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are existing members of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 31 December 2024.

    Please submit your manuscript on our website, quoting the promo code EASXF to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Lin Chen, Department of Neurosurgery, Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine, Beijing, China

    [email protected]

    Dr. Lin Chen, M.D. and Ph.D., Director of Department of Neurosurgery, focuses on neurorestoration of spinal cord injury, stoke, facial paralysis, etc., using cell therapy, neuromodulation and pharmacy; and trigeminal neuralgia and hemifacial spasm by restorative microvascular decompression surgery. 

    Tao Feng, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

    [email protected]

    Dr. Tao Feng, M.D. and Ph.D., Deputy Director of Department of Neurology, focuses on the clinical and translational medicine research of Parkinson’s disease and other movement disorders; the investigation of diagnostic biomarkers, imaging mechanisms, and non-invasive brain stimulation technique of Parkinson’s disease and Parkinsonism.

    Gengsheng Mao, Department of Neurosurgery, The Third Medical Centre Chinese People’s Liberation Army General Hospital, Beijing, China

    [email protected]

    Dr. Gengsheng Mao, the director of neurosurgery of the Third Medical Centre Chinese People’s Liberation Army General Hospital,  is a specialist in neurorestoratology, and has authored or co-authored several neurorestorative-related guides. He is proficient in open and interventional surgeries for cerebrovascular diseases, peripheral nerve surgeries for motor disorders following stroke and other diseases, as well as surgeries for brain tumors, brain trauma, and spinal cord diseases.

    View all papers in this article collection

    All about Psychogenic Non-Epileptic Seizures (PNES) and Functional Neurological Disorders (FND)

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "All about Psychogenic Non-Epileptic Seizures (PNES) and Functional Neurological Disorders (FND)", organized by Guest Advisor Dr. Daichi Sone in Neuropsychiatric Disease and Treatment

    Psychogenic non-epileptic seizures (PNES), also known as a form of functional neurological disorders (FND), is a medically unexplained seizure disorder. PNES mimics epileptic seizures, but there is no evidence that they are caused by abnormal electrical activity in the brain like epilepsy, and it is generally supposed that they are caused by psychological factors. 

    Although PNES is a common condition encountered in neuropsychiatric clinical practice, it is often misunderstood and misdiagnosed, leading to inappropriate treatments, such as unnecessary and harmful antiseizure medications for a long time. In addition, the gold standard for diagnosing PNES is video-EEG monitoring to record symptoms and EEG during PNES, but access to video-EEG monitoring varies widely from region to region, which is problematic. In addition, with appropriate treatment, such as rehabilitative and psychotherapeutic approaches, the prognosis for PNES is not necessarily poor, but the lack of a known mechanism of the disorder makes it difficult to develop a fundamental treatment. In recent years, it has attracted attention also in the field of neurology as a form of FND, and the neural mechanisms and the possibility of new treatments have been suggested. 

    This Article Collection solicits papers, original research or review articles, on any aspect of PNES, including but is not limited to, psychosocial, clinical practice, psychiatric, neurological, and neuroscientific aspects; papers on conversion disorders other than PNES or other types of FND may also be considered. It is hoped that the review of the current state and novel discoveries will develop better clinical practice for PNES and FND. 

    Keywords

    • Psychogenic Non-Epileptic Seizures (PNES)
    • Functional Neurological Disorders (FND)
    • Functional Seizures
    • Conversion Disorder
    • Epilepsy

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    The deadline for submissions is 31 August 2024.

    Please submit your manuscript on our website, quoting the promo code DPNSP to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Daichi Sone, Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan

    [email protected]

    After graduating from the University of Tokyo, Faculty of Medicine in 2008, Dr. Daichi Sone began his clinical career as a neuropsychiatrist through basic and specialized training. From 2012, he started working at National Center of Neurology and Psychiatry, Tokyo, Japan, specializing in neuropsychiatry, epileptology, and neuroimaging. He obtained PhD degree at Graduate School of Medicine, the University of Tokyo in 2017, and then, to develop the expertise in neuroimaging for epilepsy, he moved to London and launched the next career in Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology. Since 2021, Dr. Sone has been working at Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan, as a Senior Lecturer.

    View all papers in this article collection

    Cognitive dysfunction in bipolar disorder: Bio-psycho-social perspective

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Cognitive dysfunction in bipolar disorder: Bio-psycho-social perspective", organized by Guest Advisor Dr. Kuniyoshi Toyoshima in Neuropsychiatric Disease and Treatment.

    Bipolar disorder affects >1% of the global population, and it causes cognitive impairment, functional disability, and death by suicide. Bipolar disorder is also characterized by recurring manic and depressive episodes. In individuals with bipolar disorder, not only mood symptoms but also cognitive impairment affects quality of life, even during euthymic phases and in the case of young people. Cognitive impairment also correlates with illness awareness, social function, suicidal ideation, etc. Therefore, recently, cognitive dysfunction has become considered to be a treatment target.

    However, the pathology of cognitive impairment in bipolar disorder has not been elucidated. Furthermore, an effective treatment for cognitive dysfunction in bipolar disorder has not yet been established. Hence, in clinical settings, biological, psychological, and social interventions are performed in combination according to the patient’s condition.

    This Article Collection seeks papers that study cognitive impairment in bipolar disorder, in terms of the bio-psycho-social perspective. It is hoped that this Article Collection will contribute to well-being and functional recovery in individuals with bipolar disorder.

    Keywords:
    • Cognitive dysfunction
    • Bipolar disorder
    • Functional recovery
    • Well-being
    • Bio-psycho-social perspective

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code QGCFU to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Current Insights into the Epidemiology, Risk Factors, Treatment and Management Options of Seizures and Epilepsy After Stroke

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Current Insights into the Epidemiology, Risk Factors, Treatment and Management Options of Seizures and Epilepsy After Stroke", organized by Guest Advisor Dr. Beata Sarecka-Hujar in Neuropsychiatric Disease and Treatment

    Stroke is a serious medical problem resulting in several harmful neurological consequences which in both pediatric and adult patients affect everyday functioning and increase the costs of medical care and rehabilitation. Seizures and epilepsy are among the most common consequences of stroke although the incidence differs between the populations. Ischemic stroke is the cause of half of the epileptic seizures that newly occur in the population of patients above 60 years of age. Based on the time of onset of epileptic seizures after stroke, they can be divided into early (occurring up to 7 days after stroke) and late seizures (occurring up to 2 years after stroke), which are characterized by different pathomechanisms. 

    It was reported that the mortality rate of stroke patients who experience poststroke seizures is significantly higher than that of all ischemic stroke patients. Moreover, it has been shown that seizures after stroke increase disability at discharge and also prolong hospital stay. In contrast, data on pediatric stroke patients have not shown increased mortality or disability in relation to early seizures. The available data may seem quite heterogeneous due to the definitions changing in recent years. Since 1.1 million patients suffer a stroke each year in Europe and poststroke survival rates improve, the number of patients with poststroke epilepsy continues to increase. In poststroke epilepsy, antiepileptic drug therapy is overall effective and monotherapy is sufficient in most patients, but there are still some treatment issues that require in-depth evaluation. Also, it remains difficult to assess the risk of poststroke seizures however some first attempts at predicting late seizures were demonstrated with promising results. Therefore, more detailed knowledge about risk factors for poststroke seizures and epilepsy and the ability to predict their occurrence may improve the prevention and treatment of the disease. 

    The present Article Collection will focus on the current opinions on epidemiology, risk factors, classification and treatment as well as prognosis in poststroke seizures and epilepsy both in adults and children. This Collection will cover clinical cohort studies, studies on biomarkers, prospective and retrospective studies concerning epidemiology and treatment options, or neuroimaging studies. 

    Keywords

    • Stroke
    • Poststroke Seizures
    • Epilepsy
    • Poststroke Consequences
    • Antiepileptic Treatment

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    The deadline for submissions is 31 August 2024.

    Please submit your manuscript on our website, quoting the promo code BQGZY to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Beata Sarecka-Hujar, Faculty of Pharmaceutical Sciences, Medical University of Silesia, Katowice, Poland

    [email protected]

    Beata Sarecka-Hujar, Ph.D. at the Medical University of Silesia in Katowice. Dr. Sarecka-Hujar conducts research on epidemiology, risk factors for cardiovascular diseases in adults as well as on risk factors and outcomes of neurological diseases, e.g. arterial ischemic stroke, epilepsy, schizencephaly, cerebral palsy in the paediatric population. Additionally, Dr. Sarecka-Hujar is interested in modern techniques for manufacturing and controlling pharmaceutical preparations. Dr. Sarecka-Hujar is a member of the Editorial Board of several journals, including BMC Pediatrics (Associate Editor), Brain Sciences, Journal of Pediatric Genetics, and Advanced Neurology. Dr. Sarecka-Hujar is an author of over 125 full-text articles, which can be found on ResearchGate or ORCID.

    View all papers in this article collection

    Epileptic disorders: advances in the diagnostic and therapeutic strategies

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Epileptic disorders: advances in the diagnostic and therapeutic strategies", organized by Guest Advisors Dr. Luo Zhou and Dr. Bo Xiao in Neuropsychiatric Disease and Treatment.

    Epilepsy is a neurological disorder that affects a substantial number of individuals worldwide, with more than 70 million individuals suffering from this condition. It is considered to be one of the most common serious diseases of the central nervous system. The incidence of epilepsy shows a bimodal distribution, meaning that the highest risk of developing the disorder is observed in infants and older age groups. The clinical presentation of epilepsy can vary greatly from person to person, resulting in diverse symptoms and manifestations. These variations can have a profound impact on the patients’ quality of life, affecting their daily activities, social interactions, and overall well-being.

    For clinical approaches, investigations such as brain imaging and genetic testing could aid in identifying the underlying etiologies and predicting the prognosis. In recent years, the field of precision medicine has gained significant attention in the context of epilepsy. Through the discovery of genes associated with these disorders, researchers have been able to advance their understanding of the underlying biology and pathogenesis of epilepsy. This newfound knowledge has opened up possibilities for developing targeted therapies that can modify or even cure the condition. The advances in brain imaging techniques have also played a significant role in epilepsy research. These imaging modalities, including structural magnetic resonance imaging (MRI), functional MRI (fMRI), and positron emission tomography (PET) have enabled researchers to identify structural and functional abnormalities in the brain that may be responsible for causing or contributing to epileptic seizures.

    Furthermore, an improved understanding of the gradual development of epilepsy, as well as the role of epigenetic factors and pharmacogenomics, has offered hope for the development of better therapeutic strategies. Researchers are exploring both pharmacological and non-pharmacological approaches to treat epilepsy, with the aim of improving patient outcomes and enhancing their quality of life. This Article Collection will focus on the latest research progress in epilepsy diagnosis and treatment. It will cover topics such as clinical observational study, neuroimaging study, genetic analysis, mechanism research, prospects for further targeted treatment, and rehabilitation interventions. By highlighting these advances, the collection aims to provide valuable insights for clinicians, researchers, and patients alike personalized approaches for managing epilepsy.

    Keywords:
    • Epilepsy
    • Diagnostic and therapeutic strategies
    • Neuroimaging
    • Genetic analysis
    • Targeted treatment

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this Collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code TPAGK to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Suicide Prevention and Intervention: Recent Evidence and Future Directions

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Suicide Prevention and Intervention: Recent Evidence and Future Directions", organized by Guest Advisors Dr. Sidney Kennedy and Dr. Amanda Ceniti in Neuropsychiatric Disease and Treatment.

    Suicide is an ongoing global public health concern, with over 800,000 deaths annually worldwide, and an estimated 20-25 times more attempts. The enduring impacts on families and communities cannot be overstated, with recent estimates suggesting over 100 people are affected for each death by suicide. Risk and protective factors are complex, spanning biological factors such as brain connectivity and genetic markers, psychological factors such as hopelessness and psychological pain, and social/environmental factors such as housing insecurity and financial stress. Consistent with current understanding of mental health conditions, there are no single clinical or biological markers that definitively predict suicide-related outcomes, and integrated approaches may be more fruitful. Importantly, suicide is recognized as a transdiagnostic entity, occurring both across and outside of mental health conditions, providing an impetus to study its prevention and management in and of itself and not simply as a symptom of a mental health condition such as depression.

    Unfortunately, despite increasing awareness and research interest in recent decades, suicide risk prediction remains imprecise. There is a need for rigorous research on evidence-based interventions and better understanding of risk and protective factors. It is also vital to recognize the higher risk among specific marginalized communities and the need for culturally competent care. This topic is especially urgent given the ongoing mental health impacts of the COVID-19 pandemic, in which early reports demonstrated an increase in suicidal thoughts.

    This Article Collection seeks to collect and share recent perspectives in suicide research through a multidisciplinary, transdiagnostic lens. From neurobiological studies of suicide risk to qualitative studies exploring relevant social determinants of health, this collection will cover broad perspectives on suicide prevention, intervention, and management. We welcome Original Research and Review articles on the following themes:
    • Clinical topics, including risk assessment and management
    • Suicide prevention strategies, including reducing access to lethal means and digital health approaches
    • Neurobiology of suicide, including neuroimaging, genetic, biological, or neurocognitive studies to better understand the neurobiological mechanisms involved in suicide risk and identify potential predictive markers
    • Impact of COVID-19, from the broader global mental health and economic effects of the pandemic, to the direct individual impacts of COVID-19 infection and/or Long-COVID on suicide risk
    • Specific populations who may have increased suicide risk, including LGBTQ2S+ communities, Indigenous communities, racialized groups, youth/young adults, and military/veteran populations
    • Suicide intervention strategies, including the current evidence for psychotherapy, pharmacotherapy, and psychosocial interventions

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code AFTXM to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    The effectiveness of non-pharmacological interventions for people with cognitive dysfunction

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "The effectiveness of non-pharmacological interventions for people with cognitive dysfunction", organized by Guest Advisors Professor Hsin-Hung Wu, Professor Pei-Fen Wu, and Dr. Kai-Ming Jhang in Neuropsychiatric Disease and Treatment.

    There is no curable treatment for dementia. Strategies about how to prevent cognitive decline from the stages of subjective cognitive dysfunction or mild cognitive impairment into dementia are important. Appropriate care for people living with dementia (PLWD) and their caregivers, such as transferring suitable care facilities or communication skills according to their care needs, is also necessary.

    The journal is seeking original submissions and review articles on the following topics related to the effectiveness of non-pharmacological intervention:
    • Benefits of technological intervention in cognitive impairment: Technological intervention brings personalized, engaging, and innovative approaches to cognitive training, art therapy, reminiscence therapy, and social engagement and support. By leveraging technology, these interventions enhance cognitive functioning, stimulate creative expression, foster emotional well-being, and facilitate social connections, ultimately improve the overall quality of life for individuals.
    • Assistive tools, devices, data analytics, and predictive models.
    • The effectiveness of psychoeducation, behavioral therapy, multisensory therapy, therapeutic activities, individualized or group setting, on the change of cognitive function, behavior and psychological symptoms of dementia (BPSD) or physical function.
    • The effectiveness of care models, such as specialized dementia units, collaborative care models, or case manager leading care coordination, on the change of cognitive function, BPSD or physical function.
    • Benefits of different care facilities or care delivery systems on PLWD or their caregivers.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 30 September 2024.

    Please submit your manuscript on our website, quoting the promo code CPDTH to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    OncoTargets and Therapy

    Understand and target the complexity of the tumor milieu

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Understand and target the complexity of the tumor milieu" in OncoTargets and Therapy.

    The process of tumor initiation and progression is influenced by genetic/epigenetic alterations in tumor cells and the rearrangement of the tumor microenvironment (TME) through complex signaling networks. The TME consists of various components, including tumor cells, stromal fibroblasts, endothelial cells, immune cells, and extracellular matrix (ECM) components. Crosstalk between tumor cells and these non-malignant cells in the TME plays a critical role in promoting tumorigenesis, metastasis, and drug resistance.

    Interactions within the TME involve cytokines, chemokines, growth factors, and other mediators, as well as novel mechanisms such as circulating tumor cells (CTCs), exosomes, cell-free DNA (cfDNA), and apoptotic bodies that contribute to horizontal gene transfer between tumor and normal cells. Understanding these interactions is essential to understanding tumor growth and metastasis. Targeting the TME offers potential opportunities for cancer treatment and personalized therapy.

    This Article Collection seeks research and review articles that focus on the molecular interactions between cancer cells and TME components, the link between tumor heterogeneity and metabolic plasticity, and related strategies that can bridge the gap between preclinical and clinical research.

    The deadline for submissions is 31 August 2024. Please review the journal’s aims and scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code SCXVO to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Yong Teng, Emory University and Georgia Tech

    [email protected]

    Dr. Teng is an Associate Professor in the Department of Hematology and Medical Oncology at Emory University and an Adjunct Associate Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. He is the inaugural recipient of the Winship Cancer Institute Wally Award and a member of the BME Program and BDCI at Emory University. Dr. Teng's primary research interests are in tumor microenvironment, tumor metabolism and metastasis, with a focus on molecular determinants and paradigm-shifting treatment regimens.

    Nabil F. Saba, Emory University

    [email protected]

    Dr. Saba is Professor and Vice Chair of the Department of Hematology and Medical Oncology. He holds the Lynne and Howard Halpern Chair in Head and Neck Cancer Research and serves as Co-Director of the Head and Neck Cancer Multidisciplinary Program at the Winship Cancer Institute of Emory University. Dr. Saba is a recognized expert in immunotherapy for head and neck cancer and leads numerous translational research efforts focused on targeting the tumor microenvironment.

     

    View all papers in this article collection

    Open Access Emergency Medicine

    Decision making within the first hour of admission

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on “Decision making within the first hour of admission", edited by Editor-in-Chief Dr Amit Agrawal in Open Access Emergency Medicine.

    Upon submission, please use the promo code LQHJW for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series "Decision making within the first hour of admission". The deadline for manuscripts is the 31st May 2024.

    For any enquiries, please email Victoria Ship at [email protected]

    About the Thematic Series

    For a long time, the concept of the importance of decision-making within the first hour of admission has been used to improve the outcomes in trauma and stroke practice. Recently, this concept has been expanded to various other clinical disciplines including neonatal, toxicology, shock, etc. The philosophy of this approach utilizes the advancements in patient care algorithms, multidisciplinary approach, inter-team communication and collaboration protocols. The main aim of this is to shorten the delay between admission and start of definitive management, improving patient outcomes in the process. The present Series is an effort to comprehensively present the elaborative concept of decision-making within the first hour of admission and its expanded applications in one platform.

    Journal Editors are seeking original research, and review article submissions on the following topics; however this list is not exhaustive, and contributors are welcome to modify or add a title of their interest.

    Decision-making within the first hour of admission:
    • scope and opportunities
    • in trauma care
    • in the emergency room
    • and thermoregulation
    • in polytrauma care
    • in neurotrauma interventions
    • and neonatal life
    • and stroke
    • and management of shock
    • and cardiovascular medicine
    • in toxicology practice
    • role of intensive care unit
    • resuscitation and stabilization
    • role of technology
    • quality care opportunities and challenges
    • logistics challenges and solutions
    • a perspective form developed economies
    • gaps and challenges in low- and middle-income countries
    • from onset-to-intervention: how to reduce time delays
    • protocols: how to measure the impact
    • capacity building

    Submit your manuscript
    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    Open Access Journal of Contraception

    Complexities in contraception

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on “Complexities in contraception”, edited by Editor-in-Chief Professor Igal Wolman in the Open Access Journal of Contraception.

    Upon submission, please use the promo code ZKTCB for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series of “Complexities in contraception”. The deadline for manuscripts is the 31st of May 2024.

    For any enquiries, please email Darcy Hodge, Commissioning Editor at [email protected]

    About the Thematic Series

    In the modern world, contraception forms a regular part of life and medical care to cover a range of symptoms, preventative needs and additional concerns. With a wealth of choice in contraceptive care, it seems probable that complexities arise. This Thematic Series will investigate how medication-based contraceptives compare against Long-Acting Reversible Contraceptives, in terms of their efficacy, safety and use to treat multiple aspects of reproductive health. How do contraceptives go beyond their physical effects to affect psychological wellbeing? Moreover, when regular contraception fails, the efficacy of emergency contraception will also require consideration.

    An additional complexity includes access to contraceptive devices, while it is a regular part of life, it is not as easily accessible for all. This series will also investigate the demographics influencing the accessibility of contraception and the consequences to health and wellbeing when inaccessible. Beyond geographical and physical accessibility, the perception and attitudes towards contraception may form a significant part of access. How does knowledge affect outcomes when on the topic of contraception? Does this change when focus shifts to more permanent forms of contraception, or alternative methods of contraception, including male hormonal contraception.

    Even still, complexities can arise when considering the individual and their contraceptive method of choice. Responsiveness can differ by age, or by life cycle, perhaps even the influence of pre-existing comorbidities can add to the complexities of contraception. Additional factors beyond the individual, including policies and attitudes towards delivering contraception, can affect the amount of choice provided. How about the impacts of discontinuing contraception and the effect it has on patients? All of these aspects of contraception combined can prompt the need for best practices within reproductive healthcare, of which this series intends to highlight.

    The journal is seeking original submissions and review articles on the following topics related to contraception and related issues:

    • Comparative effectiveness of contraception methods (e.g., medication, LARCs)
    • Safety and efficacy of contraceptive devices and use in multiple contexts
    • Physical and psychological side effects of contraception, including emergency contraception
    • Developments in contraceptive technologies
    • Global disparities in accessing contraception and treatment of side effects
    • Consequences of lacking accessibility
    • Attitudes towards and knowledge about contraception and reproductive health
    • Permanent contraception and associated attitudes, risk factors and best practices
    • Advances in male hormonal contraception
    • Effects and outcomes of discontinuing contraception
    • Best clinical practices for reproductive health practitioners

    Submit your manuscript

    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    Open Access Rheumatology: Research and Reviews

    World Arthritis Day 2024

    Open Access Rheumatology: Research and Reviews is pleased to invite you to submit your research to the upcoming Article Collection “World Arthritis Day 2024.”

    World Arthritis Day (WAD), recognized annually on October 12th, is a global awareness event aimed to highlight and bring awareness to the existence of rheumatic and musculoskeletal disorders (RMDs) in our daily lives. Established in 1996, WAD serves as a reminder for all to continue their vital research and to not stop educating the public about this painful yet incurable disease.

    Despite the progress made in the last few decades, experts are not yet closer to discovering a cure and the prevalence of RMDs is only increasing with longer lifespans. This exponential rise has also resulted in greater adverse health outcomes in patients including a poorer quality of life, reduced physical function, increased hospitalizations, and detrimental effects on mental health. Furthermore, many patients with RMDs can also experience a secondary condition such as cancer or cardiovascular diseases and as such, it is necessary for physicians and other professionals to not only understand and help manage the patient’s conditions, but also ease the burden of diagnosis and therapy. Treating each condition in isolation will only serve to harm rather than lead to a good outcome.

    In this regard, Open Access Rheumatology: Research and Reviews would like to invite authors to submit Original Research Articles, Reviews, Clinical Studies, and other manuscript types accepted by the journal on any subject area tailored towards arthritis that could add to the current knowledge. Possible topics include, but are not limited to:

    • Pathology and pathophysiology of arthritis;
    • Risk factors, clinical factors and diagnostic measures to improve the management of patients with arthritis;
    • Approaches to pharmacological and non-pharmacological management of arthritis;
    • Epidemiological and clinical studies on the prevalence and incidence of arthritis and comorbidities in arthritis;

    Keywords

    Arthritis; Rheumatic and Musculoskeletal Diseases; Pathology; Diagnosis; Treatment

    The deadline for submissions is 12 October 2024.

    Please submit your manuscript on our website, using the promo code GQCTA for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “World Arthritis Day 2024” Collection.

    View all papers in this article collection

    Patient Preference and Adherence

    Advancing Medical Problem-Oriented Approaches in Infectious Disease Management

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “Advancing Medical Problem-Oriented Approaches in Infectious Disease Management”, organized by Dr. Ahmad Riyad Alsayed, in Patient Preference and Adherence.

    Infectious diseases remain a significant global health challenge, with the emergence of new pathogens, the spread of drug-resistant strains, and the ongoing threat of pandemics. In response to these challenges, infectious disease management has continuously evolved, adopting innovative strategies to combat common and emerging infections. This Collection aims to highlight and disseminate cutting-edge research and developments in the field, particularly on problem-oriented approaches.

    Scope and Objectives

    This Article Collection seeks to provide a comprehensive platform for researchers, clinicians, and public health experts to share their insights and findings related to problem-oriented approaches in infectious disease management. The primary objectives of this Article Collection include:

    1. Illuminating the critical issues surrounding drugs and treatment, using classification systems like drug-related problems (DRPs), treatment-related problems, or recently, the medical problems-oriented plan (MPOP), with the ultimate goal of enhancing patient outcomes and the overall quality of care in patients suffering from infectious diseases.
    2. Exploring Novel Diagnostic Tools: Papers in this Article Collection will delve into the development and application of innovative diagnostic tools, including molecular techniques, point-of-care devices, and artificial intelligence-driven algorithms, to enhance the rapid and accurate detection of infectious pathogens, considering patient acceptance and adherence.
    3. Advancements in Therapeutic Strategies: Researchers are encouraged to present studies on discovering and evaluating new therapeutic agents, vaccines, and treatment modalities for infectious diseases. Emphasis should be placed on personalized and precision medicine approaches.
    4. Surveillance and Epidemiological Studies: Contributions that focus on using epidemiological models, big data analytics, and advanced surveillance systems to predict, prevent, and manage infectious disease outbreaks will be featured.
    5. Antimicrobial Stewardship: Papers discussing the implementation of antimicrobial stewardship programs in healthcare settings and strategies to combat antimicrobial resistance will be considered for inclusion.

    The deadline for submissions is 31 December 2024. Please review the journal’s aims and scope, alongside the author submission instructions prior to completing your submission.

    Please submit your manuscript on our website, quoting the promo code EHHUY to indicate that your submission is for consideration in this Article Collection.

    Guest advisor

    Ahmad Riyad Alsayed, Applied Science Private University

    [email protected]

    The main aims of Dr. Alsayed's practice and research are to promote evidence-based medication use to improve disease outcome and health-related quality of life of patients with internal medicine-related disorders. His current research interests include clinical pharmacy, evidence-based medicine, clinical trials of effectiveness and safety, quality of life, and pharmaceutical care,  with a special interest in infectious, respiratory, diabetes, and cardiovascular diseases.​

    View all papers in this article collection

    “How are you taking your medication?” Communication and information about medicine use

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “‘How are you taking your medication?’ Communication and information about medicine use”, organized by Dr. Liset van Dijk, Dr. Marcia Vervloet, and Dr. Laura Schackmann, in Patient Preference and Adherence

    Worldwide, many people use medication on a daily basis. However, it is not always easy for them to take these medicines properly or to start a conversation with a healthcare professional about their medication use. Furthermore, information about medication is not always easy to find and understand, especially for patients with limited health literacy. Patient leaflets, for example, often are too complex and sometimes contain information that is not relevant to the patient. Also, communication about medication between healthcare professionals and patients is often one-sided and patient-centeredness is lacking. 

    Good communication has been proven to positively affect adherence (Zolnierik 2009). In addition, clear and detailed medication-related information is important to improve proper medication use. Thus, communication and information are cornerstones in supporting patients to manage their medication. Better adherence leads to better health outcomes, better quality of life, lower healthcare use (including fewer hospital admissions), and reduced healthcare costs. 

    There is increasing attention paid to patient-centered communication and information, but still more knowledge could be gathered on how improvements in this area can be achieved, especially to improve medication use/adherence. This Article Collection welcomes articles that contribute to this, including but not limited to:

    • Innovative interventions to improve written/online/printed information about medication, especially for those with limited health literacy
    • Innovative interventions to improve communication skills of health care professionals and patients in the field of medication use/adherence
    • Observational research on patient-centeredness of communication about medication use
    • Experimental studies on information provision about medication

    The deadline for submissions is 31 October 2024. All submissions will undergo a rigorous peer-review process to ensure the quality and relevance of the contributions. We kindly ask all submitting authors to review the Aims and Scope of the journal, alongside the author submission instructions prior to completing your submission. 

    Please submit your manuscript on our website, quoting the promo code MFXTF to indicate that your submission is for consideration in this Article Collection.

    Guest advisers

    Dr. Liset van Dijk, Nivel, Netherlands institute for health services research, the Netherlands

    [email protected]

    Dr. Liset van Dijk is coordinator of the Pharmaceutical Care research program at Nivel and an honorary professor of 'Pharmacy health services research', University of Groningen, the Netherlands. Her main research interests include medication adherence, pharmaceutical patient care, pharmacist-patient communication and implementation. Liset is board member of the International Society for Medication Adherence (ESPACOMP). 

    Dr. Marcia Vervloet, Nivel, Netherlands institute for health services research, the Netherlands

    [email protected]

    Dr. Marcia Vervloet works as senior researcher within Nivel’s Pharmaceutical Care research program. Her research focuses on stimulating proper medication use from the patient’s perspective. Her expertise is on topics as medication adherence, patient-pharmacy staff communication, (understandable) information about medication, digital solutions. 

    Dr. Laura Schackmann, Nivel, Netherlands institute for health services research, the Netherlands

    [email protected]

    Dr. Laura Schackmann is postdoctoral researcher at Nivel in the pharmaceutical care research program. Her work is centered on patient-centered communication, with a special interest in challenging situations at the pharmacy counter. Also, she focuses on how the provision of health/medication-use information accommodates the needs of different patient groups.

    View all papers in this article collection

     Enhancing Medication Safety: Prioritizing Risk Management and Ensuring Safe Dispensing, Prescribing, Pharmacovigilance, and Patient Adherence

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Enhancing Medication Safety: Prioritizing Risk Management and Ensuring Safe Dispensing, Prescribing, Pharmacovigilance, and Patient Adherence", organized by Guest Advisors Dr. Mansour Adam Mahmoud and Dr. Alnada Ibrahim in Patient Preference and Adherence

    Safe medication use is of paramount importance in healthcare systems. The quality of healthcare depends on the safety of medication use, that will ultimately lead to patient safety. Medication safety involves safe medication use during dispensing, prescribing, monitoring and administering medication to the patients. Any disruption occurring in these pivotal stages has the potential for patient harm. At the forefront of these efforts, pharmacovigilance emerges as a proactive process, fostering vigilance among healthcare professionals, patients, and caregivers alike. Through appropriate adverse drug reaction reporting systems, pharmacovigilance ensures the reporting of critical information to relevant regulatory bodies. These bodies subsequently utilize the aggregated data to derive meaningful conclusions and make informed decisions regarding the safety profiles of specific medications. In addition, adherence to prescribed medications assumes paramount significance. Despite their importance, numerous studies underscore the tendency of patients to deviate from their prescribed medication regimens. Effectively measuring adherence mandates the application of validated tools tailored for this purpose. In this domain, an array of methodically validated tools exists, designed to accurately measure and evaluate medication adherence. 

    Adhering to established medication safety protocols and guidelines is of utmost significance to mitigate patient harm and enhance overall patient safety. Prominent organizations including the World Health Organization (WHO), the Institute of Safe Medication Practice (ISM), the International Pharmaceutical Federation (FIP) among others, have issued vital recommendations aimed at strengthening patient safety and enhancing medication safety. Incorporating these guidelines alongside tailored quality assurance systems within hospitals, community healthcare centers, and relevant institutions holds the potential to reduce medication errors, adverse drug events, and reactions. 

    We invite scholars, researchers, and practitioners to contribute to our upcoming Article Collection focused on the critical area of safe medication usage. The Collection aims to explore various facets, including pharmacovigilance, medication safety, safe prescribing including pharmacist prescribing, and dispensing practices, ensuring the well-being of the public. 

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    Keywords

    • Medication Safety
    • Safe dispensing and Prescribing
    • Pharmacovigilance
    • Adherence
    • Patient Safety

    The deadline for submissions is 30 September 2024. Please review the journal’s Aims and Scope, alongside the author submission instructions prior to completing your submission.

    Please submit your manuscript on our website, quoting the promo code BCDLN to indicate that your submission is for consideration in this Article Collection.

    Guest advisors

    Mansour Adam Mahmoud, Department of Clinical and Hospital Pharmacy, Taibah University

    [email protected]

    Dr. Mansour Adam Mahmoud is currently working as an associate professor at the Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University. He has more than 12 years of experience in teaching, learning and research. His areas of research interest are medication safety and pharmacovigilance, clinical pharmacy practice, pharmacy education and global health. Mansour has authored and co-authored more than 100 scientific articles published in international peer-reviewed journals. He has also authored and co-authored two book chapters and one e-book. His current Google Scholar H-index is 20, i-10 31, citations more than 1500. Mansour has actively participated in the WHO Global Patient Safety Challenge: Medication without Harm which was launched in 2017 aiming to reduce medication-related harm by 50%. Dr. Mansour has taken up roles as an associate editor and spearheaded various research topics in the realm of Medication Safety, Interventions to Mitigate Patient Harm, Vaccines Safety During Emerging Infections, and the Concerns of Special Populations and Minority Groups. Recognizing his accomplishments, international organizations have honored Dr. Mahmoud with travel awards, enabling him to share his research findings in Canada, Taiwan, and the UK.

    Alnada Ibrahim, College of Pharmacy, Princess Nourah bint Abdulrahman University

    [email protected]

    Dr. Alnada Ibrahim, PhD in Pharmacy Practice, graduated from the University of Bath, United Kingdom. She is currently working as Associate Professor at the Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdurrahman University, Saudi Arabia. Her research interests lie in the area of medication safety, pharmaceutical care, assessing pharmacists' roles in a variety of capacities, clinical pharmacokinetics, and pharmacy education. She published around 25 papers in international peer-reviewed journals. She also presented various academic topics as well as research-based papers at several national and international conferences. Currently, she is working with some multidisciplinary research groups that conduct and share research across a range of issues.

     

     

    View all papers in this article collection

    Pharmacogenomics and Personalized Medicine

    Breaking Down the Intricacies of Catabolic Enzymes

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “Breaking Down the Intricacies of Catabolic Enzymes”, organized by Editor-in-Chief Dr. Martin Bluth in Pharmacogenomics and Personalized Medicine.

    Genetic polymorphisms are one way in which people vary from one another. While initial thoughts of "variance" might include a person’s physical features, it is well established that the body’s internal processes are also subject to differ dependent on a multitude of factors. This could include traits that follow them from birth, but also polypharmacy, or even diet.

    In line with the advances in modern medicine and genetic testing, research has started to explore the plethora of information linked to catabolic enzyme polymorphisms. This can involve specifying polymorphisms of interest, such as the Cytochrome P450 (CYP) family such as those including the location on the chromosome, possible allelic variations and the impact of these polymorphisms on their parent compound, metabolites or other molecules.

    Genetic polymorphisms affect many parts of human function, irrespective of specific health status. This stresses the importance of such polymorphisms further, for both promoting wellbeing in times of health, but to also understand how to approach certain illnesses given the variance in each individual case. This Collection aims to explore the role of catabolic enzyme polymorphisms for a wide variety of disease areas, such as oncology, pulmonology, immunology, psychology, cardiology and more.

    The advances in medicine can also leave researchers asking more questions. As more drug compounds reach regulators and medicine agencies, should we be considering how enzyme polymorphisms influence the efficacy and reaction of new medicines? What dangers exist when you inhibit or enhance an enzyme reaction? When considering these possibilities for new medicines, it is also imperative to acknowledge the range of possible reactions and their severity, given that polymorphisms highlight how differences between people should not be underestimated. In turn it is hoped that this Article Collection can promote best practices when prescribing treatments, by placing leading research in this collection.

    It is also hoped that research can investigate catabolic enzyme polymorphisms with a wider lens, to understand global trends in such polymorphisms and our understanding of variance on a larger scale. Thus, exploring upcoming topics of interest in this field, such as genomic testing and the use of bioinformatics in predictive technologies, elucidating the intricacies of such interaction are now within reach. These possibilities may provide more control to the individual, their medical practitioners, drug manufacturers by acknowledging human variance stretches beyond what meets the eye. These investigations, questions and early research outcomes highlight the importance of this topic for sustaining our health as a population.

    The journal is seeking original submissions and review articles from all disease areas on the following topics related to catabolic enzyme polymorphisms:

    • Identifying and understanding polymorphisms (e.g., single-nucleotide polymorphisms)
    o All aspects of enzyme metabolism (e.g., catabolism, anabolism)
    o Associated mutations, location and allelic compositions
    o Functions of interest (e.g., CYPs, steroidogenic enzymes)
    • Incidence and variance of poor metabolizers
    • Biochemical impact of polymorphisms (e.g., on parent compound, metabolites)
    • Impact of polymorphisms on drug reaction symptoms, severity and consequences
    o Variance in pro-drug and active drug reactions
    • Non-drug consumables (i.e. diet, infectious diseases) and polymorphisms
    • How epigenetic and infectious processes affect polymorphism function
    • Treatment efficacy and polymorphisms
    o Role of polypharmacy on reactions
    o Personalized dosages, drug classes and emergency medical care
    • Global trends and variation in polymorphisms
    • Progress in polymorphism genomic testing and associated benefits and costs
    • Use of bioinformatics and modelling systems for predictive testing

    All manuscripts submitted to this Article Collection are subject to desk assessment and peer review processes as part of our standard editorial process. We kindly ask all submitting authors to review the Aims and Scope of the journal, alongside the Author Information prior to completing your submission.

    The deadline for submissions is 31 May 2024.

    Please submit your manuscript on our website, quoting the promo code FEFSM to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Pragmatic and Observational Research

    Leveraging artificial intelligence to bridge research gaps and promote equity in mental health

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Leveraging artificial intelligence to bridge research gaps and promote equity in mental health” in Pragmatic and Observational Research.

    This Article Collection seeks to explore diverse aspects of mental health research conducted in real-world settings by leveraging artificial intelligence (including machine learning, deep learning, reinforcement learning, and natural language processing). Our objective is to shed light on the intersection of mental health research with real-world applications, addressing disparities, predicting risks of adverse outcomes, identifying and assessing interventions, and enhancing patient outcomes for diverse populations. 

    Contributions to this Collection should encompass a broad spectrum of topics within real-world mental health research, including: 

    • Observational studies, both prospective and retrospective, examining disparities in mental health outcomes among diverse populations, aiming to identify and address inequities.

    • Real-world research, encompassing quantitative and qualitative methodologies, exploring the impact of social determinants of health on mental health outcomes, highlighting the interaction between environmental factors and mental well-being.

    • Comparative effectiveness research evaluating psychological and pharmacological therapies for mental health disorders in real-world contexts, providing insights into their real-world efficacy and applicability.

    • Development and validation of predictive models for identifying individuals at high risk of adverse mental health outcomes based on electronic medical record data, genetic markers, and social determinants of health.

    • Integration of multimodal data sources, such as wearable sensors, social media activity, and environmental factors, to elucidate the complex interaction between biological, environmental, and social factors in mental health disorders.

    • Application of deep learning algorithms for automated phenotyping and subtyping of mental health disorders using big data to inform personalized treatment approaches.

    • Exploration of digital therapeutics and virtual reality interventions for improving access to evidence-based mental health care, particularly among underserved populations and rural communities.

    • Utilization of natural language processing techniques to analyze unstructured clinical notes and patient-reported outcomes to extract valuable insights into treatment effectiveness and patient experiences.

    • Investigation of disparities in mental health outcomes across demographic and socioeconomic groups through large-scale epidemiological studies using electronic medical record data and population health datasets.

    • Development of decision support tools powered by artificial intelligence to assist clinicians in tailoring treatment plans, predicting treatment response, and optimizing medication management for individuals with mental health disorders.

    • Examination of the impact of telepsychiatry and remote mental health services on reducing barriers to care, improving treatment adherence, and enhancing patient engagement, particularly in rural and remote areas.

    • Validation studies assessing the reliability and validity of algorithms used in real-world mental health studies, ensuring robust and accurate assessment of outcomes. 

    Through this Collection, we aim to develop a deeper understanding of the complex nature of mental health research and the growing importance of leveraging advanced technologies and data-driven approaches to address current challenges in mental health care delivery and outcomes.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this Collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code RXCNV to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 11 October 2024. For questions about this Article Collection, including inquiries regarding discounts off of the article publishing charges, please contact Commissioning Editor Dr. MK Huffman at [email protected].

    Guest Advisors

    Dr. LiRong Wang, University of Pittsburgh, School of Pharmacy

    [email protected]

    Dr. LiRong Wang is an Assistant Professor of Pharmaceutical Sciences, School of Pharmacy at the University of Pittsburgh. His research mainly focuses on developing and applying machine/deep learning algorithms for outcome related research with electronic medical records. The diseases of interest include substance use disorder, PTSD, and Alzheimer’s diseases. 

    Dr. Oshin Miranda, University of Pittsburgh, School of Pharmacy

    [email protected]

    Dr. Oshin Miranda received her doctorate from the University of Pittsburgh, School of Pharmacy. She is an active researcher deeply committed to leveraging advanced computational techniques, including deep learning and natural language processing, to enhance mental health related outcomes research using electronic medical records.

    View all papers in this article collection

    Pharmacological intervention in atrial and ventricular fibrillation: real world evidence and regulatory considerations

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Pharmacological intervention in atrial and ventricular fibrillation: real world evidence and regulatory considerations” in Pragmatic and Observational Research edited by our journal Editor-in-Chief, Professor David Price.

    In this Article Collection, Pragmatic and Observational Research hopes to shed light on the real-world effectiveness and key considerations that surround clinical interventions for atrial and ventricular fibrillation. An emphasis will be placed on real-world studies that provide significant evidence to complement data from the key phase III randomized controlled trials. Articles on non-interventional studies, administrative and claims database analyses, patient registries, electronic health records and patient surveys will be considered. Diagnostic innovations, heart monitoring approaches, big data capacities and regulatory considerations will be tackled where applicable. This collection seeks to identify drivers of progress, key barriers and real and potential solutions for clinicians and patients. The journal will pursue scholarly leadership on novel approaches within these sub-specialties. The Editors will consider Reviews, Original Research, Editorials and Reports.

    Upon submission, please use the promo code VNXRA to indicate that your manuscript will be considered for this Article Collection. The deadline for manuscripts is August 31st, 2024.

    For any enquiries, please email Jermaine Wilcock, Commissioning Editor at [email protected]

    View all papers in this article collection

    Real-World Asthma Management: A Spotlight on Pragmatic and Observational Research

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Real-World Asthma Management: A Spotlight on Pragmatic and Observational Research” in Pragmatic and Observational Research.

    Asthma is a chronic respiratory disease affecting millions of people worldwide. While significant advances have been made in understanding asthma pathophysiology and developing treatments, managing the condition in real-world clinical practice remains a challenge.

    Classical randomized controlled trials (RCTs) are designed to maximize internal validity and to establish an unequivocal cause-and-effect relationship between an intervention and an outcome; however, these trials often exclude patients in minority groups, those with comorbidities, severe illness, or those that do not adhere to treatments. Consequently, there is a critical need for complementary data derived from pragmatic and observational studies that reflect the complexities of real-world asthma management.

    To help bridge this gap, Pragmatic and Observational Research is publishing a new hot-topic Article Collection to put a spotlight on studies that evaluate outcomes associated with real-world clinical practice. In doing so, we aim to inform clinical guidelines, improve the generalizability of results, and ultimately improve patient outcomes.

    Key areas of focus for this Collection include (but are not limited to):

    1. Prospective and Retrospective Observational Studies

    2. Comparison of Pharmacological and Non-Pharmacological Interventions

    3. Patient preference, satisfaction, convenience, acceptability and adherence

    4. Pragmatic Clinical Trials

    5. Real-World Data Collection Systems

    6. Best practice and guideline reviews in real-world research

    7. Statistical Approaches to real-world Research.

    This collection is led by the Editor-In-Chief, Professor David Price, Founder and Head of The Observational and Pragmatic Research Institute, Observational and Pragmatic Research Institute, Singapore.

    Please submit your manuscript on our website, using the promo code NBAJN for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Real-world Asthma Management: A Spotlight on Pragmatic and Observational Research” Collection. We will be welcoming relevant Original Research, Reviews and Editorials up until the 30th of March 2025. Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.

     

     

     

    View all papers in this article collection

    Surgical interventions in heart valve replacement: Surgical and patient-reported outcomes

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Surgical interventions in heart valve replacement: Surgical and patient-reported outcomes” in Pragmatic and Observational Research edited by our Editor-in-Chief, Professor David Price.

    In this Article Collection, Pragmatic and Observational Research hopes to shed light on the real-world effectiveness and key consideration surrounding surgical approaches to heart valve replacement, aftercare considerations, and outcomes. An emphasis will be placed on surgical outcomes, trials comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR), morbidity, mortality, bleeding complications and longer-term efficacy. This collection seeks to identify drivers of progress, key barriers and real and potential solutions for clinicians and patients. The journal will pursue scholarly leadership on novel approaches within these sub-specialties. The Editors will consider Reviews, Original Research, Editorials and Reports.

    Upon submission, please use the promo code WOYHX to indicate that your manuscript will be considered for this Article Collection. The deadline for manuscripts is August 31st, 2024.

    For any enquiries, please email Jermaine Wilcock, Commissioning Editor at [email protected]

    View all papers in this article collection

    Psychology Research and Behavior Management

    Advancing global addiction neuroscience in the genomic era

    Dove Medical Press is pleased to invite you to submit your research to the upcoming Article Collection “Advancing global addiction neuroscience in the genomic era” organized by Guest Advisor and Editorial Board Member Professor Kenneth Blum in Psychology Research and Behavior Management.

    Addiction neuroscience is a multidisciplinary field aimed at unraveling the neural mechanisms underlying addictive behaviors, including eating disorders and behavioral addictions. Numerous neurotransmitters and second messengers contribute to overall well-being and their intricate interactions regulate the controlled release of dopamine at post-neuronal sites, particularly at the nucleus accumbens, commonly referred to as the brain's reward center. In 1995, Kenneth Blum introduced the concept of 'Reward Deficiency Syndrome’ (RDS) to highlight hypofunctionality of the brain reward circuits, clinically manifested as diminution of drives and of capacity to experience pleasure.

    Nowadays, it is widely recognized that hypodopaminergia, either acquired and/or influenced by genetic predisposition, contributes to the development of RDS. Thus, people afflicted with RDS might turn to addictive substances in an ill-fated attempt to alleviate their symptoms due to the drugs offering temporary relief from the reward deficits. Yet the ongoing use of such substances exacerbates the deficits over time, subsequently amplifying reward deficiency and stress levels. Moreover, RDS is exacerbated by negative emotions, triggering epigenetic changes like methylation on chromosomal histones, resulting in substantial disruption of gene expression. One potential solution to such deepening distress is engaging in positive and nurturing behaviors that bring about beneficial effects on gene expression and contribute to a healthier reward circuitry. The present Article Collection aims to curate high-quality manuscripts pertaining to addiction neuroscience including relevant genetic and epigenetic factors.

    Importance:

    In the United States alone, opioid-induced fatal overdoses claim the lives of over 100,000 individuals a year. Globally, around 800 million people exhibit addictive behaviors or RDS, necessitating innovative thinking to address this alarming concern. We firmly believe that early detection of preaddiction traits through tools such as genetic testing is paramount for potential preventive strategies. Shifting the focus from merely prescribing medications e.g., medication assisted therapy for opioid use disorder towards restoring "dopamine homeostasis,” that is to say, “hedonostasis,” may be a complementary approach. While articles aligned with these concepts are of utmost priority, we also encourage the exploration of other pertinent topics within this realm of addiction neuroscience.

    Topics that fit within this scope include, but are not limited to:

    • Clinical outcome studies with interventions
    • Gene-environmental studies related to addictive behaviors
    • Substance Use Disorders
    • Behavioral Addictions
    • Preaddiction
    • Neuroepigenetics
    • Nutrigenomics
    • Preventive strategies
    • Genetic assessment tools
    • Recovery aspects
    • GWAS
    • Candidate gene approaches
    • mRNA profiling studies
    • Micro-RNA and addiction
    • Biomarkers for addiction
    • Gene therapy approaches
    • Genetic edits of reward genes
    • Comorbidity across all psychiatric disorders
    • Neuroplasticity
    • Personalized addiction medicine

    Types of articles

    • Original research
    • Systematic review
    • Expert opinion
    • Editorial
    • Letters to editor
    • Case study

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 1 July 2024.

    Please submit your manuscript on our website, quoting the promo code MEZFB to indicate that your submission is for consideration in this Article Collection.

    View all papers in this article collection

    Research and Reports in Tropical Medicine

    Chagas disease: transmission and treatment

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on "Chagas disease: transmission and treatment", edited by Editor-in-Chief Dr Mario Rodriguez-Perez in Research and Reports in Tropical Medicine.

    Upon submission, please use the promo code NGEUC for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the Thematic Series of "Chagas disease: transmission and treatment". The deadline for manuscripts is the 31st of May 2024.

    For any enquiries, please email Darcy Hodge, Commissioning Editor at [email protected]

    About the Thematic Series

    Chagas disease is a neglected tropical disease that continues to sweep across endemic areas, typically unnoticed. The asymptomatic nature of the disease can leave diagnosis rates low globally until individuals affected present with symptoms. As a consequence of this there are 6–7 million infections annually, with 10,000 deaths from the disease.

    How do we tackle the ongoing Trypanosoma cruzi infections and the subsequent symptoms? As part of this, research must determine the susceptibility to Trypanosoma cruzi amastigotes, including the heterogeneity resistance and receptor antagonists that affect the likelihood of infection.

    As researchers convene to develop a vaccine for Chagas disease, we hope to encourage publications that will lessen the "neglected" aspect of this tropical disease. Moreover, improving the understanding of the latent and chronic stages of the infection can pave the way to drug development, including practical molecular and chemotherapy-based techniques. Through this the disease may become treatable and preventable in the regions affected.

    The journal is seeking original submissions and review articles on the following topics related to Chagas disease:
    • Treatment of the chronic phase
    • Efficacy of current drug treatments
    • Molecular and chemotherapy-based techniques
    • Susceptibility to Trypanosoma cruzi amastigotes
    • Metabolic heterogeneity resistance Chagas disease development
    • Receptor antagonists for Chagas disease
    • Chagas disease vaccine development and potential side effects
    • Challenges in understanding immunity correlates
    • Transmission rates through intra-domiciliary, active, transplacental and vectorial transmission
    • Vector control
    • Sentinel animals in the epidemiology of Chagas disease
    • Eco-epidemiology of Chagas disease

    Submit your manuscript
    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    Current research and opinion on neglected helminthic infections

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Current research and opinion on neglected helminthic infections" in Research and Reports in Tropical Medicine.

    Hundreds of millions of people are infected with helminthic diseases, which occur widely, though not uniformly, throughout the tropical regions of planet Earth. Although simple sanitation and treatment measures have largely eliminated helminthic disease as a serious public health problem in the developed world, helminthic diseases continue to exert a very significant burden in many of the world's most underdeveloped countries and in most of the world's most seriously impoverished regions. Many helminthic diseases are being targeted for control or elimination by national and/or international health organizations; however, most are not treated everywhere they are endemic, and some are not targeted at all. Largely due to historic neglect, research advances in the field of helminthic disease lag behind those of many other infectious diseases and thus there are opportunities to make major and rapid advances in the field helminthic disease research by learning from advances made in more intensively studied areas of infectious disease.

    This Collection aims to encourage and support the publication of research reports and comments on issues surrounding not only the helminthic diseases that are targeted for control but also those, like mansonellosis and loiasis, which presently are not.

    The Collection welcomes all types of academic articles that are published in the journal, including short and full reports from research studies, reviews and opinion pieces that deal with the diagnostics, surveillance, epidemiology, treatment and control of all helminthic diseases. It also encourages the submission of all types of academic articles on the basic biology and taxonomy of helminthic parasites and vectors and all studies concerning interactions between the causative parasites and their host immune systems. We will also consider articles studies that model and infectious disease dynamics and control strategies and that calculate helminthic disease burdens.

    Keywords

    • Neglected Tropical helminthic diseases
    • Filariasis
    • Schistosomiasis
    • Soil transmitted helminths

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code NBOJU to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 31 October 2024.

    Guest Advisors

    James Lee Crainey, Oswaldo Cruz Foundation, Brazil

    [email protected]

    Dr. Crainey has studied filarial parasites and their vectors for more than 20 years. Initially working on the genomics of filarial vectors from Africa and Europe, Dr. Crainey began studying the filarial parasites and vectors of the Amazon after leaving London for Brazil at the end of 2011. Today Dr. Crainey´s research is focused on mansonellosis, the most prevalent filarial disease in the Brazilian Amazon region where he presently lives and works.

    Thuy-Huong Ta Tang, Instituto de Salud Carlos III, Spain

    [email protected]

    Dr. Thuy-Huong Ta Tang is a research scientist based at the Malaria and Neglected Tropical Disease Laboratory of the Instituto de Salud Carlos III, Madrid, Spain. Dr. Tang has worked and published on the subject of filarial disease research and has been involved in studies in both Latin America and Africa. Dr. Tang´s review papers on mansonellosis are among the most cited in the field.

    View all papers in this article collection

    Strategies against Neglected Tropical Viral Disease

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Strategies against Neglected Tropical Viral Disease" in Research and Reports in Tropical Medicine.

    Many tropical diseases have been historically neglected because of lower prevalence, social stigma and lack of profitability. These neglected tropical diseases are endemic to poor developing countries and often promote poverty through long-lasting impacts on quality of life. Dengue and Chikungunya are categorized by the WHO as neglected tropical virus diseases. Like these, other arboviral diseases including ZIKA and Japanese encephalitis also affect developing countries in tropical and sub-tropical regions. The poor are most affected by these arboviral diseases through long-lasting sequelae with huge impact on their socio-economic status. None of these viral diseases have been prioritized in global health programs. Accordingly, adequate effective therapeutic strategies are not available for their management. Thus, despite the debate about classification, all these viral diseases can be considered neglected tropical diseases, in order to attract attention for research and development to devise effective therapeutic strategies.

    With increased globalization, climatic change and adaptation of vectors, these arboviral diseases are no longer limited to tropical or sub-tropical countries. They have become global pathogens, and with higher adaptability the disease outbreaks have become more unpredictable. This has attracted wide research attention for development of therapeutic strategies. Efforts to develop new vaccines or specific antivirals have not been very successful. While higher mutability of these viruses has been a challenge for vaccine development, inadequate elucidation of virus-host targets has posed hurdles for effective antiviral development. Nonetheless, concepts of mutable vaccines and success of mRNA vaccines against COVID-19 have fueled hopes for effective vaccine development. Further, greater insights into the virus life-cycle and host response aided by computational techniques have revealed attractive drug targets for antiviral development. Also, there have been efforts to repurpose existing drugs and use herbal drugs/alternative systems for management of these diseases. Considering the fact that virus-induced inflammation is the primary cause of morbidity and mortality, approaches have also been investigated to modulate immune and inflammatory pathways to manage these viral diseases.

    Authors are encouraged to submit original research articles and reviews that focus on, but are not limited to, the following areas:

    • Updates in vaccine development against DENV/CHIKV/JEV/ZIKA virus
    • Vaccine design through in silico approach
    • Drug targets for therapeutic intervention against Dengue
    • Updates in drug development strategies against DENV
    • Therapeutic targets for CHIKV infection
    • Drug development strategies against CHIKV
    • Drug development strategies against JEV
    • Drug development strategies against Zika virus
    • Drug repurposing against DENV/CHIKV/JEV /ZIKA virus infection
    • Structure based drug design against DENV/CHIKV/JEV/ZIKA virus
    • Complementary therapy to manage DENV/CHIKV/JEV/ZIKA virus infection
    • Herbal drugs/alternative strategy to manage DENV/CHIKV/JEV/ZIKA virus infection
    • Immune-inflammatory signalling in viral infection
    • Modulation of host factors for management of viral disease


    Keywords

    • Tropical virus
    • Antiviral
    • Vaccine development
    • Neglected disease
    • Therapeutic strategy

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code STQQX to indicate that your submission is for consideration in this Article Collection.

    The deadline for submitting manuscripts is 30 September 2024.

    Guest Advisors

    Bharat Bhusan Subudhi, Siksha O Anusandhan Deemed to be University, India

    [email protected]

    Dr. Bharat Bhusan Subudhi has been working in the field of drug development for last 19 years. He has expertise in drug design, synthesis, drug product development, analysis and toxicological/pharmacological evaluations. Antiviral development is his major research focus.

    Soma Chattopadhyay, Institute of Life Sciences, India

    [email protected]

    Dr. Soma Chattopadhyay has more than 20 years experience in the field of virology/infectious disease biology involving HSV, CHIKV, JEV and SARS-CoV-2. She has expertise in molecular virology, animal models as well as development of viral antibodies. She has worked on drug repurposing and involved in the process for development of strategy for management of CHIKV, HSV, JEV and SARS-CoV-2.

    View all papers in this article collection

    Research and Reports in Urology

    Innovations in surgery for urological malignancies

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Innovations in surgery for urological malignancies", organized by Guest Advisor Guglielmo Mantica in Research and Reports in Urology.

    Urology is one of the most varied and heterogeneous specialties in the field of surgery. The particular conformation of the genitourinary system means that urological pathologies may require endoscopic, open, laparoscopic, robotic and reconstructive surgery treatments. This variability in surgical approaches also applies to the field of treatment of genitourinary neoplasms, and often means that urology is among the first to be influenced by technological evolution in the surgical field. 

    For this reason, it is not difficult to understand how, in recent decades, urology has been one of the most innovative branches of the surgical field, in particular with the introduction of laparoscopy, robotic surgery, increasingly smaller endoscopes and powerful lasers. In recent years, the impact of new technologies has changed urological surgery and the surgical approach to tumors. 

    The most striking example is that of robotic surgery, which is rapidly replacing laparoscopic surgery and has reduced open approaches to a minimum number. Furthermore, the continuous technological updating with single port platforms, the new robots available on the market, but also the new support devices, suturing instruments and hemostatic agents, are increasingly pushing the limits of minimally invasive surgery. An example of this are the nerve – sparing techniques for radical prostatectomy (RARP), or the renal surgery increasingly aimed at partial nephrectomy (RAPN) even for large tumors. 

    Similarly, the increase in precision, ease of handling and caliber reduction of the endoscopes, together with the evolution of lasers, has also led to an increase in the number and quality of endoscopic treatments for genitourinary cancers. The benefits in this sense appear to be many: from obtaining en-bloc surgical specimens, which can be better assessed by the uro-pathologist, to the treatment of numerous tumors of the upper urinary tract (UTUC). 

    This progressive and rapid change is impacting not only the management of the patient himself but also the training of trainees and young surgeons. Innovations have been presented also in this field, in order to better train the future generations of uro-oncological surgeons. 

    In this special series we aim to provide an update of the current practical and technological innovations in the management of genitourinary neoplasms.

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 11 November 2024.

    Please submit your manuscript on our website, quoting the promo code FEZWX to indicate that your submission is for consideration in this Article Collection. Please note normal Article Processing Charges will apply.

    Guest Adviser

    Dr. Guglielmo Mantica

    Department of Urology, IRCCS Policlinico San Martino Hospital, Genoa, Italy

    Dr. Guglielmo Mantica received his medical degree in 2011 at University of Insubria-Varese and his degree in urology at University of Genova in 2018. In 2017-2018 he attended a fellowship at Tygerberg Hospital–Stellenbosch University (Cape Town, South Africa) where he was able to increase his skills and knowledge in trauma surgery, endourology and reconstructive surgery with special focus on penile transplantation. From 2018 to 2019 he had been a consultant at San Raffaele Hospital (Milan, Italy). He is currently a urology consultant at Policlinico San Martino Hospital–University of Genova (Italy).

    He has been an active member of urological societies since the beginning of his residency and he is currently a full member of EAU (European Society of Residents in Urology), YAU (Young Academic Urologists) Trauma and reconstructive urology group, associate panelist of EAU, Guidelines on Urological infections, and associate member of ESGURS (EAU Section of Genito-Urinary Reconstructive Surgeons).

    His main interests are minimally invasive urology (robotic surgery and laparoscopy), endourology, trauma and reconstructive urology. He is author of about 130 peer-reviewed articles in international journals and 7 book chapters.

     

    View all papers in this article collection

    Risk Management and Healthcare Policy

    Advancing Patient Safety Culture and Managing Healthcare Risks for Sustainable Healthcare

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Advancing Patient Safety Culture and Managing Healthcare Risks for Sustainable Healthcare", organized by Guest Advisors Prof. Hsin-Hung Wu, Dr. Chih-Hsuan Huang and Dr. Yii-Ching Lee in Risk Management and Healthcare Policy

    This Article Collection focuses on a critically important aspect of modern healthcare: “Advancing Patient Safety Culture and Managing Healthcare Risks for Sustainable Healthcare.” The evolving area of this proposal bridges the gap between patient safety, risk management, and sustainability in healthcare. As healthcare systems worldwide strive for patient-centered care, it has become crucial to recognize that a culture fostering patient safety and effective risk management strategies contributes significantly to the overall sustainability of healthcare institutions. 

    This topic’s relevance stems from the contemporary need for a safer and more efficient healthcare sector. With the rising complexity in healthcare processes, patient safety and risk management have become paramount. They form the bedrock for the trust patients place in healthcare systems. More so, effective management of these aspects often leads to significant cost savings, thereby promoting the sustainability of healthcare services. In a broader perspective, cultivating a patient safety culture and implementing comprehensive risk management plans contribute to the overall health outcomes and well-being of the society at large. 

    In the Collection within the ambit of the “Risk Management and Healthcare Policy” journal, we invite submissions encompassing our theme. Relevant subtopics include, but are not limited to, methods of enhancing patient safety culture, new and innovative approaches to healthcare risk management, the role of policy and leadership in promoting patient safety, and the influence of digital technology on patient safety and risk management. These themes explore the intersection between patient safety, risk management, and the overall sustainability of healthcare institutions. We welcome submissions of various article types, including original research articles, reviews, case studies, commentaries, and policy analyses. This Collection aims to stimulate informed dialogue, inform policy alterations, and inspire future research in these key areas of healthcare management. 

    Keywords

    • Patient Safety Culture
    • Healthcare Risk Management
    • Enhancing Patient Engagement in Healthcare
    • Healthcare Policy
    • Healthcare Quality Improvement

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 

    The deadline for submissions is 31 July 2024.

    Please submit your manuscript on our website, quoting the promo code NTEGW to indicate that your submission is for consideration in this Article Collection.

    Guest advisers

    Professor Hsin-Hung Wu, Department of Business Administration, National Changhua University of Education

    [email protected]

    Changhua, Taiwan Hsin-Hung Wu is a Professor at National Changhua University of Education (NCUE), Changhua, Taiwan since August 2006. Currently, he is Dean of College of Management at NCUE since September 2020. His research interests mainly focus on patient safety culture, dementia care and patient safety culture. He has published 220 journal papers since 1999

    Professor Chih-Hsuan Huang, Business School, Hubei University of Economics

    [email protected]

    Chih-Hsuan Huang received his PhD from the Business School in Brisbane, Australia. He is Associate Professor with the Business School at Hubei University of Economics. His research interests include patient safety, medical quality, and sustainable management. His research in these areas has appeared in a journal such as Asia Pacific Journal of Marketing and Logistics, Journal of Environmental Planning and Management, and Journal of Pediatric Nursing etc.

    Professor Yii-Ching Lee, Department of Health Business Administration, Hung Kuang University

    [email protected]

    Yii-Ching Lee is Assistant Professor at the Department of Health Business Administration at Hung Kuang University. His main areas of research interests are in medical quality, patient safety, rational bond, rational marketing, and hospital management.

    View all papers in this article collection

    Rethinking Public Health Approaches to Crisis Response: Putting People First

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Rethinking Public Health Approaches to Crisis Response: Putting People First", organized by Guest Advisors Prof. Susannah Mayhew, Dr. Luise Enria, and Dr. Alhaji N’jai in Risk Management and Healthcare Policy

    Recent decades have seen increasingly unpredictable outbreaks of zoonotic and emerging infectious diseases (such as SARS, Zika, Ebola, Covid), changing climate, widespread economic crises and regular outbreaks of violent conflict. The uncertainty of these crises makes it difficult to plan and meet the health needs of the populations facing them. Moreover, indigenous knowledge and the experiences and views of affected populations are rarely considered part of preparedness planning or crisis-response, despite being critical to it. Research on responses to epidemics highlights how a lack of community trust and involvement in formal response strategies undermines efforts to stop the spread of the disease and puts people in life-threatening positions. Experiences from agriculture show the importance of local engagement in decision-making when planning for climate-resilient livelihoods. These experiences provide critical learning to redefine our thinking on emergency responses and global health security. 

    Research has called for greater commitment to involving a variety of local first responders in public health crises as a key step to establishing the inclusive, trust-based decision-making critical for effective crisis response. However, there is little robust evidence from the health sector of “what works” or “why it works” for community engagement and involvement, the role of local knowledge, or how formal health sector and humanitarian crisis-response structures can support and sustain local action to safeguard health. Although guidelines exist on “risk communication and community engagement” they seldom detail genuinely participatory approaches or meaningful community-led action in shaping crisis-response and preparedness planning. Valuable local knowledge is therefore too often ignored. 

    This Collection welcomes submissions that detail actions, experiences, models, or mechanisms of the involvement of community members and local knowledge in responses to any clearly defined public health crisis. We welcome empirical data studies of any relevant study design, particularly those using participatory methods and those seeking to put local knowledge first. We especially welcome contributions led by authors from the global-South. 

    All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

    The deadline for submissions is 31 July 2024.

    Please submit your manuscript on our website, quoting the promo code EBOSK to indicate that your submission is for consideration in this Article Collection.

    Guest advisers

    Professor Susannah Mayhew, London School of Hygiene & Tropical Medicine

    [email protected]

    Susannah Mayhew is Professor of Health Policy, Systems and Reproductive Health at the London School of Hygiene & Tropical Medicine. Her research specialisations are in policy analysis, policy implementation, governance and accountability research – including community engagement; health systems and systems integration research (including in epidemic-response); and reproductive health and rights. She has led multi-partner research projects in numerous countries across sub-Saharan Africa and South East Asia. At present she works primarily in West and East Africa on cross-sectoral responses to climate and health challenges, including reproductive health and zoonotic outbreaks, with a focus on community involvement.

    Dr. Luisa Enria, London School of Hygiene & Tropical Medicine

    [email protected]

    Luisa Enria is Assistant Professor in Anthropology at the London School of Hygiene & Tropical Medicine. Her work applies approaches from medical and political anthropology to study how communities engage with, imagine and at times resist development and humanitarian interventions, with a particular focus on health emergencies. She worked as a social scientist on the Ebola vaccine trials in Sierra Leone as well as several projects on the political economy of emergency vaccine deployment, rumors in epidemics, assessing community engagement for vaccine campaigns in humanitarian settings and she has developed a training on citizen ethnography for Community Health Workers. She currently holds a UKRI Future Leaders Fellowship on the politics of knowledge in epidemic preparedness.

    Dr. Alhaji U. N’jai

    [email protected]

    Alhaji U. N’jai is Associate Professor in Immunology, Infectious Disease, Toxicology, environmental science, and Public Health at University of Sierra Leone with dual appointment at California University of Science and Medicine. He is also director of University of Wisconsin-Madison Global Health Institute’s One Health Center, West Africa. Dr. N’jai has a broad multidisciplinary research interest at the intersection of biomedical science (infectious disease, toxicology, immunology, genomics, systems biology), environmental science, epidemiology, One Health, anthropology, and indigenous African Knowledge systems. Since December 2014, he has led the Ebola control and infectious disease emerging in Africa (IDEA) research initiative in Sierra Leone resulting in international collaborative projects on Ebola and infectious diseases between University of Sierra Leone, University of Wisconsin-Madison, and University of Tokyo. Dr. N’jai is a principal investigator for Abbott Pandemic Defense Coalition (APDC) Acute Febrile Illness Surveillance in Sierra Leone. He is also the founder and chief strategist for Project 1808 and Koinadugu College. Dr. N’jai was deputy incident manager for Ebola in 2021 and currently serves as a senior technical advisor for the Directorate of Health Securities and Emergencies (DHSE) at Sierra Leone Ministry of Health as well as the chairman of the One Health Technical Working Group in Sierra Leone.

    View all papers in this article collection

    Substance Abuse and Rehabilitation

    Last laugh: dangers of nitrous oxide misuse

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Thematic Series on “Last laugh: dangers of nitrous oxide misuse”, edited by Editor-in-Chief Dr. Rajendra D. Badgaiyan in Substance Abuse and Rehabilitation.

    Upon submission, please use the promo code IOBXB for 20% off the advertised article processing charge and indicate that your manuscript will be considered for the Thematic Series of “Last laugh: dangers of Nitrous Oxide misuse”. The deadline for manuscripts is the 31 May 2024.

    For any enquiries, please email Darcy Hodge, Commissioning Editor at [email protected]

    About the Thematic Series

    Typical clinical use of nitrous oxide, otherwise known as laughing gas, is for sedation during painful procedures. However, in recent years the misuse of nitrous oxide as a recreational drug has become prominent, known for its instantaneous and pleasant effects. Less than pleasant, though, are the psychological and physical consequences of nitrous oxide misuse. Users may experience euphoria related to nitrous oxide use, but drug-induced psychosis, mood disorders, and traumatic brain injuries are equally as likely.

    Outcomes of misuse are not limited to the brain, as embolisms, neuropathy, myelopathy, esophagus damage and more are linked to nitrous oxide misuse. Moreover, constant inhalation of the substance may lead to vitamin deficiencies, leading to the body attempting to futilely compensate. The psychological “high” from nitrous oxide leaves individuals vulnerable to physical harm, as risk assessment falters, meaning injuries whilst intoxicated are common.

    How do we treat these psychological and physiological outcomes? Treatment can include counteracting the imbalances nitrous oxide leads to, successfully reducing side effects. For the behavior itself, research may branch out into other substances and apply effective treatments to nitrous oxide misuse. Moreover, psychological support may uncover the underlying reasons for misuse. This Thematic Series also seeks to investigate how to prevent nitrous oxide misuse as it rises in popularity as a substance, including risk factors leading to misuse, social factors affecting use, improving knowledge and more.

    The journal is seeking original submissions and review articles on the following topics related to nitrous oxide misuse and related issues:

    • Incidence of drug-induced psychosis
    • Relationship to later psychotic and mood disorders
    • Traumatic Brain Injury (TBIs) related to nitrous oxide misuse
    • Damage to the nervous system through myelopathy, neuropathy and more
    • Cardiovascular and respiratory side effects including embolisms, emphysema and more
    • Vitamin deficiencies and subsequent consequences
    • Self-injury through substance misuse
    • Treatment by countering physiological abnormalities
    • Tapering the addiction cravings and behavior using cobalamin injections
    • Efficacy of treatments for other substance misuse disorders to treat nitrous oxide misuse
    • Detection of risk factors for nitrous oxide misuse
    • Prevention through harm-reduction campaigns and information sharing

    Submit your manuscript

    https://www.dovepress.com/submit_step_1.php

    View all papers in this thematic series

    The Application of Clinical Genetics

    Genetics Disorders in Consanguineous Populations

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Genetics Disorders in Consanguineous Populations" in The Application of Clinical Genetics.

    Consanguineous marriages, which are unions between people who are closely related, have a long history in many cultures around the world. While such weddings occur in a variety of communities worldwide, they are especially widespread in some places where cultural, societal, and religious variables impact marital traditions. Consanguinity has important consequences for population genetic health since it increases the risk of inheriting genetic diseases. There has been a rise in interest and worry recently on the impact of consanguineous marriages on the prevalence and distribution of genetic disorders as well as the larger implications for clinical management, genetic counselling, and public health. 

    This Article Collection aims to highlight the complexities of genetic disorders in consanguineous populations and to spark discussion and action towards addressing the particular opportunities and challenges in this field. It is the result of collaborative efforts among researchers, healthcare professionals, policymakers, and community stakeholders, and it is composed of contributions from a wide range of disciplines. 

    With an emphasis on populations where consanguineous marriages are common, this Article Collection seeks to investigate the intricate relationship between consanguinity and genetic diseases. Understanding the impact of consanguinity on genetic disorders is crucial for informing public health policies, clinical management, and genetic counselling practices. Preferred article types for this collection include original research articles, review articles, case studies, and short reports. 

    This Collection will explore several aspects of genetic conditions in consanguineous populations through a multidisciplinary lens, including:

    1. Clinical symptoms

    2. Molecular processes

    3. Epidemiological trends

    4. Diagnostic hurdles

    5. Therapeutic strategies

    6. Public health consequences.

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 15 January 2025.

    Please submit your manuscript on our website, quoting the promo code TUCIO to indicate that your submission is for consideration in this Article Collection. Please note that articles submitted will be subject to the standard Article Processing Charge.

    Please contact Ashley Ambros at [email protected] with any queries and discount codes regarding this Article Collection.

    Guest Advisors

    Prof. Majid Alfadhel, Deputy Executive Director of King Abdullah International Medical Research Centre, Chairman of Genetics and Precision Medicine Department (GPM), Director of Medical Genomic Research Lab, King Saud Bin Abdulaziz University for Health Sciences

    [email protected]

    Dr. Muhammad Umair, Associate Research Scientist, Team Leader Functional Studies, King Abdullah International Medical Research Center (KAIMRC)

    [email protected]

    View all papers in this article collection

    Therapeutics and Clinical Risk Management

    Lymphoproliferation at the crossroad between hematology and immunology: molecular and clinical implications

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Lymphoproliferation at the crossroad between hematology and immunology: molecular and clinical implications" in Therapeutics and Clinical Risk Management.

    Lymphoproliferation, clinically expressed with lymphadenopathies, hepato-splenomegaly, or lymphoid organ infiltration, is a common feature of different diseases, ranging from infections to hematologic malignancies. In the recent years, there has also been an increasing interest in the impact of lymphoproliferative features in patients with inborn errors of immunity (IEI), as benign polyclonal lymphoproliferation is one of the leading signs in different IEIs, including the autoimmune lymphoproliferative syndrome and other immune dysregulation disorders. Moreover, the knowledge on lymphoproliferative malignancies israpidly progressing, with the increasing availability of new therapeutic regimens.

    Therefore, a deeper understanding of the diseases featured by lymphoproliferation is warranted, in order to improve the recognition and treatment of the main causes of lymphoproliferation, including IEIs and malignancies.

    This aim of this Article Collection is to offer an overview of lymphoproliferative diseases, considering the diagnostic aspect (with a specific focus on the new diseases associated with lymphoproliferation) and the therapeutic options in the setting of both polyclonal and malignant lymphoproliferation. Specifically, the possibility to have the contribution from both an immunological and onco-hematological point of view could significantly increase the impact of this Collection. This Article Collection will consider review papers and original research papers.

    Keywords

    • Lymphadenopathy
    • Inborn errors of immunity
    • Immune dysregulation
    • Lymphomas
    • Splenomegaly

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 30 November 2024.

    Please submit your manuscript on our website, quoting the promo code IHLGQ to indicate that your submission is for consideration in this Article Collection.

    Guest Advisors

    Giorgio Costagliola, Azienda Ospedaliero Universitaria Pisana (AOUP)

    [email protected]

    Medical doctor and researcher at the Pediatric Hematology and Oncology Department of the Azienda Ospedaliero Unviersitaria Pisana (AOUP), with a special focus on inborn errors of immunity. Junior member of the European Society for Immunodeficiencies and member of the Associazione Italiana Oncologia ed Ematologia Pediatrica (AIEOP) and Italian Primary Immunodeficiency network (IPINET).

    Rita Consolini, University of Pisa

    [email protected]

    Professor of Pediatrics at the University of Pisa, involved in teaching pediatric and immunology. Medical Doctor 1976 University of Pisa, Italy (pass with distinction). Expertise in Pediatrics (1979), Immunology (1982) and Haematology (1986). Member European Society for Immunodeficiencies (ESID), Associazione Italiana Oncologia ed Ematologia Pediatrica (AIEOP) and Italian Primary Immunodeficiency network (IPINET).

    View all papers in this article collection

    Machine Learning in the Realm of Therapeutics and Clinical Risk Management

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Machine Learning in the Realm of Therapeutics and Clinical Risk Management" in Therapeutics and Clinical Risk Management.

    Machine Learning (ML) and healthcare is one of the most interesting research topics in modern medicine, giving the opportunity to improve patient care, diagnosis, personalized treatment and risk management. The fast evolving of data analytics can improve the vast amount of health data analysis, aiming to improve outcomes, reduce costs and personalize healthcare. Giving the increasing use of healthcare systems that face aging populations, chronic disease and cost effective treatments, ML integration offers a hope, driving innovations of clinical care, research, and public health.

    The integration of machine learning (ML) in medicine revolutionizes healthcare by improving diagnostic accuracy, treatment personalization, risk management, and research. ML algorithms analyse large clinical datasets, identifying precise patterns and correlations for enhanced disease detection and understanding. Personalized treatment recommendations are made by analysing individual patient features, optimizing efficacy while minimizing adverse effects. ML’s predictive capabilities enable proactive risk management, predicting disease development and complications to preventive strategies. Additionally, ML drives rigorous medical research by identifying new associations and generating hypotheses from massive datasets.

    This Collection seeks to explore the impact of ML in healthcare, with contributions that explore the advancements, applications, analysis and case studies of ML in healthcare. We welcome submissions of original clinical research, but not limited to, ML’s role in diagnostics, personalized medicine, preventive healthcare, data in healthcare, clinical practices and technologies. Through this collection, we aim to encapsulate the current state, future directions, and broader implications of Machine Learning in the realm of Therapeutics and Clinical Risk Management.

    Keywords

    • Machine Learning
    • Healthcare Innovation
    • Personalized Medicine
    • Clinical Risk with Machine Learning
    • Clinical Data Mining

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code VZRCQ to indicate that your submission is for consideration in this Article Collection.

    Please note that any paper submitted is subject to the standard Article Processing Charge. Contact Zhiyuan Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

    The deadline for submitting manuscripts is 31 December 2024

    Guest Advisors

    Carlos Eric Galván-Tejada, Autonomous University of Zacatecas, Mexico

    [email protected]

    PhD. Carlos Eric Galván Tejada has excelled in merging computing with biomedicine, focusing on bioinformatics and clinical data analysis to develop non-invasive diagnostic tools for complex diseases using artificial intelligence and data science. His work has significantly advanced digital medicine and health, making notable contributions to the field through research, scientific dissemination, and collaborative projects. Galván Tejada has promoted interest in science among students and young people, emphasizing technology's role in medical practice evolution. His efforts have gained international academic recognition, evidenced by high-impact publications and active participation in health care innovation forums. Committed to education and research, he is a member of the National System of Researchers in Medicine and Health Sciences, continually pushing the boundaries of knowledge in biomedicine and medical technology.

    José M. Celaya-Padilla, Autonomous University of Zacatecas, Mexico

    [email protected]

    Acknowledgement: Valeria Maeda Gutiérrez, PhD, [email protected], Autonomous University of Zacatecas, Mexico. She would take on additional tasks and responsibilities for the Article Collection, similar to those of an advisor.

    View all papers in this article collection

    Older and newer players in the therapeutics of Cardio-Kidney-Metabolic syndrome

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Older and newer players in the therapeutics of Cardio-Kidney-Metabolic syndrome" in Therapeutics and Clinical Risk Management.

    Cardio-Kidney-Metabolic (CKM) syndrome has been recently recognized by the American Heart Association (AHA) as the close interplay between cardiovascular disease (CVD), chronic kidney disease (CKD) and metabolic risk factors, mainly diabetes mellitus and obesity. CKM syndrome has attracted scientific attention due to its growing prevalence worldwide, reaching pandemic dimensions, whereas, several newer and novel therapeutic agents, targeting various pathophysiological aspects of CKM syndrome, have emerged over the last years, such as sodium-glucose co-transporter-2 (SGLT-2) inhibitors, incretin-based agents, tirzepatide, finerenone, and many other. The aim of this Article Collection is to gather scientific evidence regarding the impact of newer therapeutic agents on various components of CKM syndrome, as adjunct to established treatment options.

    According to recent evidence from the United States, approximately 90% of the U.S. population appear to be at some stage of CKM syndrome. In addition, CVD still represents one of the leading causes of death worldwide, whereas it is also associated with substantial morbidity and healthcare costs. Based on evidence from the European Union, in 2021, more than 280 billion euros were spent for the therapeutic management of patients with some form of CVD, which was the leading cause of death, followed by cancer. Since there is an increasing prevalence of dysmetabolism, including diabetes mellitus and obesity, it is of utmost importance to early identify specific patients’ phenotypes and apply appropriate therapeutic strategies against the progression of CKM syndrome, to minimize relevant morbidity and of course mortality.

    Sub-topics of specific interest

    • Older antidiabetic drug classes and CKM syndrome
    • SGLT-2 inhibitors and CKM syndrome
    • Incretin-based agents and CKM syndrome
    • Novel anti-obesity drugs and cardio-renal implications
    • RAAS blockers and CKM syndrome
    • Implications of artificial intelligence as a therapeutic tool in CKM syndrome
    • Novel technologies in the therapeutic management of patients with CKM syndrome

    Preferred article types

    • Original articles
    • Systematic reviews and/or meta-analyses
    • Narrative reviews

    Keywords

    • Cardiovascular disease
    • Chronic kidney disease
    • Diabetes mellitus
    • Obesity
    • Therapeutics

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    Please submit your manuscript on our website, quoting the promo code ZDHVP to indicate that your submission is for consideration in this Article Collection.

    Please note that any paper submitted is subject to the standard Article Processing Charge. Contact Zhiyuan Zhang at [email protected] with any queries and discount codes regarding this Article Collection.

    The deadline for submitting manuscripts is 31 December 2024.

    Guest Advisors

    Manfredi Rizzo, University of Palermo, Italy

    [email protected]

    Prof. Rizzo is Professor of Internal Medicine at the School of Medicine, University of Palermo, Italy with a joint position as Head of the Unit of Diabetes and Cardiovascular Prevention at the University Hospital (Policlinic) of Palermo. He is also the Head of the Cardiometabolic Research Laboratory of the Department of Internal Medicine at the University of Palermo.

    Dimitrios Patoulias, Aristotle University of Thessaloniki, Greece

    [email protected]

    Dimitrios Patoulias, MD, MSc, PhD, FRCP(Lond), FNEASO, FNSCOPE, is an Internal Medicine physician with special interest in Cardiometabolic Medicine. He has authored or co-authored >250 peer-reviewed articles indexed in PubMed database, mainly in the field of Cardiometabolic Medicine. His current h-index is 18.

    View all papers in this article collection

    Unlocking the Secrets of the Nervous System: Unveiling the Biomarkers of Neurological Diseases

    Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Unlocking the Secrets of the Nervous System: Unveiling the Biomarkers of Neurological Diseases" in Therapeutics and Clinical Risk Management.

    This Collection aims to compile groundbreaking research and insights into the biomarkers associated with neurological diseases. Biomarkers play a crucial role in understanding the pathophysiology of neurological disorders, aiding in early diagnosis, prognosis prediction, and monitoring the efficacy of therapeutic interventions. The gathered articles will explore the diverse range of biomarkers, from genetic and protein markers to imaging and clinical biomarkers, that are instrumental in unravelling the complexities of neurological diseases.

    The importance of identifying and understanding biomarkers in neurological diseases cannot be overstated. These markers provide valuable information about the disease process, ultimately facilitating personalized medicine approaches and more effective treatments. By elucidating the intricate relationship between biomarkers and neurological diseases, we can unlock new avenues for research and intervention, thereby improving patient outcomes and contributing to the global fight against these debilitating conditions.

    We invite authors to submit original research articles, comprehensive reviews, and perspective pieces that delve into the various aspects of biomarkers in neurological diseases. Submissions should focus on topics such as the identification and validation of new biomarkers, the role of biomarkers in disease progression and treatment response, and the challenges and opportunities in translating biomarker research into clinical practice. Through this article collection, we aim to create a valuable resource for researchers, clinicians, and anyone with an interest in the dynamic field of neurological diseases and their associated biomarkers.

    Keywords

    • Neurological Diseases
    • Biomarkers
    • Prognosis
    • Disease Monitoring
    • Clinical Applications

    All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

    The deadline for submitting manuscripts is 31 December 2024.

    Please submit your manuscript on our website, quoting the promo code RFPYX to indicate that your submission is for consideration in this Article Collection.

    Guest Advisor

    Xiaoqiao Dong, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine

    [email protected]

    Dr. Xiaoqiao Dong holds a doctoral degree and is a chief physician and master's degree supervisor. He specializes in clinical work related to traumatic brain injuries, spontaneous cerebral hemorrhage, and subarachnoid hemorrhage, and conducts basic and clinical research on acute brain injuries. Dr. Dong has participated in more than 30 projects, published over 70 SCI articles, received 9 awards for scientific and technological progress, and obtained 3 invention patents.

    View all papers in this article collection